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Abstract 
Decidualization denotes the transformation of endometrial stromal cells into 
specialised secretory decidual cells, a process indispensable for pregnancy. 
Decidualization of the human endometrium is not dependent on an implanting embryo 
but initiated during the mid-luteal phase of the cycle by elevated progesterone levels 
and local paracrine signals. Consequently, decidualization is a reiterative process 
directly linked to menstrual repair and rapid oestrogen-dependent growth. The 
extraordinary regenerative ability of the endometrium depends on endometrial 
mesenchymal stem cells (eMSCs) with inexhaustible self-renewing and differentiation 
capacity. Cyclic regeneration and rapid proliferation also render the stroma 
intrinsically heterogeneous, harbouring not only eMSCs but also endometrial transit 
amplifying (eTAs), mature, and senescent fibroblast subpopulations. Several lines of 
evidence presented in this thesis demonstrated that imbalance in these 
subpopulations is associated with reproductive failure. Quantification of clonal 
(eMSCs/eTAs) cells in mid-luteal biopsies obtained in consecutive cycles revealed 
increased levels in the 2nd biopsy obtained from miscarriage but not infertile patients, 
indicating that the tissue response to injury (i.e. the 1st biopsy) differs between patient 
groups. Further, in-depth characterization of primary stromal cell cultures prior to in 
vitro fertilisation (IVF) treatment showed that disordered temporal changes in the 
secretome of decidualizing cultures are associated with subsequent implantation 
failure. Additional characterization of perivascular eMSCs, which drive endometrial 
regeneration, highlighted the unique properties of these cells in terms of gene 
expression, metabolism, clonogenic and angiogenic potential. Importantly, eMSCs 
also formed 3D structures that resemble the uterine mucosa when cultured in 
Matrigel. These novel organoids termed endometrial regenerative bodies (ERBs), 
epithelialize when co-cultured and decidualize in response to differentiation cues. In 
sum, I provided evidence that dyshomeostasis between stromal subpopulations, 
which may be caused by eMSCs deficiency or dysfunction, precedes reproductive 
failure. Further, the ability of eMSCs to form ERBs provides a powerful new tool to 
study physiological and pathological implantation events in vitro.  
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Chapter 1  
2 
1 Introduction 
1.1 The human uterus 
The human uterus has a single cavity formed by the fusion and canalization of 
basement membranes of paramesonephric (Müllerian) ducts around eight weeks of 
gestation. Intensive growth of uterus occurs between 16 to 24 weeks (Figure 1.1). The 
mesenchyme then differentiates into stroma and myometrium around 22 weeks of 
gestation (O'Rahilly, 1983, O’Rahilly, 1989). Uterine adenogenesis or uterine glands 
formation from the epithelial lining of the uterus begins in the prenatal period. A 
defined lumen is formed in fetal urethra, vagina, uterus, and Fallopian tubes by around 
14 weeks of gestation (Terruhn, 1980). Further glandular cell proliferation is initiated 
after the birth, continued till puberty when glands extend from luminal epithelium to 
the myometrium (O’Rahilly, 1989, Shelton et al., 2012).  
Placental enzymes involved in steroid production and metabolism increase the 
circulating levels of progesterone and oestrogen resulting in fetal exposure to steroid 
hormones. (Hill et al., 2010). Following birth, the levels of progesterone drop rapidly. 
Though the fetal endometrium is exposed to greater levels of steroid hormones than 
maternal tissues, it lacks decidual transformation (Brosens et al., 2015). Proliferative 
activity of fetal endometrium during the third trimester of pregnancy was found to be 
caused by placental hormones rather than ovarian hormones (Spivack, 1934). A 
classical study by Ober and Bernstein detailed the changes in the endometrium and 
ovaries from 169 fetal autopsies. The endometrium in these 169 foetuses could be 
classified as 68% as proliferative, 27% as secretory and 5% as progestational. More 
than half of the proliferative group demonstrated a resting phase whereas most of the 
secretory group showed an early secretory phenotype of subnuclear vacuolation. The 
progestational changes were similar to decidualization or menstrual breakdown (Ober 
and Bernstein, 1955). Increasing evidence of neonatal uterine bleeding indicates that 
3 
the stromal compartment of fetal endometrium becomes responsive to hormonal 
action during latter stages of pregnancy (Brosens et al., 2015). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Fetal Müllerian ducts fuse to form uterus. 
Urogenital ridge is bipotential, in the absence of sex-determining Y chromosome, 
Wolffian duct degenerates. The Müllerian ducts fuse to form a simple columnar 
epithelial tube that eventually differentiates into the Fallopian tubes, uterus, cervix and 
the upper portion of the vagina. Figure adapted from (Teixeira et al., 2008) 
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1.2 The human endometrium 
Human endometrium, the inner lining of the uterus, is a complex and dynamic tissue 
as it undergoes cyclical proliferation, decidualization, shedding, restoration and 
regeneration for over 400 cycles throughout the reproductive lifespan of women. 
Every cycle is tightly regulated by ovarian steroid hormones, oestrogen and 
progesterone (de Ziegler et al., 1998, Jabbour et al., 2006). Following menstruation 
or parturition, the endometrium displays a controlled tissue remodelling, resulting in a 
scar-free tissue regeneration. (Salamonsen, 2003, Evans and Salamonsen, 2011).   
1.3 Structure of the human endometrium  
The endometrium is composed of various cell types including epithelial cells, stromal 
fibroblasts, leukocytes and endothelial cells. Epithelial cells within the endometrium 
are classified as either luminal or glandular epithelium. The endometrial stroma 
consists of extracellular matrix and fibroblasts, which differentiates during the 
decidualization process under the influence of progesterone and local paracrine 
signals (Gellersen & Brosens). The stroma is supported by spiral arteries and 
harbours resident immune populations such as macrophages and uterine natural killer 
cells (uNK) (Beier and Beier-Hellwig, 1998, Diedrich et al., 2007, Bulun and Adashi, 
2003). The vascular compartment of the endometrium is characterised by spiral 
arteries surrounded by perivascular cells (Gargett et al., 2012a).  
Morphologically, the endometrium can be divided into the functional and basal layers. 
The functionalis responds to hormonal stimuli and sloughs off after decidualization in 
response to falling progesterone levels in a non-conception cycle (Ferenczy and 
Bergeron, 1991). The functionalis also acts as the site of embryonic implantation. 
Ovarian hormones have a strong influence on cellular functions and morphology 
throughout the reproductive age of a woman resulting in cyclical regeneration and 
remodelling (Kabir-Salmani et al., 2008).  
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The basalis layer is the origin of regeneration following the menstrual destruction of 
the functional layer (Padykula et al., 1984). The basal layer is permanent and contains 
the origins of endometrial glands enclosed by dense stroma (Spencer et al., 2005). 
This layer is not clearly bifurcated in non-menstruating species (Gargett et al., 2012b). 
The histological organisation is shown in Figure 1.2.  
A normal menstrual cycle lasts 28 days, though the length varies up to 35 days. The 
first day of bleeding is considered day 1 of the cycle. Conventionally, the menstrual 
cycle is divided into three phases based on uterine cycle as (i) proliferative (ii) 
secretory phase and (iii) menstrual phase; based on ovarian cycle as (i) Follicular 
phase and (ii) luteal phase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Histological organisation of endometrium 
(Image is taken from www.proteinatlas.com) 
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1.4 Proliferative phase 
The proliferative phase is marked by the regeneration of the functionalis under the 
influence of oestrogen, secreted by the developing follicle. During the secretory 
phase, endometrial stromal cells undergo a transformation, acquiring a secretory 
phenotype due to progesterone and oestrogen produced by corpus luteum. The 
menstrual phase is denoted by a sudden fall of oestrogen and progesterone due to 
degeneration of the corpus luteum, causing the functional layer to collapse. 
Endometrial responses to these ovarian hormones are achieved by specific nuclear 
hormone receptors present in both epithelial and stromal cells of the endometrium, 
along with growth factors and angiogenic factors (Sivridis and Giatromanolaki, 2004). 
The menstrual cycle is a tightly controlled cellular remodelling process driven by 
complex interactions between the hypothalamus, pituitary, ovaries and endometrium. 
The hypothalamus produces gonadotropin-releasing hormone(GnRH), which 
regulate follicular stimulating hormone (FSH) and luteinizing hormone (LH) secretion 
from the pituitary. These hormones act on the ovaries and result in follicular 
maturation, ovulation and corpus luteum formation (Figure 1.3).  
Oestrogen produced in the ovaries leads to endometrial proliferation and extensive 
angiogenesis. Oestrogen levels increase during two occasions during the menstrual 
cycle, firstly during late follicular phase before ovulation and LH surge, and secondly 
during the mid-luteal phase. The effect of oestrogen is exerted through oestrogen 
receptors alpha (ERα) and beta (ERβ), encoded by ESR1 and ESR2, respectively. 
Oestrogen receptors are expressed by endometrial stromal cells, glandular epithelial 
cells, and perivascular stromal cells.  
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Figure 1.3. Phases of the menstrual cycle. 
Sequential rise and fall of pituitary hormones regulate ovarian oestrogen and 
progesterone production that control the progression of the endometrium through the 
menstrual cycle. 
  
8 
1.5 Secretory Phase 
Progesterone concentrations increase during the secretory phase and peak around 
the mid-secretory phase. Progesterone action is exerted via two of its receptor 
isoforms: progesterone receptor A (PR-A) and progesterone receptor B (PR-B), both 
encoded by single gene PGR. Progesterone limits the mitogenic action of oestrogen 
by causing differentiation of the stromal cells. Oestrogen and progesterone control 
PGR and its receptor isoforms. Progesterone is indispensable for the transformation 
of endometrial stromal cells for achieving pregnancy.  
During this progesterone-induced phase of the cycle, there is an influx of immune 
populations including leukocytes, macrophages and neutrophils. In addition to this, 
vasoconstriction of spiral vessels occurs along with an increase in prostaglandin 
synthesis and an induction of vascular endothelial growth factor (VEGF) expression 
(Irwin et al., 1996). Upon progesterone withdrawal, chemokines and cytokines 
secreted by resident cells and immune cells cause breakdown of the ECM via 
secretion of various proteases including matrix metalloproteases (MMPs) and tissue 
inhibitor of metalloproteinases (TIMPs) (Critchley et al. 1999). The tissue damage 
during menstruation and the high influx of immune reactive cells are analogous to 
inflammation. 
1.6 Decidualization  
The hallmark of the menstrual cycle is the process of decidualization during which the 
stromal cells undergo morphological and physiological differentiation. Decidualization 
is induced during the mid-secretory phase of the menstrual cycle and is driven by a 
post-ovulatory rise in ovarian progesterone and intercellular cyclic adenosine 
monophosphate (cAMP) levels. Decidualization of endometrial stromal cells (ESCs) 
and progenitor cells is crucial for proper implantation as well as the onset of 
menstruation. The endometrial stromal cells differentiate into specialised secretory 
phenotype to provide a nutritive and immune tolerant matrix for embryo implantation 
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and placental formation (Brosens et al. 2002). In humans, the process of 
decidualization is maternally controlled and does not require any signal from the 
embryo. This differentiation process is pronounced in species where there is deep 
trophoblast invasion that breaches the maternal blood vessels (Ramsey et al. 1976, 
Brosens et al. 2002). 
The process of decidualization starts after ovulation around day 18 with the formation 
of oedema in the upper stromal layer. The stromal cells surrounding the spiral arteries 
show cellular morphology transformation on day 23. By day 25, the oedema is 
replaced by large stromal cells with large nuclei (Rock and Bartlett, 1937, Gellersen 
and Brosens, 2014a).  
Decidualization is associated with striking morphological changes. The frequent 
elongated fibroblastic structure changes as the nucleus become circular, the number 
of nucleoli increases, rough endoplasmic reticulum and Golgi bodies dilate and lipid 
droplets and glycogen accumulates within the cytoplasm (Kajihara et al. 2014).  
Prolactin (PRL) and Insulin-like growth factor binding protein-1 (IGFBP-1) are used as 
a marker of stromal cell differentiation cultured in vitro. Amniotic fluid is reported to 
contain massive amounts of PRL with maximum levels between 18-26 weeks of 
pregnancy which is produced by the decidua (Golander et al., 1978, Riddick et al., 
1978). PRL production by decidualizing stromal cells starts before pregnancy (around 
day 21)  and increases throughout the pregnancy (BRAVERMAN et al., 1984). IGFBP-
1 peaks before PRL by around 16 weeks of pregnancy (Wathen et al., 1993). IGFBP-
1 regulates the bioavailability of IGF-1, as this balance is crucial for normal growth 
and development of the foetus (Carter et al., 2004).   
1.7 Role of decidualization 
Decidual cells provide a better environment for trophoblast invasion compared to non-
decidual cells (Gonzalez et al., 2011). Time-lapse imaging studies reveal that decidual 
stromal cells have a tendency to be migratory and migrate toward to the implanting 
10 
competent embryo (Weimar et al., 2012). This process of migration and attraction 
towards competent embryo is achieved by Elastin microfibril interfacer 1, a connective 
tissue glycoprotein produced by decidual stromal cells (Spessotto et al., 2006) and 
PDGF-AA secreted by trophoblast cells (Schwenke et al., 2013).  
Endometrial stromal cells mount a tailor-made response to the single implanting 
embryo. This selection process either allows or rejects the implanting embryo 
(Teklenburg et al., 2010a, Brosens et al., 2014a). Flushing of the uterine lumen with 
conditioned medium of competent human embryos (i.e. resulting in a successful 
pregnancy following transfer) induces a highly specific gene network enriched in the 
major implantation and metabolic genes. By contrast, flushing with conditioned 
medium of poor quality human embryos triggers a stress response in the murine 
uterus (Brosens et al., 2014a). These observations complement other studies 
demonstrating that both positive and negative embryo selection takes place at 
implantation (Brosens et al., 2014a).  
Decidualized stromal cells act as major gatekeepers and modulators of immune cells 
in the maternal-fetal interface. The decidua traps the uterine dendritic cells (uDCs) 
thus preventing them from migrating into lymph nodes for antigen presentation to 
cytotoxic T cells (Volchek et al., 2010). Further T cell tolerance is achieved by 
silencing decidual genes that encode for chemokines, by expressing lectin (galectin-
1)(Barrientos et al., 2014, Bevan et al., 1994) and enzyme (indoleamine 2,3-
dioxygenase) that suppress T cell action (Kudo et al., 2004).  
1.8 Reprogramming during decidualization 
Following decidualization, stromal cells undergo cellular reprogramming by which 
these cells acquire specialist functions that are needed for pregnancy. Several of the 
factors produced by these cells such as tissue plasminogen activator (tPA), 
upregulation of tissue factor (TF), the primary initiator of coagulation and plasminogen 
activator inhibitor 1 (PAI1) are necessary for maintaining tissue homeostasis 
11 
(Lockwood et al., 1998, Lockwood et al., 1993, Lockwood et al., 1994)  and vascular 
integrity. An important function of decidual cells is to confer resistance to 
environmental stress signals. This is achieved by silencing specific stress signalling 
pathways such as JNK (Leitao et al., 2010, Leitao et al., 2011); upregulation of various 
free radical scavengers (Sugino et al., 2002a, Sugino et al., 2002b), and silencing of 
circadian oscillations, leading to a periodic decidual gene expression. 
Marked epigenetic and transcriptional reprogramming underpins the acquisition of the 
decidual phenotypes as shown by some genome-wide studies (Lucas et al., 2015, 
Grimaldi et al., 2012, Popovici et al., 2000, Carson et al., 2002, Riesewijk et al., 2003). 
Even short-term exposure to deciduogenic cues can cause massive changes in gene 
expression (Takano et al., 2007). These changes vary in an exemplary manner as the 
differentiation proceeds, to be precise, the initial proinflammatory response created 
due to decidualization shifts to anti-inflammatory response in the course of 
differentiation (Salker et al., 2012a). The transcriptional changes are translated into 
marked protein alterations that affect most cellular compartments/functions including 
cell structure and motility, followed by endocytosis/exocytosis, protein biosynthesis, 
DNA repair, and mitosis (Paule et al., 2010).  
1.9 Progesterone signalling 
Ovarian progesterone is essential for female sexual characteristics, ovulation, 
implantation and maintenance of pregnancy throughout the gestation period (Lydon 
et al., 1995). PR-A is less transcriptionally active when compared to PR-B, but plays 
a major role functionally in the decidualization process, a notion supported by the 
finding that the endometrium of PR-A knockout female mice cannot mount a decidual 
response (Lydon et al. 1995). Progesterone binding cause a conformational change 
of the receptor resulting in receptor phosphorylation, dimerization and sumoylation. In 
fact, global cellular hypo sumoylation upon decidualization prevents PR-A 
sumoylation upon ligand binding and transforms the receptor from a weak to a strong 
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transactivator (Jones et al., 2006a). The activated receptor binds to promoter regions 
of progesterone-responsive genes, and recruit co-activators, co-repressors and basal 
transcriptional machinery (Rowan & O’Malley, 2000; Wagner et al.,1998). Over recent 
decades this ‘classical’ model of progesterone action has become more complex by 
the discovery of interacting transcription factors (Christian et al., 2002; Richer et 
al.,1998; Takano et al., 2007), targeting miRNAs (Lam et al., 2012), and rapid non-
genomic progesterone signalling (Moussatche and Lyons, 2012). In addition to 
ovarian steroid hormone receptors, the androgen-, glucocorticoid- and 
mineralocorticoid receptors all have been implicated in the decidual transformation of 
HESCs, in vitro and in vivo (Cloke et al., 2008). 
The action of progesterone is exerted via its nuclear receptors PR-A and PR-B either 
by activation or repression of target genes (Kastner et al., 1990). PR-A differs from 
PR-B by 164 N-terminal amino acids, but both isoforms display equal ligand and DNA 
binding affinities (Li and O'Malley, 2003). PR-A is a dominant inhibitor of PR-B and 
other nuclear receptors, whereas PR-B has more transcriptional activity compared to 
PR-A (De Mattos et al., 2004). PR-A and PR-B double knockout mice display a failed 
decidual response and subsequent impaired implantation (Brosens et al., 1999, 
Conneely et al., 2001). Isoform regulation is essential as its perturbation is linked 
endometrial neoplasia (Arnett-Mansfield et al., 2001). Thus, PR-A and PR-B are 
tightly regulated in a spatiotemporal manner throughout the menstrual cycle. PR-A is 
expressed by stromal cells throughout the cycle whereas its expression in epithelial 
cells is restricted to the proliferative phase. PR-B is expressed widely in epithelial and 
stromal cells during proliferative phase while decidualization downregulates its 
expression (Mangal et al., 1997, Mote et al., 2000, Mulac-Jericevic and Conneely, 
2004). 
Apart from progesterone receptors, micro RNAs (Lam et al., 2012) and promotor 
regulating RNAs (Lee, 2012) also play a role in governing the action of progesterone. 
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Progesterone binding to PR results in a conformational change which induces 
phosphorylation, chaperone proteins dissociation, dimerization of receptor, specific 
progesterone response elements (PREs) binding to target genes, and transcription 
machinery recruitment. Various coactivators and corepressors are involved in 
regulation of these steps (Wagner et al., 1998, Shibata et al., 1996). 
1.10 Cyclic adenosine monophosphate (cAMP) signalling 
Some stimulatory and inhibitory signals are involved in the highly timed and spatial 
differentiation process of decidualization. The major stimulatory signals arise from the 
ovarian progesterone and intercellular cAMP. Cyclic AMP is a secondary messenger 
molecule that is controlled through ligand binding to the G-protein coupled receptor 
(GPCR). Gα, a subunit of trimeric Gαβγ of the G protein, is released upon ligand 
binding and regulates the activity of adenylyl cyclase. Adenylyl cyclase synthesises 
cAMP from adenosine triphosphate (ATP). Cyclic AMP then binds to the regulatory 
subunits of protein kinase A (PKA), a cytoplasmic enzyme, which causes the release 
of catalytic subunits. These catalytic subunits bind to the nuclear targets of cAMP 
response element binding protein (CREB) and related cAMP response element 
modulator (CREM) (Skålhegg & Taskén. 2000). Phosphorylated of CREB/CREM 
along with co-activator CREB binding protein (CBP) binds to cAMP responsive 
element (CRE) leading to expression of the target genes. During decidualization, 
GPCR is activated by binding of luteinizing hormone/human chorionic gonadotropin 
(LH/hCG), corticotrophin releasing hormone (CRH), relaxin (RLX) and prostaglandin 
E2 (PGE2) (Tseng et al. 1992, Tang & Gurpide 1993, Frank et al. 1994, Ferrariet al. 
1995).  
 Expression of prolactin (PRL) during late secretory phase is routinely used as a 
marker for decidualization as its expression is driven by the convergence of cAMP 
and progesterone pathways. The decidual PRL (dPRL) promoter varies from the 
pituitary PRL promoter (Berwaer et al. 1994, Gellersen et al. 1994) and contains a 
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binding site for CCAAT/enhancer-binding protein β(C/EBPβ), which is known to be 
crucial for cAMP-induced decidualization.  C/EBPβ interacts with FOXO1a protein and 
activates the decidual PRL promoter. Both of these proteins were shown to 
accumulate in the nuclei of the decidualized stromal cells (Pohnke et al. 1999, 
Christian et al. 2002). In vitro decidualization experiments also showed that signal 
transducer and activator of transcription 5 (STAT5) also activates the dPRL promoter 
region (Mak et al. 2002). 
1.11 Progesterone and cAMP signalling 
Primary endometrial stromal cells express all components of progesterone signalling 
pathway, but only a few genes are acutely responsive to progesterone on its own. 
Convergence of cAMP and progesterone signalling pathways is required for complete 
decidualization (Figure 1.4). This convergence is accomplished via a range of 
mechanisms including post-translational modifications, epigenetic alterations and the 
action of decidualization specific transcription factors (Gellersen and Brosens, 
2014a). Pre-treatment of endometrial stromal cells with cAMP followed by 
progesterone promotes the activity of the dPRL promoter and protein expression of 
PRL (Brosens et al. 1999). This suggests that cAMP sensitises the ESCs to 
progesterone via regulation of the PKA pathway, modifying PR function (Gellersen & 
Brosens, 2003). Thus, 8-bromo-cAMP, an analogue of cAMP is used along with 
medroxyprogesterone acetate (MPA), to differentiate stromal cells into decidualized 
cells, in vitro. 
cAMP enhances the hormone-dependent transcriptional activity of PR via disruption 
of PR and its corepressors such as nuclear receptor co-repressor 1 and nuclear 
receptor co-repressor 2, and increased interaction with coactivators such as Proto-
oncogene tyrosine-protein kinase Src and CREB-binding protein (Rowan et al., 2000, 
Wagner et al., 1998). Cyclic AMP is activated via PKA-dependent and independent 
pathways, also resulting in increased expression of transcription factors such as 
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CEBP/β, STAT5 and FOXO1, which have the ability to interact with PR (Christian et 
al., 2002a, Richer et al., 1998, Takano et al., 2007). FOXO1 enhances the activity of 
decidua specific promotor of PRL through CEBP/β via an incomplete PRE motif 
(Christian et al., 2002b). STAT5 induces activity in the presence of cAMP and 
progestin (Mak et al., 2002).  The model of activated PR interacts with multiple cAMP-
dependent TFs to form a multimeric complex that targets decidual genes. This was 
substantiated by a recent study using chromatin immunoprecipitation (ChIP) with 
massively parallel DNA sequencing (Lynch et al., 2011). 
1.12 Cell fate decisions 
Different signalling pathways are spatially and temporally coordinated in response to 
ovarian steroid hormones. These pathways cumulatively determine the molecular 
basis of endometrial stromal cellular fate, which in turn determines the quality of 
decidualization and receptivity.  Stromal cells can shift their appropriate response 
based on the presence or absence of a competent or incompetent embryo. These key 
decisions are made by various transcription factors and signalling proteins that are 
present at the junctions of different signalling pathways.  
For example, PLZF, a member of poxvirus and zinc finger (POZ)/ broad-complex, 
tramtrack, and bric-`a-brac (BTB) and Kruppel zinc finger (or POK) family of 
transcription factors, is highly conserved among mammals (Suliman et al., 2012). It is 
massively upregulated upon treatment with progesterone but not by cAMP. During the 
menstrual cycle,  PLZF accumulates in the nuclei of stromal cells during mid to late 
secretory phase.(Fahnenstich et al., 2003). It has an antiproliferative effect and can 
prevent apoptosis by inhibiting proapoptotic member of B-cell lymphoma 2 (Bcl2) 
class of proteins (Yeyati et al., 1999, Parrado et al., 2004). This antiapoptotic 
response of PLZF is balanced by a proapoptotic cAMP-induced C-terminal fragment 
of Heparin-binding epidermal growth factor-like growth factor (HB-EGF-C). The 
balance between progesterone induced PLZF and HB-EGF-C is believed to be 
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participating in endometrial stromal fate by the balancing anti- and pro-apoptotic 
signals respectively (Brosens and Gellersen, 2006, Nanba et al., 2003).  
FOXO1, part of multimeric transcription factor complex drives expression of the main 
decidual markers such as PRL and IGFBP1, following decidualization. In the absence 
of an implanting embryo and progesterone, FOXO1 plays a vital role in the 
proapoptotic pathway. Nuclear accumulation of FOXO1 is cAMP-dependent, 
however, upon progesterone treatment, FOXO1 translocates to the cytoplasm and is 
rendered inactive. Progesterone withdrawal towards the end of menstrual cycle 
causes rapid nuclear re-accumulation of FOXO1. This re-accumulation enables 
FOXO1 to target proapoptotic mediators such as Bcl-2 Interacting Mediator Of Cell 
Death (BIM) (Labied et al., 2006) and Fas ligand (FASLG) (Kayisli et al., 2003, 
Brosens and Gellersen, 2006). 
Another important cell fate decision-making molecule is p53 which is stabilised by 
cAMP. Increased p53 levels following decidualization are hypothesised to be 
transcriptionally inert, however, can exert its repressive action through protein-protein 
interactions. Following progesterone withdrawal, transcriptional activity of p53 is 
activated resulting in menstrual breakdown. The balance between inert and activated 
p53 may serve as a key fate deciding molecule in the endometrium (Christian et al., 
2002a, Brosens and Gellersen, 2006). 
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Figure 1.4. Progesterone and cAMP coordinated signalling pathway. 
Ligand binding to GPCR results in an increase of secondary messenger cAMP 
production activating subsequent PKA-dependent and independent pathways, 
resulting in accumulation CEBP/β, FOXO1 and STAT5 in the nucleus. PR-A bound 
with progesterone interacts with these factors resulting in transcription of decidua 
specific genes. SRC, CBP, CARM are coactivators whereas Nuclear receptor co-
repressor (NCoR)1/R2 are disrupted repressors. Figure adapted from (Gellersen and 
Brosens, 2003)  
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1.13 In vitro decidualization protocol 
Various protocols have been established for decidualizing endometrial stromal cells 
in vitro. Among these protocols most commonly used protocols involve: (i) Estradiol 
and progesterone or a progesterone analogue; (ii) factors inducing cyclic AMP or an 
analogue and (iii) cAMP analogue in combination with progestin.  The other protocols 
and the duration of treatments are as follows (Gellersen and Brosens, 2014b):  
Table 1.1. Differentiation protocols 
 Treatment  Duration Endpoint Reference 
8-bromo cyclic AMP 12-24 hours Induction of 
Prolactin promotor  
(Telgmann et al., 
1997) 
8-bromo cyclic AMP 1-3 days mRNAs of PRL 
and IGFBP1 
(Samalecos et 
al., 2009) 
8-bromo cyclic AMP 2 days Microarray 
analysis 
(Popovici et al., 
2000) 
Corticotropin-
releasing hormone 
8 days Prolactin 
secretion-
enhanced with 
Medroxy-
progesterone 
(Ferrari et al., 
1995) 
Follicle stimulating 
hormone in the 
presence/absence of 
Luteinizing 
hormone/Human 
chorionic 
gonadotropin 
4-6 days Prolactin secretion (Tang and 
Gurpide, 1993) 
Medroxyprogesterone 10-20 days PRL mRNA, 
IGFBP-1 mRNA 
(Tseng et al., 
1992) 
Medroxyprogesterone 
and 8-bromo-cAMP 
4-10 days Prolactin secretion (Brosens et al., 
1999) 
Medroxyprogesterone, 
estrogen and activin A 
10 days Prolactin secretion (Jones et al., 
2002) 
Medroxyprogesterone, 
estrogen and 
Prostaglandin E2 
3 days Prolactin secretion (Frank et al., 
1994) 
Medroxyprogesterone 
and Insulin-like growth 
factor 1 
28 days  Prolactin secretion (Rosenberg et 
al., 1991) 
Medroxyprogesterone 
and Relaxin 
6 days  Prolactin secretion (Telgmann et al., 
1997) 
19 
Medroxyprogesterone 
and Relaxin in the 
presence or absence 
of estrogen 
5 days  Prolactin secretion (RONG HUANG 
et al., 1987) 
Medroxyprogesterone 
or progesterone 
20 days Prolactin secretion (HUI ZHU et al., 
1990) 
Progesterone + 
cortisone+ 8-bromo-
cAMP 
4 days PRL mRNA, 
IGFBP-1 mRNA 
(Kuroda et al., 
2012) 
Progesterone + DES 
+ epidermal growth 
factor 
25 days Prolactin secretion (IRWIN et al., 
1991) 
Progesterone + DHT+ 
8-bromo-cAMP 
4-8 days Prolactin and 
IGFBP-1 secretion 
and prolactin 
mRNA 
(Cloke et al., 
2008) 
Progesterone + 
Estrogen 
10-15 days Prolactin secretion (Irwin et al., 
1989) 
Progesterone + 
Estrogen 
14 days IGFBP-1 secretion (Hess et al., 
2007) 
Progesterone + 
Estrogen + epidermal 
growth factor 
10 days  Microarray 
analysis 
(Popovici et al., 
2000) 
Progesterone + 
Estrogen + 
Interleukin-11 
12 days Prolactin and 
IGFBP-1 secretion 
(Dimitriadis et al., 
2002) 
 
The duration and experimental design varies between these in vitro studies however 
these treatments cause the cellular reprogramming required to acquire specialist 
functions to accommodate the invading partly allogenic embryo. 
1.14 . Implantation 
Successful implantation of a blastocyst is achieved by bidirectional crosstalk between 
the endometrium and embryo. Perturbation of this crosstalk, for example, caused by 
aberrant decidualization, compromises trophoblast invasion and may ultimately cause 
loss of pregnancy (Zhang et al., 2013). Traditionally, implantation was thought to be 
the result of active trophoblast invasion into a passive maternal decidua (Boyd 1980). 
Recent co-culture studies have brought a paradigm shift in the way we understand 
how stromal cells behave in the presence of a blastocyst. This study visualised the 
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invasive and migratory property of stromal cells, as the embryo was actively 
encapsulated by decidual stromal cells (Grewal et al., 2008, Teklenburg et al., 2010a). 
Approximately, 2-8% of the endometrial epithelial cells are ciliated and display 
microvilli (Masterton et al., 1975).  Upon contact with underlying stromal cells, the 
embryo expands beneath the epithelia and invades further. The stromal layer, though 
not decidualized, initiates differentiation by the presence of increasing progesterone 
levels (Gellersen and Brosens, 2014a).Trophoblast cells differentiate further to 
numerous primary syncytial elements and mononuclear cytotrophoblast. The 
epithelial cells cover the surface of the embryo following penetration (Aplin and 
Ruane, 2017).  Key adhesion molecules such as mucins, integrins play a major role 
in the process of implantation. A receptive endometrium and the timing of implantation 
are critical for a successful implantation. A temporary period termed the ‘window of 
implantation’ ensures that a competent embryo is embedded into an optimal 
environment. Stromal cells and progenitors, upon differentiation, confer the 
endometrium with the ability to be both receptive and selective to a competent 
embryo. For successful implantation, the decidual cells must maintain control of the 
invasiveness of the embedding embryo to form the feto-maternal interface. Studies 
show that only decidualized human endometrial stromal cells encapsulate competent 
embryos and allow its expansion, compared to undifferentiated stromal cells. These 
differentiated cells, which express high levels of MMPs are motile and move around 
the embryo to encourage its expansion (Weimar et al. 2013).  
Decidualization plays a vital role in conferring immunotolerance to the semiallogeneic 
embryo. Decidualized stromal cells modulate the local immune cell environment by 
increasing the influx of uterine NK cells, neutrophils and macrophages (Reiger et al., 
2004). Animal studies show that the uterine dendritic cells (uDCs) are trapped by 
decidual stromal cells, preventing the migration of uDCs and identifying the embryo 
(Erlebacher 2013). Studies have shown that the decidual cells exhibit an initial 
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proinflammatory response, followed by an anti-inflammatory response with 
immunomodulatory properties. In decidua, uNK cells are suggested to suppress T- 
cells by apoptosis using galectin-1 (Blois et al. 2007). 
Decidualized stromal cells are thought to act as a biosensor to selectively trigger 
tissue destruction when they encounter a developmentally compromised embryo, 
through some unknown mechanisms. Thus, decidualization not only creates a 
proinflammatory and anti-inflammatory response but also reactivates the 
inflammatory phenotype to prevent the embedding of an incompetent embryo (Salker 
et al. 2012). 
The receptive state of the endometrium which is needed for successful implantation 
is acquired approximately six days after the postovulatory rise in progesterone and 
lasts around 2 to 4 days. This is known as the window of implantation and coincides 
with the spontaneous decidualization of the endometrium. In the absence of a 
fertilised egg, progesterone levels fall, leading to menstruation. The maternally 
controlled decidualization process in humans, which precedes menstruation, is 
considered to be an essential method of maintaining the reproductive fitness of 
mother (Haig. 2010). Progesterone signal withdrawal from decidualizing endometrium 
is a common signal for menstruation or menstrual-like shedding to discard the 
implanting incompetent embryo (Gellersen and Brosens, 2014a).  
1.15 Menstruation 
In the absence of implantation, the corpus luteum decays, progesterone levels 
decline, initiating a cascade of events in the functional endometrial layer that leads to 
tissue breakdown, menstrual shedding and scar-free repair (Jabbor et al. 2006). The 
concept of menstruation as an inflammatory event was proposed by Finn in 1986 as 
it shares features of inflammation (Finn, 1986). In a non-conception cycle, the 
inflammatory events before menstrual shedding is governed by the fall of ovarian 
steroid hormones, oestrogen and progesterone during the late secretory phase. The 
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fall in progesterone releases NF-κB from its inhibition by IκB which leads to induction 
of inflammatory gene networks which results in an influx of inflammatory cells. 
Interactions between inflammatory cells and decidualized stromal cells result in the 
release of a spectrum of pro-inflammatory mediators including chemokines, cytokines 
and prostaglandins. Pro-inflammatory factors and inflammatory cells lead to 
production and activation of a degradative enzyme cascade, particularly matrix 
metalloproteinases, ultimately resulting in the rapid breakdown of the extracellular 
matrix (Salamonsen, 2003, Salamonsen et al., 1999). 
1.16 Relevance of hypoxia in menstruation 
Declining levels of progesterone results in a cascade of molecular changes inducing 
myometrial contraction and vasoconstriction of spiral arterioles of the endometrium. 
These changes create a hypoxic environment in the functional layer similar to necrosis 
or ischemic injury (Markee, 1940). Transcription factor formed by HIF isoforms bind 
to hypoxia responsive elements (HRE) and regulate some physoxia responsive genes 
that are expressed in menses (Critchley et al., 2006, Maybin et al., 2011, Maybin et 
al., 2012).  
Some contradictions exist in accepting that hypoxia plays a vital role in regulating 
tissue degradation and initializing the tissue repair process (Zhang and Salamonsen, 
2002). In a xenograft model, endometrial functional layer explants were implanted in 
immunodeficient mice to determine whether physoxia plays a role in destruction or 
regeneration of endometrium upon hormone withdrawal or replenishment.  The 
results showed that hormone withdrawal caused tissue destruction along with 
increased production of MMPs and TIMPs. However, there was no apparent change 
in partial oxygen pressure or  HIF1α staining in the tissues. This study also analysed 
the oxygen level following hormone replenishment which found no evidence of 
physoxia (Coudyzer et al., 2013). However, a recent study with high throughput 
techniques showed that a spatial and temporal gradient of physoxia is necessary for 
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rapid tissue breakdown as well as for the regeneration of normal endometrial 
architecture (Cousins et al., 2016). 
1.17 Angiogenesis in human endometrium 
Amongst various physiological changes that occur during the menstrual cycle, there 
is profound angiogenesis in response to physoxia and sex steroid hormones. The 
major regulator of angiogenesis and remodelling is local physoxia environment. 
Reconstruction of the new vascular network and rapid vessel growth following 
menstrual destruction is regulated by oestrogen whereas progesterone regulates the 
vessel maturation. The tightly controlled angiogenesis is mediated by various pro- and 
anti- angiogenic factors such as vascular endothelial growth factor (VEGF), soluble 
VEGF receptor 1 (sVEGFR-1), angiopoietin (ANGPT), stromal cell-derived factor 1 
(SDF-1/CXCL12), IL-8 and angiogenin (Okada et al., 2014). 
Physoxia induces VEGF expression through physoxia inducible factor-1α (HIF-1α) 
(Lin et al., 2004). The effect of physoxia on VEGF production in endometrial stromal 
cells may have a physiological relevance in the process of menstruation, 
postmenstrual repair and angiogenesis (Tsuzuki et al., 2011). Oestrogen was 
reported to increase VEGF expression in endometrial stromal cell culture (Okada et 
al., 2010). 
The maturation of newly formed blood vessels is induced by ANGPT1 associating 
with endothelial cells, pericytes and vascular smooth muscle cells. ANGPT2, an 
antagonist of ANGPT1, is involved in neovascularization along with VEGF. Increased 
ANGPT2/ANGPT1 ratio is associated with neovascularization. Physoxia reduces 
ANGPT1 expression whereas there is no change in the levels of ANGPT2. As 
physoxia increases VEGF expression, high ANGPT2/ANGPT1 ratio results in higher 
new blood vessel formation (Okada et al., 2014).  Oestrogen also has similar effects 
to physoxia in the way it induces VEGF and attenuates ANGPT1, thus playing a role 
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in the reconstruction of vascular architecture of the endometrium (Tsuzuki et al., 
2013). 
1.18 Blood supply to the uterus 
Ovarian and uterine arteries supply blood to the uterus. The uterine arteries arise from 
the anterior division of internal iliac artery and branch into arcuate arteries. These 
arcuate arteries further branch into radial arteries which penetrate the myometrium to 
provide blood to all layers of the endometrium. In the endometrium, radial arteries are 
modified into basal and spiral arteries that supply the functionalis layer. Basal arteries 
support the basalis layer of the endometrium, and these arteries do not respond to 
hormonal cues. In the absence of an implanting embryo, constriction of terminal 
arteries occurs, resulting in endometrial breakdown and shedding of the stromal and 
glandular compartments (Emedicine.medscape.com, 2017).    
1.19 Spiral arteries 
The radial arteries branch into spiral arteries upon reaching the myo-endometrial 
junction. Spiral arteries are separated from each other by a distance of 1-6 mm (Boyd 
and Hamilton, 1970). Before pregnancy, spiral arteries respond by growth and 
decidualization. The growth of spiral arteries is massive as it has to allow about 600 
ml/minute of blood into the intravillous space (Figure 1.5). Research on spiral artery 
remodelling comparing normal and preeclampsia patients revealed that 
decidualization did not reach a myometrial layer that occurs in normal pregnancy. In 
a normal pregnancy, the mean diameter of myometrial spiral arteries in the placental 
bed was 500 µm whereas it was only 200 µm in cases of preeclampsia (Brosens et 
al., 2010, Brosens et al., 1972). Failure in physiological transformation is also 
considered as a cause for intrauterine growth restriction (IUGR) as there is a high 
vascular resistance that reduces the flow of blood to the intrauterine space (Brosens 
et al., 2010).  
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1.20 Perivascular niche 
The initial perivascular niche was reported in hematopoietic stem cells because of 
their sinusoidal endothelium association both in bone marrow and spleen (Kiel et al., 
2005). Perivascular localisation of hematopoietic stem cells (HSCs) within bone 
marrow is suggested as a reason for regulation of quiescence nature. Chondroitin 
Sulfate Proteoglycan 4 (CSPG4) coated arterioles are shown to maintain the 
quiescence nature, but their deletion induces HSCs cycling   (Bourke et al., 2009, 
Kunisaki et al., 2013).  Apart from these number of factors secreted by endothelial 
cells and MSCs (e.g. stem cell factor) within this perivascular environment is reported 
to be vital for maintaining the niche conditions. Plastic adherent non-hematopoietic 
perivascular cells capable of forming fibroblastic colony-forming units (CFU-F) 
(Friedenstein et al., 1970) are termed as mesenchymal stem cells (MSCs) (Caplan, 
1991). With the use of flow cell sorting CD10, CD13, CD44, CD73, CD90, CD105 
expressing mesenchymal stem cells were isolated from the perivascular cells (Oh and 
Nör, 2015). These cells exhibited potential to differentiate into mesenchymal lineages 
such as osteocytes, chondrocytes and adipocytes (Doherty et al., 1998, Farrington-
Rock et al., 2004). 
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Figure 1.5. Vascular architecture within the uterus. 
Uterine arteries branch into arcuate arteries and radial arteries which supply blood for 
the myometrial layer. Spiral arteries penetrate and supply blood to the functionalis 
layer of the endometrium. Figure adapted from (Robertson, 1976) 
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1.21 Stem cells 
Regeneration following menstruation in each cycle is due to the presence of stem 
cells within the endometrium, a concept which was put forth four decades ago and 
was proven recently in 2007 (Gargett et al., 2007). Stem cells are initially involved in 
the embryological development and in due course help to maintain tissue 
homoeostasis throughout the lifetime. Stem cells are non-lineage specific, with 
potential plasticity with uni, multi -or pluri- potency. Asymmetric cell division results in 
one progenitor cell, which can differentiate into a particular lineage, and self-renewal 
of the stem cell (Figure 1.6). They reside in a microenvironment - ‘niche’ that provides 
support for the stem cells by cell-cell or cell-matrix interactions. 
Embryonic stem cells and somatic stem cells are the two primary classifications of 
stem cells. Embryonic stem cells are embryonically derived, whereas somatic stem 
cells are undifferentiated stem cells amongst differentiated cells in adult tissues. 
Somatic stem cells comprise of mesenchymal and hematopoietic stem cells. 
Mesenchymal stem cells with a potential to differentiate into osteoblasts, adipocytes, 
chondrocytes and hematopoietic stem cells into blood lineage cells. There are some 
sources for mesenchymal stem cells including the umbilical cord, cord blood, bone 
marrow, and menstrual blood. Stem cells are usually quiescent unless there is a need 
to repair or regenerate when they migrate and replenish or recruit critical immune cells 
by chemokine/cytokine action. Immunomodulatory properties of mesenchymal stem 
cells are elicited in mice via nitric oxide, and in humans through some factors including 
indoleamine-2, 3-dioxygenase (IDO) and Leukaemia inhibitory factor (LIF) (Spaggiari 
et al...2010; Nasef et al. 2008). In vivo studies tracked the mesenchymal stem cell 
niche to be perivascularly located (Crisan et al. 2008, Hirschi et al. 1996). 
As the embryo develops, pluripotential nature decreases thus giving rise to 
multipotent or unipotent somatic stem cells, which are found in most organs of the 
human body. The presence of stem cells within the endometrium was proposed four 
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decades ago based on the cyclical nature of the tissue. However, the actual evidence 
of stem cell existence in human endometrium was put forth in 2007 following in vitro 
and in vivo analysis (Gargett et al., 2007). This identified two types of stem cell 
populations within endometrium: epithelial stem cells (eESCs) and mesenchymal 
stem cells (MSCs).  
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Figure 1.6. Cartoon showing stem cell undergoing asymmetric division. 
Plasticity potential decreases as the division continues, whereas the differentiation 
potential increases. It is proposed that large colonies during CFU assay arise from 
stem cells and cells at progenitor stage give rise to smaller colonies. 
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1.22  Endometrial stem cells - Epithelial stem cells 
The existence of ESCs came into light based on the fact that all endometrial glands 
are monoclonal in origin suggesting that they arise from a common progenitor cell. 
Following menstruation, a portion of glands remains in the basal layer of the 
endometrium. The epithelial cells from this layer re-epithelize the exposed surface 
and proliferate into the regenerated functionalis layer under the influence of 
oestrogen. Epithelial stem cells can form colony forming units (CFUs) and are 
proposed to be residing in the remaining glands following tissue destruction. ESCs 
constitute 0.08% of the endometrial epithelial cells and show immense self-renewal 
properties in vitro by undergoing 34 population doublings and the ability to differentiate 
into large glands in a 3D microenvironment.  Stage-specific embryonic antigen 1 
(SSEA-1, or CD15) is considered as a marker of ESCs as it is expressed strongly in 
the basal endometrial glands obtained via hysterectomy. SSEA-1 is strongly 
expressed in the glands of post-menopausal women and shows a similar gene profile 
as basal glands obtained from cycling women. In culture, SSEA-1+ ESCs have higher 
telomerase activity, longer telomeres and are proliferatively quiescent. When cultured 
in a 3D environment, SSEA-1+ ESCs form spheroids and further differentiated into 
spheres with polarised epithelium (Gargett et al., 2009). ESR1 and PR are expressed 
in lower levels in SSEA-1+ ESCs suggestive of their naïve state. Another marker, 
LGR5 (leucine-rich repeat containing G-protein-coupled receptor 5) is used to identify 
a rare epithelial stem cell population in the lower functionalis layer near the basalis 
layer. (Barker et al., 2007).  
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1.23 Endometrial stromal stem cells  
1.23.1 Label-retaining cells (LRC)-evidence from mouse 
studies- 
Stem cells remain quiescent, and this property is exploited to identify adult stem cells 
by labelling with 5-bromo- 2-deoxyuridine (BrdU). Since stem cells divide infrequently, 
they have the capacity to retain the dye for a longer period in comparison to actively 
proliferating cells. In mouse endometrium, the BrdU label is maintained by 6-9% of 
the stromal cells and 3% of epithelial cells (Cao et al., 2014). Oestrogen receptor (ER) 
was absent in the majority of these stromal and epithelial LRCs. However, 16% of the 
stromal LRC possessed ER. It can be speculated that these ER+ LRCs might be 
involved in the estrogen-induced proliferation of the endometrial during the 
proliferative phase. In vitro, although ER negative, epithelial and stromal LRCs 
proliferated in response to oestrogen (Cervello et al. 2007, Chan & Gargett, 2006).  
1.23.2 Endometrial stromal stem cells - evidence from 
human studies 
Human endometrium is remarkably resilient; it undergoes cyclical changes, 
proliferates, sheds and regenerates, coordinated by the rise and fall in circulating 
ovarian steroid hormones. The active cyclical regeneration and remodelling of 
endometrial glandular and stromal components imply the presence of stem/progenitor 
cells which are thought to play an indispensable role in tissue maintenance and 
function of the uterus (Teixeira et al. 2008). 
Stem cells were identified in the endometrium by clonal, proliferative, differentiation 
potential (Table 1.2) and self-renewal properties (Gargett et al. 2004). The colony 
forming units from these endometrial stem cells were shown to give rise to two types 
of colonies, large colonies containing cells capable of self-renewal, and small colonies 
containing endometrial transit amplifying cells (eTAs) which acquire differentiation 
markers (Gargett et al. 2009). 
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Though there are some markers for isolation of mesenchymal stem cells, the W5C5 
antibody was found to select for a perivascular population of cells enriched within both 
endometrium and bone marrow. W5C5 is an antibody for SUSD2, (Sushi domain 
containing 2) a type I integral membrane protein. These SUSD2 expressing W5C5+ 
cells are found around the spiral arteries of the endometrium. W5C5 is a cognate 
antibody for SUSD2 (Sivasubramaniyan et al., 2013). These endometrial 
stem/progenitor cells can differentiate into neural lineages (Wolff et al., 2011), 
pancreatic lineages (Li et al., 2010, Santamaria et al., 2011) and hepatocytes 
(Santamaria et al. 2011). Cultured perivascular cells are enriched in for CD146+ / 
PDGFRβ+ and are capable of only four of the mesenchymal lineages: adipogenic, 
myogenic, osteoblastic and chondroblastic. Platelet-derived growth factor subunit B 
(PDGFRB) gene encodes for CD140b, a tyrosine kinase receptor, and reported to be 
crucial for vascular development.  CD146 is a class of cell adhesion molecule and a 
marker of endothelial cell lineage. Cells which lacked these markers were unable to 
differentiate (Gargett et al. 2009). A previous study indicated W5C5+ population 
constitutes 7% of the total HESCs (Murakami et al. 2013). 
A recent study reported that clonogenic cells derived from CD140b+ and CD146+ 
perivascular cells are found consistently throughout the menstrual cycle (Figure 1.7). 
These cells display high self-renewal capacity. This study also showed that the basalis 
layer contained a higher percentage of stem cells when compared to the functionalis 
(Shan et al., 2016).  
Another study analysed the transcriptomic profile of CD140b+ and CD146+ 
perivascular cells and demonstrated that these stem cells are the precursors of the 
endometrial stromal cell population. This study also confirmed that endometrial stem 
cells are localised perivascularly around the smaller blood vessels (Spitzer et al., 
2012).  Various markers used for identifying stem cells within endometrium are listed 
in Table 1.3. 
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Further studies profiled the transcriptome of freshly isolated MSCs, non-MSC stromal 
cells using CD140b/CD146 markers with their short and long-term clonal 
counterparts. This analysis confirmed that MSCs are bonafide precursors of clonal 
non-perivascular HESCs and non-clonal HESCs. Based on this transcriptomic 
analysis, and to avoid confusion, I propose a simplified nomenclature (Table 1.4). 
Briefly, clonal cells isolated from the perivascular cell fraction are designated as 
eMSCs; eTA cells denote clonal cells isolated from the non-perivascular cell fraction; 
ePSCs indicate SUSD2+ perivascular population, the SUSD2- non-perivascular 
population is represented by EnSCs and HESCs represented mature progeny cells 
and suggested decidual stromal cells are further down the lineage of endometrial 
stromal cells when treated with progesterone (Barragan et al., 2016). 
1.23.3 Side population (SP) 
The side population (SP) phenotype is also used as a marker for stem cells.  SP cells 
are capable of effluxing Hoechst 33342 due to the presence of ATP-binding cassette 
(ABCG2) transporter. Clonogenic endometrial cells are enriched with SP cells. In 
culture, isolated SP cells are slow growing, a characteristic feature of stem cells. 
Schwab and Gargett (2007), showed that these SP cells are found in proximity to 
those expressing platelet-derived growth factor receptor beta (PDGFRβ) and CD146. 
Moreover, SP cells are capable of regenerating into entire endometrium when 
transplanted into immunocompromised mice (Masuda et al. 2010). Another study 
established that these side population cells constitute 0.00-5.11% of the total cell 
population of a normal endometrium (Kato et al. 2007). 
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Table 1.2. Differentiation potential of endometrial stem/progenitor cells 
Markers 
expressed 
Differentiated 
into 
Possible 
Therapeutic 
potential 
Reference 
CD146, CD105 
and CD90 
Smooth muscle 
cells (SMCs) 
Bladder 
reconstruction 
Shoae-Hassani 
et al... 2013; 
Gargett et al. 
2009 
PDGF-Rβ, CD146 
Dopaminergic 
neurons 
Parkinson’s 
disease 
Wolff et al... 2010 
PDGFβ-R, 
CD146, CD90 
Insulin-
secreting cells- 
pancreatic 
beta cells 
Diabetes 
Santamaria et al. 
2011 
CD73, CD146, 
CD90 
Hepatocyte-like 
cells 
Liver-related 
disorders 
Yang et al. 2014 
PDGF-Rβ, CD146 
Adipocytes, 
osteoblasts, 
chondrocytes 
 
Wolff et al. 2007; 
Dimitrov et al. 
2008; Gargett et 
al. 2009 
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Table 1.3. Different markers for endometrial stem/progenitor cells 
Stem cell marker Property Reference 
Low Hoechst 33342 
fluorescence 
DNA stain that specific for 
side population 
(Masuda et al., 2012b) 
BrdU Label retaining cells (Cervello et al., 2011) 
CD146 and 
PDGFRβ 
Pericyte markers; 
Fluorescence-activated cell 
sorting (FACS) 
(Schwab et al., 2005) 
SUSD2 
Uses W5C5 antibody; 
Perivascular markers; MACS 
sorted 
(Masuda et al., 2012b, 
Murakami et al., 2014) 
LGR-5 and SSEA-1 
Endometrial epithelial 
progenitor cells 
(Valentijn et al., 2013, 
Sun et al., 2009) 
 
  
36 
Table 1.4. Simplified nomenclature of subpopulations of HESCs 
Simplified Terminology Specific marker/s 
Endometrial mesenchymal 
stem cells (eMSCs) 
Clonal SUSD2+ 
Endometrial transit 
amplifying cells (eTAs) 
Clonal SUSD2- 
Endometrial pericytes 
(ePCs) 
SUSD2+ 
Endometrial stromal cells 
(EnSCs) 
SUSD2- 
Endometrial pericytes 
(ePCs) 
CD146 and Platelet-derived growth factor 
receptor β (PDGFRβ) co expression 
MenSCs 
CD146 and Platelet-derived growth factor 
receptor β (PDGFRβ) co-expression from 
menstrual blood 
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Figure 1.7. Endometrial perivascular cell localisation. 
Epithelial cells with the ability to form colonies are proposed to be located at the base 
of the glands. SUSD2+ and CD140b/CD146+ pericytes are localized adjacent to the 
blood vessels (v). Side population (SP) cells express markers for endothelial as well 
as pericytic origin. Figure adapted from (Gurung et al., 2015). 
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1.24 Menstrual blood-derived stem cells (MenSCs) 
CD146+/PDGFR-β+ cells have been isolated from menstrual blood (Schwab and 
Gargett, 2007), and are designated MenSCs. MenSCs also express MSC markers 
such as CD9, CD44, CD29, CD73, CD90 and CD105 along with pluripotency markers 
OCT-4, C-KIT and Stage-specific embryonic antigen-4 (SSEA-4) but lack expression 
of STRO-1, a marker which is expressed in perivascular cells isolated from 
endometrial biopsies. MenSCs undergo 68 passages when cultured in vitro, 
demonstrating its proliferative property. These cells showed tri-lineage differentiation 
potential of differentiating into osteoblasts, chondrocytes and adipocytes (Meng et al., 
2007a, Musina et al., 2008, Patel et al., 2008). Menstrual blood perivascular cells 
produce high amounts of MMPs and factors promoting angiogenesis (Gargett et al., 
2014). Menstrual blood perivascular cells showed varied differentiation potential by 
differentiating into cardiomyocytes, hepatocytes, and neural and pancreatic lineages 
from all three germ layers (Meng et al., 2007b, Patel et al., 2008). MenSCs are 
considered to be an easily available source for cardiac stem cell therapy (Bockeria et 
al., 2013).  
1.25 Clonogenicity 
A unique property of stem/progenitor cells is that they can form a clone from a single 
cell. Studies proved that the endometrial stromal stem/progenitor cells and epithelial 
cells could form colonies when seeded in a low cell concentration. The clonogenic 
capacity is lower in epithelial cells compared to stromal cells. Growth factors play a 
major role in the formation of colonies. Basic fibroblast growth factor (bFGF) is 
required for endometrial stromal progenitor cells to form colonies, whereas PDGFβ, 
tumour growth factor alpha (TGFα) and epidermal growth factor (EGF) are important 
in colony formation from epithelial progenitor cells (Chan et al., 2004). 
Clonogenicity varies between epithelial and stromal progenitor cells during the various 
stages of the menstrual cycle. High clonogenicity was elicited by stromal progenitor 
39 
cells during proliferative phase, and by epithelial progenitor cells during the secretory 
phase. Chan et al. (2004) could show that within 15 days, 0.22% of endometrial 
epithelial cells and 1.25% of stromal cells were capable of forming individual colonies. 
Clonogenicity was higher in both ePCs and SP cells compared to EnSCs. ePCs also 
demonstrated differentiation potential like that of mesenchymal stem cells from any 
other source. The differentiation potential of clonogenic endometrial stromal 
stem/progenitor cells by inducing the cells into adipogenic lineage (Dimitrov et al., 
2008).  A study analysing endometrial tissue biopsies showed that clonogenic 
potential is enriched in ePCs population compared to EnSCs. Interestingly, the body 
mass index (BMI) negatively correlated with the proportion of ePCs, suggesting that 
the plasticity of the endometrium is compromised in obese individuals, which may 
potentially result in adverse pregnancy outcomes. (Murakami et al. 2013). 
1.26 Decidualization effect on ePCs 
Preliminary studies from our lab suggest that the decidual markers PRL and IGFBP1 
are expressed at similar levels in both ePCs EnSCs. However, upon decidualization 
ePCs express a significantly different secretome when compared to EnSCs. Analysis 
of the cytokine profile at transcription levels shows that ePCs cells elicit a pro-
inflammatory response on decidualization, in comparison to the anti-inflammatory 
responses mounted by EnSCs. Secretome analysis of conditioned medium from 
differentiating and non-differentiating ePCs show that decidualization induced 
perivascular cells to secrete high levels of immunomodulatory factors (Murakami et 
al., 2014).  
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1.27 Trophoblast invasion into decidua 
In normal human pregnancy, the fetal trophoblast cells invade into the wall of the 
uterus in a complex and tightly controlled process. From tips of anchoring villi, 
cytotrophoblast cell columns are formed and a shell develops through which 
extravillous trophoblasts invade decidua. By the eighth week of gestation, interstitial 
cells from extravillous trophoblasts reach the superficial myometrium (Pijnenborg et 
al., 1981). In the uterus, the blood vessel diameter decreases sequentially as it 
progresses through myometrium and endometrium. Spiral arteries supply blood to the 
endometrial layer and span inner myometrium and for decidua in the case of a 
pregnant uterus. During pregnancy, placental bed spiral arteries undergo vascular 
remodelling from high resistance low flow vessels into low resistance high flow 
vessels (Whitley and Cartwright, 2010).   
Perivascular cells which are terminally differentiated and are capable of switching 
between contractile and proliferative phenotype surround the spiral arteries in the 
endometrium (Kaplan-Albuquerque et al., 2005). The contractile phenotype is due to 
expression of contractile proteins such as α-actin, smooth muscle myosin heavy 
chain, calponin, and smooth muscle 22α. Perivascular cells do not proliferate, migrate 
or synthesise extracellular proteins (Owens et al., 2004). In response to changes in 
extracellular cues, perivascular cells adopt a more synthetic phenotype leading to 
proliferation and migration. 
During spiral artery remodelling, a change in phenotype of perivascular cells might 
lead to increased sensitivity to apoptotic stimuli (Su et al., 2006) or increased 
migration (Newby, 2006). Defects in the phenotype switching might lead to altered 
vessel structure, loss of layered organisation of cells or migration away from lumen 
as evidenced in atherosclerosis (Newby, 2006).  
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Decidualization is associated with the influx of maternal natural killer cells that are 
present during spiral artery remodelling and eventually decrease during mid-
gestation. In mice, it was shown that uNK cells are involved in spiral artery remodelling 
stimulated with interferon gamma (IFNγ) (Ashkar et al., 2000). In humans, it was 
demonstrated that uNK cells along with IFNγ produce TNFα, LIF, CSF-1and IL-8 
(Ashkar and Croy, 2001, Hanna et al., 2006). IFNγ has been shown to antagonise 
decidual PRL expression (Christian et al., 2001).IFNγ can cause apoptosis as well as 
the proliferation of perivascular cells. IFNγ may prime the perivascular cells for death 
receptor-induced apoptosis (Bai et al., 2008). Interferon γ can increase TRAIL 
production in trophoblasts (Phillips et al., 1999). Immunohistochemical studies show 
that uNK cells and macrophages are localised at the site of spiral artery remodelling 
suggesting that immune cells may play a role in the reorganisation of vascular cells 
and smooth muscle layer separation (Smith et al., 2009). uNK cell also produces a 
myriad of angiogenic factors including VEGF, PLGF and Ang-2 (Hanna et al., 2006).A 
defect in vascular remodelling leading to uteroplacental hemodynamics has been 
considered to be a causative factor for pre-eclampsia (Hanna et al., 2006).  
1.28 Endometrial scratch 
Intentional injury to the endometrium of a woman wanting to conceive is termed as 
endometrial scratching. This insult to the endometrium is considered to increase the 
chance of an embryo implanting in turn increasing the chance of pregnancy. Various 
instruments are utilized to perform the biopsy. The most used instrument for 
performing endometrial scratch is a thin flexible plastic tube, 3mm wide, called a 
Pipelle catheter. The Pipelle is inserted through the cervix into the uterus and moved 
back and forth and rotated to cause some disruption. It is a simple, inexpensive 
outpatient procedure without anaesthetic and less time consuming.  
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1.29 Relevance of hypoxia in stem cell niche 
The stem cell niche is defined as a specific anatomical compartment that includes 
cellular and acellular factors that combine both systemic and local cues to regulate 
the biology of stem cells (Jones and Wagers, 2008, Li and Xie, 2005). This specialised 
microenvironment is a combination of cells, blood vessels, matrix glycoproteins and 
in a 3D environment (Scadden, 2006). Stem cells’ self-renewal and potential to 
differentiate is maintained by the interaction and communication with this 
microenvironment (Scadden, 2006). 
The physiological oxygen concentration in the stem cell niche is maintained between 
2-8% (Simon and Keith, 2008). The purpose of low oxygen concentration is to prevent 
the oxidative stress that is developed by reactive oxygen species during aerobic 
respiration (Busuttil et al., 2003). The oxygen concentration in the stem cell niche are 
as follows: hematopoietic niche: 1-6% O2 (Grant and Root, 1947, Cipolleschi et al., 
1993, Chow et al., 2001) ; mesenchymal niche: 2-8% O2 (Kofoed et al., 1985, Harrison 
et al., 2002, Matsumoto et al., 2005) and neural stem cell niche: 1-8% O2 (Dings et 
al., 1998, Erecińska and Silver, 2001). 
As the physiological oxygen concentration in the stem cell niches is low, hypoxia could 
be termed as ‘physoxia’. Though the laboratory oxygen concentration is termed 
normoxia, however it is rather high oxygen concentrations as opposed to physiological 
oxygen levels. So, I define this lab oxygen levels as ‘hyperoxia’. 
Below 5% O2 concentration, glucose uptake and lactate production are high in MSCs 
compared to 21% O2. Oxygen concentration over 5% O2 concentration showed no 
difference compared to normal lab oxygen conditions. Oxygen consumption by stem 
cells was less in MSCs (Papandreou et al., 2006, Brown et al., 2007, James et al., 
1995). Physoxia is shown to enhance proliferation in adipose-derived MSCs (Kakudo 
et al., 2015). 
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Mesenchymal stem cells located perivascularly exhibit low oxygen concentrations. 
Physoxia may serve as a stimulus to mobilise stem cells to sites of injury (Rosova et 
al., 2008). Studies show that MSCs cultured under physoxia showed low 
differentiation potential as the physoxia condition help in maintaining the quiescence 
state. MSCs cultured in hypoxic culture conditions show increased migratory 
phenotype than cells maintained in normal laboratory oxygen conditions (Rosova et 
al., 2008). Under physoxia, the Akt signaling pathway is activated and upregulates c-
Met, a receptor for hepatocyte growth factor (HGF) (Rosova et al., 2008) which 
increases expression of VEGF, upregulates the phosphorylation of focal adhesion 
kinase (Lee et al., 2010) and increases the chemokine receptors such as CXCR4 and 
CX3CR1 expression (Hung et al., 2007). In several disease models, hypoxic or 
ischemic tissues are shown to produce cytokines and chemokines (Liu and 
McCullough, 2013). MSCs are responsive for recruitment of humoral factors to sites 
of injury, ischemia, and physoxia (Ceradini and Gurtner, 2005; Rafii and Lyden, 2003). 
Following recruitment, these cells respond to the ischemic site by expressing 
angiogenic factors (Potier et al., 2007). Murine MSCs cultured in glioma cell 
conditioned media under low oxygen condition formed capillary-like structures thus 
showing angiogenic phenotype (Annabi et al., 2003). In conclusion, low oxygen 
tension is certainly an important regulator in deciding the cell fate and in the 
maintenance of MSCs stemness. 
1.30 Relevance in disorders 
Stem/progenitor cells are involved in tissue homoeostasis and regeneration 
throughout the menstrual cycle, and studies are showing their relevance in 
endometrial disorders which may lead to pregnancy failure. 
A recent pilot study involving endometrial tissues obtained by biopsies from obese 
women has shown that there is a deficiency of ePCs clonogenic cells compared to 
the normal weight controls. The clonogenic efficiency of both ePCs, as well as EnSCs, 
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reduces with an increase in the body mass index of the subjects. It was understood 
from this study that endometrium of obese women has lower plasticity and 
regenerative potential compared to women with normal body weight. There was an 
increase in numbers of pregnancy losses in these obese women (Murakami et al. 
2013). 
Endometrial stem cells can be a potential cause of endometriosis as recent evidence 
has shown the presence of stem cells in the menstrual blood (Ulrich et al. 2013). 
Endometriosis can cause pelvic pain and infertility. The incidence rate is 6-10% in all 
women, and 35-50% of these women suffer the consequence of pelvic pain and 
infertility. The cells isolated from endometriotic lesions are variable as few presented 
one type of cells whereas some had polyclonal cells. Another theory suggests an 
extrauterine origin of stem cells which cause endometriotic lesions. To prove this 
theory, Du and Taylor (2007) implanted wild type endometriotic implant in a 
hysterectomized LacZ expressing transgenic mouse. They could observe the LacZ 
expressing cells in the otherwise wild-type endometriotic lesions implant. Bone 
marrow derived stem cells which are thought to be involved in endometrial 
regeneration may also cause endometriotic lesions (Sasson et al. 2008). 
In human reproduction, it is estimated that 30% of embryos are lost before 
implantation, 30% result in early pregnancy loss, and a further 10% of clinically 
recognised pregnancies. Thus, the loss of pregnancy and embryo wastage is much 
high in humans. (Rai and Regan, 2006) 
In Europe, recurrent pregnancy loss (RPL) is defined as three or more consecutive 
miscarriages whereas in the United States of America it is defined as two or more 
losses (Quenby et al., 2002). On an average, 0.5-1% of couples will experience RPL 
(Tho et al., 1979). There are some factors which are associated with RPL, such as 
perturbation in anatomy and subclinical endocrine, immunological and clotting 
disorders (Li, 1998). However, unequivocal evidence for a causal link between 
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subclinical disorders and RPL is invariably lacking, and most, if not all, interventional 
trials have so far been unsuccessful (Quenby et al., 2002). Based on the emerging 
role for decidual cells in embryo biosensoring (Brosens and Gellersen, 2010), RPL 
has recently been attributed to impaired decidualization (Weimar et al., 2012, Salker 
et al., 2011a, Salker et al., 2010). Further, recent work from our lab has linked the 
aberrant decidual response in RPL patients to a deficiency in eMSCs and eTA cells, 
leading to heightened endometrial senescence and a blunted decidual response 
(Lucas et al., 2015). Further, the concept that lack of embryo quality control at 
implantation causes RPL is supported by epidemiological evidence that 40% of 
affected women are ‘super fertile’, defined by time-to-conception for each pregnancy 
of less than or equal to 3 cycles (Salker et al., 2010). RPL patients showed increased 
PROK-1 expression which promotes embryo-endometrial interaction and extended 
proinflammatory phenotype (Koot et al., 2012). Aberrant decidualization and poor 
endometrial quality control are thought to result in a prolonged ‘window of 
implantation’, which allows out-of-phase implantation in an unaccommodating uterine 
environment. However, the cumulative rate of successful pregnancies is high in RPL 
(Lucas et al., 2016a), indicating that embryo-endometrial interactions at implantation 
are intrinsically dynamic and may changes from cycle to cycle. 
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Table 1.5. Abnormal decidualization in reproductive pathologies 
 
 Defect Effect References 
Deregulated LIF Infertile women Indispensable for 
decidualization 
and implantation 
(Stewart et al., 
1992, Franasiak et 
al., 2014) 
Aberrant 
decidualization 
Endometriosis Eutopic 
endometrium and 
ectopic lesions 
(Aghajanova et al., 
2010a, 
Aghajanova et al., 
2010b, Klemmt et 
al., 2006, 
Aghajanova et al., 
2009, Minici et al., 
2008) 
Irregular CpG 
methylation 
Endometriosis Increased 
methylated CpG 
sites in ectopic 
lesions-leading to 
blunted decidual 
response 
(Dyson et al., 
2014) 
Refractoriness to 
progesterone 
treatment 
Endometriosis Very low gene 
expression 
alterations 
 
Disordered IL33-
ST2L-sST2L axis 
Recurrent 
pregnancy loss 
Prolonged 
proinflammatory 
response during 
decidualization 
(Salker et al., 
2012a) 
Reduced 
endometrial MSCs 
Recurrent 
pregnancy loss 
Abnormal 
decidualization 
(Murakami et al., 
2013b) 
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1.31 Hypothesis and Research aims 
The extraordinary regenerative ability of the endometrium to adapt to changes, 
physiological or otherwise, depends on eMSCs with inexhaustible self-renewing and 
differentiation capacity. However, cyclic shedding, regeneration and rapid oestrogen-
dependent growth also render the stromal compartment intrinsically heterogeneous. 
The imbalance between various stromal cell subpopulations (i.e. eMSCs, TA cells, 
ePCs and mature EnSCs) may account for the aberrant decidual response associated 
with either implantation failure or early pregnancy loss. Based on this changing 
endometrial paradigm, the specific research aims of my project were: 
1. To assess the robustness of clonal eMSCs /eTAs cell isolation from mid-luteal 
biopsies. Colony-forming unit-fibroblast (CFU-F) activity was measured in freshly 
isolated HESCs from mid-luteal biopsies from RPL and infertile patients. To assess 
the robustness of this assay - a prerequisite for investigating the role of endometrial 
progenitor cells in reproductive failure - experiments were performed in triplicate and 
repeated in two consecutive cycles. This experimental design also enabled 
assessment of the impact of tissue injury (i.e. biopsy) on endometrial clonal cell 
populations in different patient groups. 
2. To validate the link between aberrant decidualization and reproductive failure. 
Although impaired decidual responses in primary HESCs has been associated with 
major reproductive disorders, such as endometriosis and RPL, there is as yet no 
evidence that the same mechanism underpins sporadic implantation failure. To test 
this possibility, a detailed study was carried out to examine the decidual response in 
primary cultures established from biopsies obtained from unselected patients in the 
cycle before a successful or failed IVF treatment cycle. 
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3. In-depth characterization of eMSCs / ePCs cells. Accumulating evidence indicates 
that eMSCs residing in the perivascular niche are the primary drivers of endometrial 
regeneration and, by extension, its function. However, these cells are only partly 
characterised. My analysis fortuitously revealed that eMSCs have a unique ability to 
form 3D organoids that resemble the gross triangular morphology of the endometrium. 
These new organoids termed endometrial regenerative bodies (ERBs), provide 
potentially a new model to study physiological and pathological implantation events. 
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Chapter 2 
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2 Materials and Methods 
2.1 Materials 
Material Supplier Catalog number 
β-estradiol Sigma-Aldrich 
E2758 
 
8-Bromoadenosine 3',5'- cAMP Sigma-Aldrich 
B7880 
 
6-well plates Corning 
3598 
 
12-well plates Corning 
3513 
 
24-well plates Corning 
3506 
 
96 well plates Corning 
3599 
 
Antibiotic/Antimycotic (Penicillin, 
streptomycin, amphotericin B) 
Gibco 
15240-062 
 
BSA 
 
Sigma-Aldrich A2153 
Cell Recovery Solution Corning 
354253 
 
Cell scrapers Corning 
3010 
 
Cell strainer, 40 µm Fisher Scientific 
22363547 
 
Charcoal Sigma-Aldrich Sigma-Aldrich 
C9157 
 
Chloroform VWR 
100034Q 
 
Cleaning agent for removing 
RNase (RNAzap) 
Sigma-Aldrich 
R2020 
 
Collagenase Sigma-Aldrich 
C9891 
 
Cytokeratin 18 antibody  Mouse Abcam 
AB668 
 
DNAse I for tissue digestion Roche 
11284932001 
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DPX mounting medium Leica 3808600E 
Dulbecco’s modified Eagle 
medium (DMEM)/F12 nutrient 
(Ham) (1:1) medium with red-
phenol 
 
Gibco 11039-021 
Eosin Y Sigma-Aldrich 
HT110132 
 
Epidermal growth factor (EGF) Peprotech 
AF100-15 
 
Eppendorf tubes 1.5 ml Starlab 
E1415-1500 
 
Eppendorf tubes 0.6 ml Starlab 
E1405-0600 
 
Ethanol Fisher Chemical 
E/0650DF/17 
 
Falcon tubes  14 ml 
 
Greiner Bio-one 188261 
Falcon tubes  50 ml 
 
Greiner Bio-one 
227270 
 
Fetal bovine serum (FBS) Gibco 
10500-64 
 
FGF10 Peprotech 
100-26 
 
Filter paper Whatman 
3001-861 
 
Formaldehyde, 4% 
 
VWR 9713 
Glass-bottom Petri-dishes Mat Tek 
P35GCol-1.5-10-C 
 
Glass Pasteur pipettes Fisher Scientific 
1156-6963 
 
Glass slides 
 
Thermo Scientific BS7011/2 
Gloves Kimtech Science 
90626 
 
Glycogen Invitrogen 
10814-010 
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Insulin Sigma-Aldrich 
91077C 
 
Isopropanol (2-Propanol) Sigma-Aldrich 24137 
L-glutamine Gibco 
25030-024 
 
Matrigel 
 
Corning 354230 
Medroxiprogesterone 17-acetate Sigma-Aldrich 
M1629 
 
Nuclease-free water Ambion 
AM9932 
 
Parafilm Bemis 
PM-996 
 
PBS Fisher Scientific 
102092521X-PBS 
 
PCR plates FAST Applied Biosystems 
4346906 
 
PCR plates non-FAST 
 
Applied Biosystems N8010560 
PCR plate sealing film Excel Scientific 
TS-RT2-100 
 
Pipette tips 10 µl Alpha Laboratories 
ZP1010S 
 
Pipette tips 40 µl Alpha Laboratories ZP1204S 
Pipette tips 100 µl Alpha Laboratories ZP1200S 
Pipette tips 300 µl Alpha Laboratories ZS3300S 
RTCA plates (E-plate) ACEA Biosciences 
05469813001 
 
Scalpels Swann-Morton 
0501 
 
Secondary antibody, anti-mouse 
Alexa-Fluor 488 
Molecular Probes 
A11088 
 
 
Secondary antibody, anti-mouse 
Alexa-Fluor 
Molecular Probes 
A21424 
 
Serological pipettes 5 ml Greiner Bio-one 
606 180 
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Serological pipettes 10 ml Greiner Bio-one 
607 180 
 
Serological pipettes 25 ml Greiner Bio-one 
760 180 
 
STAT-60 AMS Biotechnology 
CS-502 
 
Sybr green Applied Biosystems 
4367659 
 
Syringes 20 ml BD Plastipak 
300613 
 
Syringes 50 ml BD Plastipak 
300865 
 
Syringe filter Sartorius Stedim 
Biotech 
16534-K 
 
Vectashield mounting medium with 
DAPI 
Vector Laboratories H-1500 
Vimentin antibody Mouse Cell Signalling 
3390 
 
Medium 200 Thermo Fisher 
Scientific 
M-200-500 
Low Serum Growth Supplement 
(LSGS) 
Thermo Fisher 
Scientific 
S00310 
Luna Automated BF Cell Counter Labtech L10001 
Cell Counting Slides Labtech L12002 
 
MiniMACS Separation columns 
Miltenyi 130-042-201 
 
MiniMACS Separator 
Miltenyi 130-042-102 
 
XF24 FluxPak 
Seahorse 
Bioscience 
100867-100 
XF Base Medium Seahorse 
Bioscience 
102353-100 
 
Oligomycin 
Sigma-Aldrich O4876-5MG 
 
Carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone 
Sigma-Aldrich C2920-10MG 
Rotenone Sigma-Aldrich R8875-1G 
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Seahorse XF24 Cell Culture 
Microplates 
Agilent 
Technologies 
 
Seahorse XF24 FluxPaks Agilent 
Technologies 
 
 
2.2 Methods 
2.2.1 Endometrial tissue biopsy processing 
An endometrial biopsy was obtained using a Pipelle endometrial sampler (CCD, 
Paris). Biopsies were transferred to the laboratory in Dulbecco’s modiﬁed Eagle's 
medium (DMEM)/F12 medium supplemented with 10% dextran-coated charcoal-
treated fetal bovine serum (FBS) and 1% antibiotic-antimycotic solution (Invitrogen, 
Paisley, UK). The tissues were washed twice in DMEM/F12, finely minced, and 
enzymatically digested with collagenase (134 U/ml; Sigma-Aldrich, Gillingham, UK) 
and deoxyribonuclease type 1 (156 U/ml; Roche, Burgess Hill, UK) for one h at 37oC. 
The digestion mixture was shaken every 20 minutes to enhance the process. After 
centrifugation at 125  g for 5 min, the pellet, consisting of dispersed endometrial 
cells, was re-suspended in FBS containing 20% dimethyl sulfoxide (DMSO), frozen at 
an approximate rate of -1°C / min and the following day, stored in liquid nitrogen. 
2.2.2 SUSD2 magnetic separation 
Following previously described protocol (Masuda et al., 2012b, Murakami et al., 
2013a), with several modifications, human endometrial stromal cells (HESCs) were 
isolated as single-cell suspensions from mid-luteal biopsies. Samples were washed 
in DMEM/F-12 medium (Invitrogen), thoroughly minced, and enzymatically digested 
with collagenase (0.5mg/ml; Sigma-Aldrich) and deoxyribonuclease (DNase) type I 
(0.1 mg/ ml; Roche) for 1hour at 37°C in CO2 incubator. The dissociated cells were 
filtered through a 40 µm cell strainer (Fisher Scientific). Stromal cells and blood cells, 
present as a single-cell suspension, passed through the cell strainer to remove the 
undigested fragments, mostly comprising of glandular clumps. Stromal single-cell 
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suspensions were layered over Ficoll-Paque PLUS (GE Healthcare) and centrifuged 
to remove erythrocytes. The medium/Ficoll-Paque PLUS interface, containing stromal 
cells, was carefully aspirated, washed with DMEM/F-12 Medium, twice. It was then 
subjected to magnetic bead separation to isolate ePCs and EnSCs as described 
previously. Briefly, freshly isolated HESC suspensions (up to 1x106 cells/100µl of 
Magnetic Bead buffer consisting of 0.5% BSA in PBS) were incubated with 
phycoerythrin (PE) conjugated anti-human W5C5 antibody (5µl/1x106 cells; 
BioLegend) on ice for 20 minutes. Cell suspensions (up to 1x106 cells/80 µl of 
Magnetic Bead buffer) were then incubated with anti-PE-magnetic-activated cell 
sorting Micro Beads (20 µl/1x106 cells; Miltenyi Biotec) on ice for 20 minutes. Cell 
suspensions (up to 1x106 cells/500 µl of Magnetic Bead buffer) were applied onto MS 
columns (Miltenyi Biotec) in a magnetic field, followed by washing with 500 µl of 
Magnetic Bead buffer three times. Although W5C5 cells passed through the column, 
magnetically labelled ePCs were retained on the column. The columns were removed 
from the magnetic field, and ePCs cells were flushed with 1 ml of Magnetic Bead 
buffer.   
2.2.3 RNA sequencing 
Total RNA from freshly magnetically isolated ePCs and EnSCs cells were extracted 
using RNA STAT-60 (AMS Biotechnology) following the manufacturer's protocol, 
including DNase treatment (Invitrogen). RNA quality was analysed using Agilent 2100 
Bioanalyzer (Agilent Technologies) and assessed with the Eukaryotic Total RNA 
Nano program according to the manufacturer's instructions. RNA integrity number 
score was made sure that for all samples were at least 9. Transcriptomic alignments 
were identified with bowtie-0.12.8 (Langmead et al., 2009), samtools-0.1.18, and 
tophat-2.0.4 (Trapnell et al., 2009) against the University of California Santa Cruz 
hg19 reference transcriptome from the Illumina iGenomes resource.  
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Gene counts were estimated using HTSeq-0.5.3p3(http://www-
huber.embl.de/users/anders/HTSeq/).Transcripts per million were calculated as 
recently described (Wagner et al., 2012). Count data from the Top Hat-HTSeq pipeline 
were analysed using three different methods for differential expression detection, i.e., 
DESeq, baySeq, and edgeR (Robinson et al., 2010, Anders and Huber, 2010, 
Hardcastle and Kelly, 2010). Gene transcript abundances between ePCs and EnSCs 
were considered significantly different if the false discovery rate value (baySeq and 
edgeR) or adjusted P value (DESeq) was < .01. Differentially expressed genes were 
retained if they were detected by at least two of the methods used.  
2.2.4 Primer designing 
Sequences were obtained from the PubMed Human Genome database 
(https://www.ncbi.nlm.nih.gov/gene/). Primers were designed using Primer-Blast and 
Universal Probe Library Assay Design Center from Roche. Primers were designed 
were checked whether they followed the following requirements: Melting temperature 
(Tm) was made sure to be between 58.0°C and 59.9°C. Tm was made to differ 
between forward and reverse primer by greater than 1˚C. Total amplicon length was 
set to between 75 and 110 base pairs. At the 3’ end of the primer, of the last five 
bases, two bases should be either G or C. There is no more than four of the same 
base consecutively. Primer length was set to be between 18-24 bases. Primers are 
required to be exon spanning. Melting temperature (Tm) is calculated with the formula 
Tm = 69.3 + (41(GC/L)) - (650/L), where GC is the number of G and C bases in the 
primer and L is the number of nucleotides in the primer. Designed primers were cross-
referenced using the Primer 3 Output Programme. 
2.2.5 Primer efficiency 
Primers were optimised to determine efficiencies. Forward and reverse primers were 
used at 300nM in a total volume of 19μl in an SYBR Green master mix and loaded 
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onto a 96-well plate. 1μl of pooled cDNA or 1μl nuclease free water was added per 
well in triplicate. The amplified product of the triplicate well combined, mixed with 
loading dye and ran on a 1% agarose gel, which ran for approximately 50 minutes at 
100V. The purified product was excised from the gel using Qiagen Gel Extraction Kit 
(as described below) and cDNA concentration measured. Purified cDNA was serially 
diluted between 100pg/μl to 10ag/μl in 1/10 dilution factor providing eight dilutions. 
The serial dilutions were amplified using the appropriate primers and an SYBR Green 
Master Mix and Ct Values measured. The log of the concentration of cDNA was 
plotted against average Ct values. To calculate primer efficiencies, the following 
calculation was used.  
Primer efficiency= 
−1
10 the gradient of the line
 
2.2.6 RNA extraction 
To minimise risks of RNA degradation, RNase-free plastic-ware and nuclease free 
water was used throughout, and the surfaces were cleaned with RNase ZAP. Total 
RNA was extracted from cells and tissues using STAT-60 reagent- a monophasic 
solution of phenol and guanidine isothiocyanate, which maintains RNA integrity and 
disrupt other cellular components.  400μl of reagent RNA Stat-60 reagent was added 
per well in a 6 well plate ensuring all cells were covered. Cells were scraped 
thoroughly using a Corning cell scraper and transferred to pre-chilled RNase-free 
1.5ml Eppendorf tubes, placed on ice. Cold chloroform (neat) in a 20% volume of 
initial STAT-60 was added to the solution and mixed well by vortexing. This solution 
was allowed to stand at room temperature for 5 minutes and was transferred to dry 
ice. Samples were stored at -80°C. Samples were defrosted on ice and centrifuged at 
12,000 x g at 4°C for 30 minutes to separate the sample into an aqueous and an 
organic phase. RNA remains exclusively in the colourless upper aqueous phase. The 
aqueous phase was carefully transferred into 50% volume of cold isopropanol(neat), 
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incubated at room temperature for 10 minutes to precipitate the RNA. RNA was 
pelleted by centrifugation at 12,000 x g at 4°C for 15 minutes, washed twice with 1ml 
70% cold ethanol and air-dried for 2 minutes. The pellet was dissolved in an 
appropriate volume of nuclease-free water. RNA concentration and quality were 
assessed by Nanodrop. Satisfactory values were considered equal to or greater than 
1.80 on the 260/280 absorbance scale, indicating pure RNA without any protein 
contamination. Samples were stored at -80°C or cDNA synthesis was carried out. 
2.2.7 cDNA synthesis 
For cDNA synthesis, I used QuantiTech Reverse Transcription Kit (Qiagen). All 
reagents were thawed on ice, mixed and centrifuged briefly to prevent any 
concentration gradients. gDNA wipeout buffer(7x) in a volume of 2 µl was added to 
1μg of template RNA made up to a total volume of 14μl with RNase-free water, to 
remove any traces of genomic DNA. The samples were incubated at 42°C for 2 
minutes and placed immediately on ice. A reverse transcription master mix was 
prepared to a volume of 10% greater than that required. Per reaction, 1μl of 
Quantiscript Reverse Transcriptase was added to 4μl 5x Quantiscript RT Buffer, along 
with 1μl RT Primer Mix. This was then added to the 14μl template RNA, reactions 
were mixed and stored on ice. Minus RT controls were also used in which 1μl 
nuclease free water replaced the 1μl of Quantiscript Reverse Transcriptase. All other 
stages were identical. Reactions were incubated at 42°C for 30 minutes, then 
inactivated by incubation at 95˚C for 3 minutes. cDNA samples were diluted with 30µl 
nuclease free water to give a final volume of 50µl.    
2.2.8 Gene expression analysis by qRT-PCR 
Genes of interest were amplified using SYBR Green detection reagent. Reactions 
were carried out on a 96-well plate in a total volume of 20μl. Primers were used at a 
concentration of 300nM and a 50:50 ratio between forward and reverse primers. 1μl 
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of cDNA template was added to the well and set up in triplicate for technical replicate. 
Non-template controls in which 1μl nuclease free water replaced the cDNA were also 
used. The optical plate was sealed with an optical cover, briefly centrifuged to remove 
air bubbles and placed in the qRT-PCR machine.  Thermocycling conditions were as 
follows:   1) 50°C for 2 mins 2) 95°C for 10 mins 3) 95°C for 15 seconds 4) 60°C for 1 
min Dissociation curves were also run to determine that the amplified products were 
specific, and that SYBR Green I fluorescence is a direct measure of accumulation of 
the product of interest.   
2.2.9 Secretome analysis 
Conditioned media collected from decidualized and undifferentiated EnSC cultures as 
well as embryo droplets were randomized and assayed in duplicate for 45 cytokines, 
chemokines and growth factors [BDNF, EGF, Eotaxin (CCL11), FGF-2 (FGF basic), 
GM-CSF, CXCL1 (GROα), HGF, IFNγ, IFNα, IL-1RA, IL-1β , IL-1α, IL-2, IL-4, IL-5, IL-
6, IL-7, CXCL8 (IL-8), IL-9, IL-10, IL-12 p70, IL-13, IL-15, IL-17A, IL-18, IL-21, IL-22, 
IL-23, IL-27, IL-31, CXCL10 (IP-10), LIF, CCL2 (MCP-1), CCL3 (MIP-1α), CCL4 (MIP-
1β), βNGF, PDGF-BB, PLGF, CCL5 (RANTES), SCF, CXCL12 (SDF1α), TNFα, LTA 
(TNFβ), VEGF-A, VEGF-D] using a multiplex suspension bead immunoassay 
(Ebioscience), according to the manufacturer’s protocol and as described previously 
43, but with some modifications. Briefly, 50 μL of conditioned media was mixed with 
50 μL of antibody-conjugated, magnetic beads in a 96 DropArray plate (Curiox 
Biosystems, Singapore) and rotated at 450 rpm for 120 min at 25°C while protected 
from light. Beads were internally dyed with different concentrations of two spectrally 
distinct fluorophores and covalently conjugated to antibodies against the 45 cytokines, 
chemokines and growth factor. The plate was washed three times with wash buffer 
(PBS, 0.05% Tween-20) on the LT210 Washing Station (Curiox) before adding 25 μL 
of the secondary antibody and rotating at 450 rpm for 30 min at 25°C protected from 
light. Subsequently, the plate was washed three times with wash buffer, and 10 μL of 
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streptavidin-phycoerythrin added and rotated at 450 rpm for 30 min at 25°C protected 
from light. The plate was again washed thrice with a wash buffer; 60 μL of reading 
buffer was then added, and the samples read using the Bio-Plex Luminex 200 
(BioRad). The beads are classified by the red classification laser (635 nm) into its 
distinct sets, while a green reporter laser (532 nm) excites the phycoerythrin, a 
fluorescent reporter tag bound to the detection antibody. Quantitation of the 45 
analytes in each sample was then be determined by extrapolation to a 6-point 
standard curve as the amount of fluorescence detected by the reporter laser is 
proportional to the amount of target present in the sample where data analysis of 
experimental data was carried out using five-parameter logistic regression modelling 
47.  Calibrations and validations were performed before runs and on a monthly basis 
respectively. Twenty-two factors [FGF-2 (FGF basic), GM-CSF, IFNγ, IFNα, IL-1RA, 
IL-1β, IL-1α, IL-2, IL-5, IL-7, IL-9, IL-10, IL-15, IL-17A, IL-21, IL-22, IL-23, IL-31, 
PDGF-BB, PLGF, SCF, LTA (TNFβ)] with measurements missing from >50% of 
samples were excluded. 
2.2.10 Human embryo culture 
The ethics committee of the Institutional Review Board of the University Hospital (UZ 
Brussel, Vrije Universiteit Brussel) and the Belgian Federal Ethical Committee for 
Scientific Research on Human Embryos approved this study and reviewed and 
approved the informed consent form. All experiments were performed in accordance 
with relevant guidelines and regulations. Vitrified day 5 blastocysts, which became 
available for research with written informed consent and after the legally determined 
storage period of five years, were warmed using the Vitrification Thaw Kit (Vit Kit-
Thaw; IrvineScientific) and left to recover for 3 hours before morphological scored by 
an experienced independent clinical embryologist (according to Gardner and 
Schoolcraft criteria) (Table S2) 44,45. For assisted hatching, the zona pellucida was 
removed by pronase treatment (1 mg/ml; Sigma) for 10 min at 37°C. The resulting 
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zona-free blastocysts were washed 3 times in human tubal fluid (HTF) 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (IVF Basics) medium 
containing albumin (CAF-DCF, Brussels, Belgium). Blastocysts were left to recover 
for 3 hours from pronase treatment and scored again on morphology (data not 
shown). Good quality late day 5 blastocysts were allocated randomly to pooled culture 
supernatant of undifferentiated EnSCs and cells decidualized for 2 or 8 days. The 
blastocysts were incubated undisturbed for 24 hours at 37°C in 5% carbon dioxide 
and 6 % oxygen. Day 6 blastocysts were morphologically evaluated, and growth rates 
(0, 1 or 2) determined, reflecting the degree of development based on expansion and 
morphology scores of inner cell mass (ICM) and trophectoderm (TE). A growth rate 
of ‘0’ denotes that the embryo was degraded or failed to develop further; ‘1’ indicates 
moderately or significantly expanded embryo with a “C”-score for the TE and/or ICM; 
and significantly expanded embryos with ≥ “B”-score for the TE and/or ICM were 
scored ‘2’ (Table S2). The microdroplets were stored individually at -80°C for multiplex 
secretome analysis. 
2.2.11 Real-time analysis   
Real-time quantitative polymerase chain reaction was used to determine mRNA 
abundance, indicative of gene expression, using the ABI PRISM 7500 Sequence 
Detection System. An SYBR Green based assay was used in which a fluorescent 
signal is emitted once SYBR Green is incorporated into double-stranded DNA. 
Therefore, as the PCR progresses, higher quantities of double-stranded DNA 
accumulated and is measured at each cycle, thus allowing DNA concentrations to be 
quantified and assigned a Ct (cycle threshold) value. Ct values are defined as the 
number of cycles required for the fluorescent signal to cross a given threshold (i.e. 
exceeds background level). The analysis was carried out using the Delta Delta Ct 
Method, by which comparisons between the Ct values of the samples of interest with 
a control or normalizer such as a non-treated sample. The Ct values of both the 
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normalizer and the samples of interest are adjusted to the housekeeping gene L19. 
This results in a fold change value indicating the relative fold change of expression 
between the sample of interest and the normalizer. 
2.2.12 Cell migration and proliferation-real time analysis 
A Real-Time Cell Analyser (RTCA) DP xCELLigence instrument, was utilised with 
specialised microtiter culture plates containing an interdigitated gold microelectrode 
for assessing cell proliferation and migration. The principle in which xCELLigence 
works is that cell contact with the electrode increased the impedance across these 
gold arrays and reported as an arbitrary ‘cell index’ value as an indication of 
confluency and adherence. ePCs and EnSCs cells were seeded into 16-well E-plates 
at a density of 10,000 cells per well and cultured in DMEM supplemented with 10% 
FBS until confluent. The RTCA DP instrument was placed at 37°C in a humidified 
environment with 5% CO2. Individual wells within the E-plate were referenced 
immediately and monitored first every 15 min for 3 hours and then hourly for 2-3 days. 
Changes in cell index were captured and analysed using the RTCA Software v1.2 
supplied with the instrument.  
2.2.13 Gel contraction measurement 
For measuring the contractibility force, cells were cultured up to 90% confluence. The 
media for this assay was prepared by following the formulations as mentioned below 
(contraction media): 
10X DMEM 135 µL 
0.5M NaHCO3 118 µL 
1M NaOH 13.5µL 
L-Glutamine 13.5µL 
P/S 13.5µL 
FCS 67.5µL 
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Water 58.6mL 
 
The cells were trypsinized and resuspended in the contraction media. The number of 
cells was enumerated using automated Luna cell counter. The cells were centrifuged 
and resuspended in collagen containing media which was prepared as follows: 
Collagen Type I 675 µL 
1M NaOH 12.6µL 
Cells 106/mL 105 µL 
 
The cells in collagen gel (1.5 ml) was pipetted into 6-well plates. This step was carried 
on ice to prevent the gelation of collagen. The plates were incubated in incubator till 
the gel was set. DMEM with 5% FBS (1.5ml) was added to the solid gel to feed the 
cells within the gel.  The following day, the gel was dislodged from the plate using a 
gauge needle. The plate with floating gel was incubated further, and the media was 
changed to DMEM with 1% FBS after 8 hours. The gels were passed on to our 
collaborators in engineering department where the gel contraction per single cell was 
measured using a depth sensing indentation device.  
2.2.14 Measurement of oxygen consumption rate 
A day before the experiment, Flux Pak was hydrated by adding 1 ml of XF calibrant 
solution to the bottom plate. Care was taken not to scratch or damage the bottom of 
the electrodes. The Flux Pak was incubated in the 37oC, no CO2 incubator, overnight. 
XF Media was prepared with 200 ml of seahorse DMEM media by adding 0.9 of 
glucose (25mM) and 2ml of sodium pyruvate (100mM). pH was adjusted to 7.4. The 
drugs were prepared from stock for the following concentrations: (i)Oligomycin: 10 
mM;(ii) Carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone (FCCP):10 mM 
(iii)Rotenone: 20 mM. Each drug was prepared in 4 ml volume in 10x the 
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concentration so that when mixed with the media it achieves the expected 
concentration.  The XF seahorse instrument was switched on and was allowed to run 
overnight to maintain the temperature. On the day of the experiment, XF media was 
filtered using a syringe filter. DMEM media from the XF cell culture plate was removed, 
and 650 ul of XF media was added to each well-containing cells (20,000 cells/well), 
incubated at 37oC with no CO2 for 1 hour. The drugs were loaded to ports of the 
Fluxpak in the following order. A: Oligomycin: 75µl; B: FCCP: 83 µl; C: Rotenone: 93 
µl. While the cells were in incubation, the software was programmed, and calibration 
step was carried out using Fluxpak with drugs. The program was run; the output was 
saved and analysed.  
2.2.15 Colony forming unit assay 
Freshly isolated stromal cells after Ficoll gradient separation and freshly isolated 
ePCs and EnSCs were seeded at a clonal density of 50 cells/cm2 in a fibronectin 
coated 60mm dish or 6-well plate in culture medium containing basic fibroblast growth 
factor (bFGF) (10 ng/ml) (Merck Millipore, Watford, UK). Half media change was 
carried out on day 7, 10 and 12. The cells were either stained or passaged on day 15. 
The staining was done using hematoxylin. Clusters of ≥ 50 cells were counted, and 
the CE was determined from the formula:  
CE (%) =  
𝐧𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐜𝐨𝐥𝐨𝐧𝐢𝐞𝐬
𝐧𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐜𝐞𝐥𝐥𝐬 𝐬𝐞𝐞𝐝𝐞𝐝
 × 100. 
2.2.16 Physoxia induction 
Physoxia was induced using Modular Incubator Chamber (Billups - Rothenberg Inc. 
California) and a cylinder containing 3% oxygen. The chamber was charged every 
day with 3% oxygen for 4 minutes at 20 bar pressure. The tightly sealed chamber 
containing the plates were maintained at 37°C with 5% CO2 along with the control 
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cells without physoxia. Each condition was carried out in triplicates. At the end of 10-
day incubation, the cells were treated for further experiments or harvested for RNA. 
2.2.17 Differentiation 
For decidualization experiments, colonies from ePCs and EnSCs were placed in 
phenol red-free 2% DCC-FBS supplemented DMEM-F12 overnight, and hormonal 
treatments were carried out the following day. For standard decidualization treatment, 
eMSCs and eTAs were treated in phenol red-free DMEM/F12 containing 2% DCC-
FBS with 0.5mM 8-bromo-cAMP in combination with and 1µM medroxyprogesterone 
acetate. All experimental treatments were carried out in a reverse time course up to 
eight days. 
2.2.18 In vitro angiogenesis assay 
Aliquots of frozen Corning Matrigel (Fisher Scientific) was placed on ice, and a 
micropipette tip box was kept in the freezer to prevent the matrix formation while 
dispensing. Chilled Matrigel (50 µL) was added to each well and was incubated in 
37oC for 1 hour. After incubation, 5x104 cells harvested from eMSCs and eTAs were 
added on top of the Matrigel in 200 µl volume of Medium 200 containing Low Serum 
Growth Supplement (LSGS). The cells were incubated in 37oC overnight. Following 
day, wells were imaged using phase contrast microscope with 4x objective. The 
images were quantified for the area covered by either cells or tubes using ImageJ 
thresholding method. 
2.2.19 ERB formation  
While carrying out in-vitro angiogenesis assay, I fortuitously observed the formation 
of tissue structures (ERBs) on the surface of Matrigel. This protocol was designed 
and optimised for ERB formation. 
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ePCs and EnSCs were subjected to CFU-A assay to enrich eMSCs and eTAs and 
was allowed to grow for 12 days. On day 12, colonies were washed with sterile PBS, 
trypsinized and enumerated using automated Luna cell counter. The cells were 
resuspended in Media 200 which was supplemented with LSGS supplement. 
Aliquoted Matrigel which was stored in -20oC was thawed on ice for 13-15 minutes. 
Once Matrigel is liquefied, 50 µl was pipetted into a well of 96 well plate. 105 MSCs or 
TAs were added to the Matrigel and media was made up to 200 µl. The plate was 
then incubated at 37oC with 5% CO2. Following day, plates were assessed for ERB 
formation.  
2.2.20 Time-lapse imaging  
The formation of ERB was recorded for 48 hours for every 10 minutes using an 
Olympus microscope. The temperature control system and CO2 were turned on a day 
before the experiment to equilibrate the setup and to maintain the conditions similar 
to the incubator. The set up involved a glass bottom dish with a clonal ring which 
formed a similar surface area of a 96-well plate. The same method for ERB formation 
was followed.  
2.2.21 ERB co-culture 
ERBs were allowed to form from MSCs following the protocol mentioned earlier. 
Human endometrial epithelial cells were cultured from frozen in a T25 flask were 
harvested and counted using automated Luna cell counter. 104 epithelial cells were 
added to the preformed ERB and incubated for three days. After three days, ERBs 
were fixed using 4% Formalin.  
2.2.22 ERB paraffin embedding/sectioning 
The ERBs were fixed using 100 µl formalin for 30 minutes and were transferred from 
Matrigel to 0.6 ml Eppendorf tube caps using a gauge needle and bent glass pipette. 
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1% agarose made with sterile PBS was added on to the ERB to fill the cap. The 
agarose disc, once set, was transferred into a Cell path system II hex cassette for 
processing overnight using Leica ASP200 S Fully Enclosed Tissue Processor. The 
processed agarose pad within the cassette was then set in paraffin wax and kept at 
4oC to form a block. The paraffin wax was placed on ice for at least half an hour to 
prevent wax from shredding while sectioning.  
Paraffin sections were done using a microtome to 5 µm thickness and allowed to float 
in a water bath at 40 oC and then placed onto glass slides. The excess wax on the 
slide was removed by placing the slides in the oven at 65 oC. 
The slides were rehydrated by a transferring across series of baths of xylene, 100% 
and 70% isopropanol and then rinsed in distilled water. Then slides were placed into 
citrate buffer (pH 6.0) and pressurised in a Pickcell unit for 2 hours and allowed to 
stand overnight. The slides were then gently washed with distilled water, and the 
tissue section was marked using a hydrophobic pen.    
Slides were then blocked with 1% BSA for 1 hour at 4oC and then incubated in primary 
antibody (1:200) overnight at 4oC. The following day, slides were washed with 1% 
BSA for 20 minutes at 4oC on rolling stage. Slides were incubated with secondary 
antibody for 1 hour at the same concentration as the primary antibody. Slides were 
then washed with 0.2% TBS-T for 30 minutes on a shaker. Slides were mounted using 
Vector hard set 4',6-diamidino-2-phenylindole (DAPI) and covered with a coverslip. 
Slides were allowed to dry and imaged by confocal and spinning disk microscopy.   
2.2.23 Effect of agitation 
To check the effect of agitation, preformed ERBs and preformed ERBs with epithelial 
cells were transferred into a new 96-well plate with organoid media and was agitated 
using an orbital plate shaker at 250 rpm for over two days. 
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2.2.24 ERB decidualization 
ERBs were formed in the presence of angiogenic medium (Medium 200 
supplemented with LSGS) and was left undisturbed for 48 hours. After 48 hours, the 
angiogenic media was withdrawn and was incubated in DMEM supplemented with 
2% DCC for 1 hour. Following that, MPA and cAMP were added to the low serum 
media and was maintained for 0,2,4,6,8 days. After six days, the ERBs were fixed 
with formalin and stained with hematoxylin and eosin. The rest of the ERBs were 
maintained in low serum media supplemented with cAMP and MPA for eight days, 
following a reverse time course, RNA was harvested using STAT-60.  
2.2.25 ERB physoxia vs. hyperoxia culture 
Previously I found that oxygen concentration has a significant effect on some colonies 
formed and size of the colonies, I wanted to analyse whether it has some effect on 
the formation of ERBs. CFU-A was carried out in physoxia and hyperoxia using freshly 
isolated ePCs. The cells were cultured up to ten days and trypsinized using trypsin-
EDTA. The number of cells was enumerated using automated Luna cell counter. 105 
MSC cells were seeded in Matrigel in the presence of angiogenic media.  
The cells were exposed to different oxygen concentrations in the following way: 
Physoxia eMSCs           Physoxia for ERB formation 
Physoxia eMSCs           Hyperoxia for ERB formation 
Hyperoxia eMSCs           Physoxia for ERB formation 
Hyperoxia eMSCs           Hyperoxia for ERB formation  
The dishes were checked for ERBs the following day and imaged using phase 
contrast microscope using 4x objective. The ERBs were then measured using 
ImageJ. 
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2.2.26 Statistical analysis 
GraphPad Prism 6 (GraphPad Software Inc.) was used for statistical analyses. Data 
were checked for normal distribution using Kolmogorov-Smirnov test. Unpaired or 
paired t-test was performed, as appropriate, to determine statistical significance 
between groups for normally distributed data. Mann-Whitney U test was used for non-
normally distributed data. For comparing more than three groups, the data were 
analysed using One-way Analysis of Variance (ANOVA), followed by t-test with 
Bonferroni adjustment for pairwise comparisons. P < 0.05 was considered significant. 
Hierarchical clustering using Euclidean distance (MeV version 4.9.0) was performed 
on the cytokine profiles after the normalisation of significantly differential factors by 
first centring the data to the median and scaling it by division with the standard 
deviation. Secretome data was further analysed by partial least squares regression 
(PLSR) modelling (Unscrambler X version 10.1) after the normalisation of data by first 
centring the data to the median and scaling it by division with the standard deviation. 
Full cross-validation was applied in PLSR to increase model performance and for the 
calculation of coefficient regression values. The Chi-square test was used to 
determine differences in embryo growth rates. 
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3 Assessment of the robustness of clonal EnSCs isolated 
from mid-luteal biopsies. 
3.1 Introduction 
 
Several studies reported a positive effect of endometrial injury during secretory phase 
on implantation in women suffering recurrent implantation failure following IVF 
treatment (Barash et al., 2003, Raziel et al., 2007, El-Toukhy et al., 2012, Potdar et 
al., 2012, Karimzadeh et al., 2009, Narvekar et al., 2010, Gnainsky et al., 2010, Almog 
et al., 2010). How endometrial trauma or injury improves implantation and clinical 
pregnancy rates in subsequent cycles are unclear at present. Notably, tissue injury 
was first reported to trigger decidualization in the guinea pig over a hundred years 
ago (Loeb, 1907). In fact, trauma has been used as a means to induce decidualization 
in various animal models, including mice (Bany, 2013). Trauma can be caused by 
intraluminal needle scratch, running a thread or, less traumatic, infusion of sesame oil 
through the uterine lumen (Croy et al., 2013).  
In clinical setting, endometrial injury/biopsy/trauma is termed as ‘endometrial scratch’. 
Endometrial scratch is a routine and easy procedure that is being carried out in 
implantation clinic prior to IVF for improving the chance of embryo implantation (Nastri 
et al., 2013).Endometrial scratching is carried out using Pipelle biopsy. This intentional 
damage to endometrium was reported to increase the chance of pregnancy in ART 
(Barash et al., 2003). Though the mechanism of how scratch improves the pregnancy 
is not explored, there are speculations of how it might work: (i) the scratch in previous 
cycle might induce decidualization thus increasing the chance of pregnancy (Li and 
Hao, 2009, Garris and Garris, 2003); (ii) might increase the secretion of factors that 
aid in implantation (Gnainsky et al., 2010); (iii) scratch might alter the asynchronous 
endometrium (Li and Hao, 2009). 
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The impact of tissue injury triggered by a biopsy, commonly referred to as an 
‘endometrial scratch’, on endometrial stem cell populations has not yet been 
investigated. However, there are insights from other tissues. For example,  a recent 
study identified two populations of quiescent stem cells in muscle:  G0 and GAlert cells  
(Rodgers et al., 2014). Characterization of GAlert cells revealed that these cells are in 
an intermediate state between quiescence and activation, i.e. poised to proliferate in 
respond to environmental stimuli like tissue damage without a need for an activation 
stage (Rodgers et al., 2014).  
Wound healing following injury depends on coordinated interplay between various 
cells, growth factors and extracellular matrix proteins (Wu and Chen, 2014). In the 
case of vascular injury, cytokines released by vascular endothelium and activated 
platelets alter the stem cell niche and mobilise hematopoietic stem cells by providing 
a signalling gradient enabling homing to the site of injury. A similar mechanism might 
operate in the endometrium following physiological (e.g. menstruation and 
parturition), pathological (e.g. miscarriage) or iatrogenic tissue injury (Youn et al., 
2011). 
Puck and Marcus first reported clonogenic assay when clones formed from single 
mammalian cell when seeded in a suitable medium (Puck and Marcus, 1956). 
Following this, various in vitro techniques were developed for various kinds of stem 
cells. Eventually clonogenic assay became an alternate method for demonstrating its 
functional properties. Clonogenic property was used as a tool to identify adult stem 
cells based its ability to form colonies when seeded in low cellular density (Franken 
et al., 2006). Both epithelial and stromal cells isolated from endometrial basalis have 
the potential to form colonies when subjected to colony forming unit-fibroblast (CFU-
F) assay. A small population of human endometrial epithelial cells (0.22–0.52%) and 
stromal cells (1.25%) was shown to possess clonogenic activity in vitro (Chan et al., 
2004). Both epithelial and stromal cells initiated two forms of colonies (i) small, loosely 
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arranged and (ii) large, densely packed. Most of the colonies were small, and near 
about 37% of epithelial colonies were large and in case of  stromal cells only 1 in 60 
colonies were large (Chan et al., 2004). It is postulated that larger colonies are formed 
by committed progenitor cells with higher proliferation capability whereas the smaller 
colonies are formed by less proliferative transient amplifying cells. Also the stem cells 
with ability to form larger colonies are capable of entering the cell cycle when placed 
in a favourable in vitro environment, as stem cells have large nucleus-cytoplasmic 
ratio (Radley et al., 1999). 
The role of endometrial tissue injury in improving implantation and life birth rates has 
been the subject of considerable controversy. Interestingly, there are yet no studies 
on the impact of endometrial injury on life-birth rates in recurrent miscarriage patients.  
In this chapter, I used CFU-F to quantify clonal (eMSCs / TA cells) in the endometrium 
following biopsy-induced endometrial injury. The clonogenic assays were performed 
in patients who attended the Implantation Research Clinic with a history of early 
pregnancy loss and nulliparous patients undergoing IVF treatment.  The recurrent 
miscarriage was defined as 3 or more consecutive miscarriages and ‘sporadic 
miscarriage’ as less than three miscarriages.  
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3.2 Results 
3.2.1 Study cohort: demographic variables 
Luteal-phase endometrial biopsies were obtained in 2 consecutive cycles from 
eighteen women. The miscarriage group consisted 10 women, 7 of which suffered 
recurrent miscarriages and 3 sporadic miscarriages. The infertile group was 
heterogeneous, consisted of 8 infertile patients receiving IVF treatment for 
unexplained infertility, male factor and Polycystic ovary syndrome (PCOS). 
Demographic and clinical details are summarised in Table 3.1. The median (± SEM) 
age of the miscarriage and infertile groups was 35 (± 1.5) years and 37 (±1.4) years 
respective (P > 0.05). The median body mass index (BMI) in the miscarriage and 
infertile groups were comparable (BMI: 23± 1.7 and 20 ± 0.8, respectively), although 
the data were incomplete. 
3.2.2 Miscarriage versus Infertile: Colony-forming unit-
fibroblast (CFU-F)  
Primary endometrial stromal cells were isolated from all biopsies as described in 
Chapter 2 and frozen at -80°C until further analysis. To assess the CFU-F, frozen 
endometrial stromal suspensions from paired biopsies were thawed and subjected to 
colony forming assays. To evaluate the robustness of the assay, each assay was 
performed in triplicate. Figure 3.1 and Figure 3.2 show colony formation in the 1st and 
2nd biopsy from miscarriage and infertile groups, respectively. 
The average (± SEM) CFU-F activity of stromal cells in the 1st biopsy was significantly 
lower in the miscarriage group (2.06 ± 0.9%) when compared to infertile group (5.36 
± 0.97%), P < 0.05 (Figure 3.3 A). However, in the 2nd biopsy endometrial CFU-F 
activity in miscarriage group was comparable to the infertile group: 5.23 ± 1.1% versus 
3.23 ± 0.7%, respectively (P > 0.05; Figure 3.3 B).  
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Comparison of CFU-F activity of stromal cells between 1st and 2nd biopsy in each 
patient group showed that tissue injury significantly increased CFU-F activity in the 
miscarriage group (P < 0.05), but not in the infertile group (Figure 3.4 A, B). Notably, 
increased number of colonies was observed in 6 out of 7 recurrent miscarriage 
patients, and 2 out 3 patients who suffered sporadic miscarriages in the miscarriage 
group. CFU-F activity in miscarriage group was 2.06 ± 0.9 % and 5.23 ± 1.1 % (mean 
± SEM, n=10) for the 1st and 2nd biopsy, respectively. In infertile group, CFU-F activity 
was 5.36 ± 0.97 % and 3.23 ± 0.7 % (mean ± SEM, n=8) for the 1st and 2nd biopsy, 
respectively.   
There is a significant increase in the fold induction of CFU-F activity in miscarriage 
group compared to infertility group (P < 0.05) (Figure 3.5). The data suggest that the 
CFU-F which was low following first biopsy increases following the endometrial injury 
in the miscarriage group whereas there was no difference in the case of the infertile 
group. 
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Table 3.1. Characteristics of women from whom the biopsies were obtained. 
ID Age Live-births 1st trim loss BMI Phase Other 
1.1 29 0 5 17 S Recurrent miscarriage 
1.2     S  
2.1 42 0 5 24 S Recurrent miscarriage 
2.2 
    
S  
3.1 34 0 4 26 S Recurrent miscarriage 
3.2 
    
S  
4.1 43 0 7 36 S Recurrent miscarriage 
4.2 
    
S  
5.1 31 0 4 23 S Recurrent miscarriage 
5.2 
   
 S  
6.1 31 0 20 21 S Recurrent miscarriage 
6.2 
    
S  
7.1 36 0 9 22 S Recurrent miscarriage 
7.2 
    
S  
8.1 39 0 1 25 S Sporadic Miscarriage 
8.2 
    
S  
9.1 36 Un  2 23 S Sporadic Miscarriage 
9.2 
    
S  
10.1 32 0 1  Un S Sporadic Miscarriage 
10.2     S  
11.1 37 0 0 Un  S Infertility 
11.2 
    
S  
   12.1 37 0 0 Un S Infertility 
12.2 
    
S 
 
13.1 41 0 0 22 S Infertility 
13.2 
    
S 
 
14.1 37 0 0 24 S Infertility 
14.2 
    
S 
 
15.1 29 0 0 20 S Infertility 
15.2 
    
S 
 
16.1 39 0 0 Un  S Infertility 
16.2 
    
S 
 
17.1 34 0 0 20 S Infertility 
17.2 
    
S  
18.1 41 0 0 20 S Infertility 
18.2 
    
S 
 
*S stands for secretory phase. Un stands for unknown. 
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Figure 3.1. CFU-F of paired biopsies from miscarriage patients. 
The abundance of clonogenic cells in the follow-up biopsies in women with 
miscarriages compared to the initial biopsies. Representative images of CFU-F assay 
plates in triplicates  obtained after subjecting primary EnSCs to colony-forming 
assays. RM denotes recurrent miscarriage and SM for sporadic miscarriage.
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Figure 3.2. CFU-F of paired biopsies from the infertile group. 
Reduction of clonogenic cells in the follow-up biopsies in women with other infertility 
(INF) issues, compared to the initial biopsies. Representative images of CFU-F assay 
plates in triplicates obtained after subjecting primary EnSCs to CFU-F assay. 
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Figure 3.3. Cloning efficiency comparing miscarriage and infertility groups 
Colonies with > 50 cells were counted, and cloning efficiency (CE) calculated. A. CE 
between the first biopsies in women with miscarriage and infertile group. B. Cloning 
efficiency of second biopsies in women from miscarriage and infertile group.  * 
indicates P < 0.05. Data represent mean ± median. 
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Figure 3.4. Cloning efficiency comparing first and second biopsies within each group 
Colonies with > 50 cells were counted, and cloning efficiency (CE) calculated. A. Comparison of CE between the first biopsy and the second 
biopsy in women who had miscarriages. B. Cloning efficiency of first and second biopsy in the infertile group.  * indicates P < 0.05. Data represent 
mean ± median. Each sample pair is coded with the same colour
B A 
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Figure 3.5. Relative CFU-F in miscarriage and infertile group. 
Colonies with > 50 cells were counted, and cloning efficiency (CE) was calculated. 
Fold change in CE was calculated between the first biopsy and the second biopsy 
from miscarriage and infertile group.  * indicates P < 0.05. Data represent mean ± 
SEM. 
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3.3 Discussion 
Tissue repair and regeneration following injury or trauma is a coordinated process 
that involves proliferation, migration, and recruitment of stem cells and subsequent 
differentiation into tissue-specific lineage (Li and Clevers, 2010). Stem cells reside in 
their niche to replenish and repair tissues in response to insult. This is achieved by 
their remarkable proliferative capacity. Due to the asymmetric property of stem cells, 
a subset remains in a quiescent state for a prolonged period. The quiescent state of 
stem cells is, therefore, the key to maintaining cellular and tissue homoeostasis (Li 
and Clevers, 2010).  
Quiescent stem cells are characterised by reduced RNA content (Fukada et al., 2007), 
lack of expression of proliferation markers (Gerdes et al., 1983), and the ability to 
retain DNA labels (Conboy et al., 2007). Maintenance of these cells in a quiescent 
state is regulated at epigenetic, transcriptional and post-transcriptional level. Although 
in a quiescent state, stem cells sense environmental stimuli and have the ability for 
re-entering the cell cycle and proliferate (Cheung and Rando, 2013). The quiescent 
state is regulated by mechanisms that are energetically favourable in transforming 
low metabolic stem cells to rapid global responses needed for activation (Cheung and 
Rando, 2013).  
The role of endometrial tissue injury in improving implantation and life birth rates has 
been the subject of considerable controversy. A systemic review and meta-analysis 
of 7 randomised clinical trials (RCT) with 907 participants reported that endometrial 
injury improved clinical pregnancy rates significantly (P < 0.00001) in women with 
recurrent implantation failure (Coughlan et al., 2015). The clinical pregnancy rate 
considerably improved following an injury to the endometrium in women with recurrent 
implantation failure (Confidence interval (CI) 95% CI 2.04–6.01, P <0.00001) and 
suggestive of benefit in women embarking on their first cycle but without significance 
(95% CI 0.93–1.86, P =0.12). Another RCT compared the implantation rates in 115 
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participants who randomised into an endometrial biopsy or control group. Following 
biopsy, the implantation rate in the biopsy group was 10.9% compared to 3.38% in 
the control group. Clinical pregnancy rate was 27.1% in biopsy group whereas it was 
8.9% in the control group. (Karimzadeh et al., 2009).  
The absence of a discernible impact of the biopsy of CFU-A of isolated HESCs from 
infertile subjects was disappointing. However, it should be noted that this patient 
group was clinically heterogeneous. Hence, it would be interesting to assess the 
impact of tissue injury on clonal endometrial cell populations in patients with recurrent 
implantation failure.  
The mechanism underpinning the effects of endometrial injury remains poorly 
understood. A similar mechanism for stem cell recruitment following vascular injury 
might be taking place in human endometrium following biopsy-induced trauma. Upon 
vascular injury, hematopoietic stem cells (HSCs) increase in the circulation in clinical 
and experimental conditions. HSCs need to be mobilised from their bone marrow 
niche to the peripheral circulation to be recruited to the site of injury. This is achieved 
by the release of soluble factors at the injury site that forms a concentration gradient. 
G-coupled protein receptor CXCR4 and its ligand CXCL12 are identified as important 
factors that maintain HSCs within the bone marrow and also for recruitment at the site 
of injury (Rocha and Broxmeyer, 2010).  High levels of CXCL12 retain HSCs within 
the bone marrow, and low levels lead to mobilisation. The CXCL12 level is 
significantly increased in the blood flow following an injury (Petit et al., 2002), and 
expression is partly controlled by oxygen concentration (Ceradini et al., 2004).  
Adhesion molecules within the bone marrow such as Vascular cell adhesion protein 
1 (VCAM-1) (Papayannopoulou and Nakamoto, 1993), hyaluronic acid (Avigdor et al., 
2004) and P- and E- selectins (Xia et al., 2004) are cleaved, releasing  HSCs adhered 
to the niche within the bone marrow. Neutrophil elastases and cathepsin G cleave 
VCAM-1 which releases the adhered stem cells, permitting their mobilisation to the 
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blood stream (Lévesque et al., 2001). Platelets, the first line in wound repair, also play 
a role in recruiting HSCs and MSCs to the injured site. MSCs which are recruited to 
injured sites are capable of differentiating into endothelial cells and releasing 
proangiogenic factors (Langer et al., 2006).  
CXCR4 and CXCL12 or stromal-derived factor 1 (SDF1) interaction, which is vital for 
homing of stem cells to the injured site, is enhanced by nitric oxide, interactions of 
Jagged/Notch and MCP1/CCR2, growth factors such as VEGF and G-CSF.  
Following injury, endothelial nitric oxide (eNOS) increases the expression of SDF-1 
through the cGMP-dependent mechanism, where nitric oxide acts as a gaseous 
signalling molecule, which eventually causes the recruitment of stem cells to the site 
of injury (Li et al., 2009). In Notch knockout mouse models, perturbation in 
neovascularization is apparent, which shows that Notch1 binding to its ligand Jagged 
is involved in the recruitment of stem cells (Kwon et al., 2008). There was reduced 
CXCR4 expression following Notch knockout (Li et al., 2011b). MCP1 and its receptor 
CCR2 act as chemotactic signal responsible for homing and differentiation at the site 
of ischemia (Belema-Bedada et al., 2008). miR-16 family miRNA play a role in G0 to 
G1 transition (Linsley et al., 2007). Epigenetic control of quiescence can be 
maintained by activation loci marked by permissible histone marks. For example, 
H3K4me3-rich genes are functionally important for activation and proliferation (Fuda 
et al., 2009).  
Another likely mechanism could be reprogramming of stromal cells by senescence-
associated secretory profile (SASP) produced from injury-induced decidual cells. 
Animal studies have shown that insult or injury to the endometrium induces 
decidualization. For example, in mice, intraluminal needle scratch, running a thread 
through the uterine lumen, or luminal infusion of oil can induce a decidual phenotype. 
(Deb et al., 2006) (Bany, 2013).  
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My experimental results show that there is an increase in clonal population following 
tissue trauma in the miscarriage group, from which we can speculate that there is an 
activation of the stem cell niche in response to the injury. The endometrial injury is 
thought to correct asynchrony through the wound healing process (Almog et al., 
2010).  
Our recent lab finding reveals that decidualization represents a transitional pathway 
which polarises HESCs into an acutely senescent subpopulation and expanded 
eMSCs population. The acute senescence phenotype was characterised by an 
increase in expression of tumour suppressor proteins such as p53, p16, increase in 
expression of senescence-associated heterochromatin foci proteins such as Histone 
H1, Macro-H2A and H3K9me3. Nuclear size enlarges and is associated with 
decreased Lamin B1 expression. This senescent phenotype results in SASP, which 
drives the decidual inflammatory response. Meanwhile, the expanded eMSCs drives 
anti-inflammatory responses to decidual cues. This transformation renders the 
endometrial stroma into the mature decidual matrix, suitable for pregnancy.  
Tissue injury is associated with accumulation of senescent cells which enhances the 
in vivo reprogramming of the adult cells. Interleukin 6 (IL-6) a component of SASP, is 
shown to be essential for the reprogramming process.  In mice, the expression of the 
four transcription pluripotent factors Octamer-binding transcription factor 4, SRY (sex 
determining region Y)-box 2, Kruppel-like factor 4, C-Myc( OCT4, SOX2, KLF4 and 
MYC),  also induces cellular senescence, and these senescent cells, in turn, produce 
signals that facilitate the reprogramming of neighbouring cells (Mosteiro et al., 2016). 
 
Emerging evidence has implicated endometrial pro-inflammatory cytokines and 
increased the abundance of macrophages and dendritic cells (Gnainsky et al., 2015).  
This is a plausible explanation as a transient inflammatory stromal response upon 
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decidualization has been shown to induce the expression of receptivity markers 
(Salker et al., 2012a). However, recurrent miscarriage is linked to an already 
prolonged and disordered pro-inflammatory decidual response (Salker et al., 2012a, 
Lucas et al., 2016b). Hence, there is a significant need for a clinical trial to assess the 
impact of this procedure in recurrent miscarriage patients. Whether the patient-
specific response to tissue injury relates to intrinsic differences in clonal HESC 
populations warrants further investigations. 
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4 Analysis of the link between aberrant decidualization and 
reproductive failure 
4.1 Introduction 
Implantation is the rate-limiting step in assisted reproduction treatment (Tan et al., 
2014). Clinically, failed implantation is defined by the lack of detectable human 
chorionic gonadotropin (hCG) levels in either serum or urine 14 days after the 
intrauterine transfer of one or more embryos. By default, failed implantation is a 
retrospective diagnosis, rendering it difficult, if not impossible, to discern if caused by 
a hostile endometrium, impaired embryo quality, or an iatrogenic event. Nevertheless, 
genome-wide expression studies have identified endometrial signature genes that are 
predictive of recurrent implantation failure (Tan et al., 2014), defined as the absence 
of pregnancy following serial transfers of high-quality embryos (Koler et al., 2009, Koot 
et al., 2016). Interestingly, these studies have also challenged the prevailing concept 
that implantation failure merely reflects a lack of expression of receptivity genes during 
the window of implantation (Diaz-Gimeno et al., 2011). Instead, the gene signatures 
associated with RIF point towards more fundamental defects in cell cycle regulation, 
cell motility, epithelial-mesenchymal transition (EMT), and signalling pathways 
involved in stem cell maintenance (e.g. WNT and Notch) (Koot et al., 2016, Koler et 
al., 2009).   
Endometrial stromal cells (EnSCs) play a critical role in the implantation process, not 
only by relaying hormonal signals to the overlying surface epithelium (Chen et al., 
2013, Cooke et al., 1997, Li et al., 2011a), but also by controlling the influx and 
function of various immune cells, including uterine natural killer cells (Collins et al., 
2009, Gellersen and Brosens, 2014a, Nancy et al., 2012). Upon invasion, the 
implanting embryo is rapidly surrounded and encapsulated by migrating decidualizing 
stromal cells. As the differentiation process unfolds, gap and tight junctions form 
between decidualizing cells. Consequently, the conceptus becomes anchored in the 
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endometrium and forms a matrix that enables coordinated trophoblast invasion 
(Gellersen and Brosens, 2014a, Wang et al., 2004, Weimar et al., 2013). Growing 
evidence indicates that decidual cells are exquisitely responsive to embryonic signals 
and play a critical role in embryo biosensoring and selection (Brosens et al., 2014c, 
Macklon and Brosens, 2014a, Teklenburg et al., 2010b). On the other hand, 
decidualization transforms EnSCs into secretory cells that determine the embryonic 
microenvironment upon breaching of the luminal epithelium. Whether failed 
implantation can be attributed to an altered endometrial microenvironment that 
impacts directly on embryo development and survival is not known.  
 
Decidualization of the human endometrium is not dependent on embryo implantation 
but initiated during the mid-luteal phase of each cycle in response to the postovulatory 
rise in progesterone and increasing endometrial cAMP levels. Consequently, 
decidualization is a reiterative process, linked to cyclic activation of mesenchymal 
stem-like cells (MSCs) and subsequent differentiation into mature stromal cells in 
regenerating endometrium (Lucas et al., 2016b, Gellersen and Brosens, 2014a). The 
endometrium harbours abundant MSCs that are multipotent, immuno-privileged, and 
highly regenerative (Cervello et al., 2011, Gargett et al., 2012a). Functional repair of 
the endometrium requires activation of poised progenitor cells, induction of transit-
amplifying cells and differentiation of mature progeny, which collectively determine 
the tissue response to deciduogenic and embryonic cues. The mechanisms that 
control this regenerative pathway and ensure homeostatic balancing of the different 
stromal cell populations are poorly understood. Arguably, disruption of this process 
will give rise to dysfunctional EnSCs. Studies on primary EnSC cultures have provided 
ample evidence that programming defects are linked to reproductive failure. For 
example, endometriosis is associated with progesterone resistance, defined by the 
refractoriness of cultured EnSCs to deciduogenic cues (Aghajanova, 2010; Al-
Sabbagh, 2012; Klemmt, 2006; Sherwin, 2010; Velarde, 2009; Aghajanova, 2010; 
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Aghajanova, 2010). By contrast, purified EnSCs from women with a history of 
recurrent miscarriage mount a prolonged and highly disordered pro-inflammatory 
response upon treatment with deciduogenic stimuli (Macklon and Brosens, 2014a, 
Salker et al., 2011b, Salker et al., 2012b, Lucas et al., 2016b).  
In this study, we examined the clonogenicity, decidual response and secretome 
changes in cultured EnSCs purified from mid-luteal biopsies obtained in the cycle prior 
to Assisted reproductive technology (ART). We demonstrate that successful 
implantation is associated with coordinated temporal changes in the secretome of 
differentiating EnSCs that transform a hostile maternal microenvironment into an 
optimal milieu for implantation. We further show that a disordered EnSC secretome 
response precedes sporadic failed implantation following ART.  
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4.2 Results 
4.2.1 Successful versus failed implantation: demographic 
and treatment variables 
Twenty women were enrolled in this study; 18 of Caucasian origin, 1 Indian and 1 
mixed race. None of the women were smokers. Following IVF, ICSI (n = 10) or frozen 
embryo transfer (n = 1) in a natural cycle, 10 subjects had a positive pregnancy test, 
indicating that embryo implantation had occurred. Nine women, including two twin 
pregnancies, had live births. One subject suffered a pregnancy loss at 6 weeks’ 
gestation. The failed implantation group consisted of 10 subjects. As shown in Table 
4.1, there were no significant differences (P > 0.05) in patient characteristics, 
reproductive history, ovarian reserve, treatment characteristics or embryo number 
and quality, as assessed by standard morphological criteria, between the pregnant 
and non-pregnant groups. The median time between the biopsy and embryo transfer 
in the pregnant group was 33 days (range: 30 -36 days) and 35 days (range: 32 - 40) 
days in the non-pregnant group (P > 0.05).  
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Table 4.1. Demographic and treatment details of the study population 
  Pregnant  
(n = 10)* 
Non-pregnant  
(n = 10)* 
Age, years (± SD) 34.0 (±2.9) 35.5 (±3.3) 
Duration of infertility, months (± SD) 35.4 (±15.4) 39.0 (±12.9) 
Cause of infertility Male Factor 
Anovulation 
Unexplained 
Mixed 
Previous live births (range) 
3 5 
1 2 
3 2 
3 1 
0.3 (0-2) 0.1 (0-1) 
ART cycle number (range) 1.5 (1-3) 1.4 (1-4) 
BMI (kg/m2) 24.9 (±3.0) 24.2 (±2.0) 
AMH (pmol/L) 15.2 (±13.3) 24.9 (±22.9) 
AFC 22.3 (±8.9) 27.9 (±19.6) 
IVF 3 (30%) 6 (60%) 
ICSI 6 (60%) 4 (40%) 
FER 1 (10%) 0 
Dose of gonadotropin (IU) 2700.0 (±1002.7) 2448.8 (±872.5) 
Duration of stimulation (days) 11.7 (±1.7) 11.5 (±1.3) 
Number of oocytes collected 14.6 (±6.4) 14.9 (±8.9) 
Single embryo transfer (n) 8 6 
Embryos of good quality (%/total) 91.7% (11) 57.1% (8) 
 
*There was no significant difference (P > 0.05) in patient or treatment characteristics. BMI: 
body mass index, AMH: antimullerian hormone, AFC: antral follicle count, ICSI: 
intracytoplasmic sperm injection, FER: frozen embryo replacement 
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Figure 4.1. The abundance of clonogenic cells in primary EnSC cultures before 
successful (pregnant) or failed embryo implantation (non-pregnant). 
(A) representative images of clones obtained after subjecting primary EnSCs to 
colony-forming assays. (B) Colonies with > 50 cells were counted, and cloning 
efficiency (CE) calculated. Triangles in the failed implantation group indicate primary 
EnSC cultures deficient in clonogenic eMSCs, defined by CE of  1%. 
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4.2.2 Colony-forming unit-fibroblast (CFU-F) activity  
To assess the CFU-F activity of EnSCs, frozen endometrial cell suspensions were 
thawed, expanded in T25 flasks following differential plating, and subjected to colony-
forming assays at passage 1 (Figure 4.1). The average endometrial CFU-F activity 
(mean ± SEM) was 8.1 ± 1.3% and 6.3 ± 1.4% in the pregnant and non-pregnant 
group, respectively (P > 0.05). Notably, endometrial CFU-F activity was  1% in 3 
women who suffered failed implantation, indicating relative MSC deficiency (Figure 
4.1). 
4.2.3 Responsiveness of EnSCs to deciduogenic cues  
For differentiation experiments, EnSCs were plated in 6-well plates, grown to 
confluency, and then treated or not with 8-br-cAMP and MPA for 2 or 8 days.  The 
median time in culture before the decidualization experiments was 22.5 days (range: 
14 - 27 days) and 21 days (range: 12 - 40 days) in the pregnant and non-pregnant 
group, respectively (P > 0.05). The expression of three highly sensitive decidual 
marker genes, PRL, IGFB1 and HSD11B1, was determined at each time-point by RT-
qPCR. As shown in Figure 4.2, decidualization elicited multiple-log increases in the 
expression of all 3 marker genes; but the level of induction varied greatly between 
cultures in both the pregnant and non-pregnant group. Furthermore, there was no 
significant difference (P > 0.05) in the expression of these decidual marker genes 
between the two clinical groups at any of the time-points. Also, the induction of 
decidual marker genes was not distinct in the 3 cultures exhibiting relative MSC 
deficiency (Figure 4.2). 
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Figure 4.2. Induction of decidual marker genes. 
EnSCs from the pregnant and non-pregnant group (n = 10 in each group) were subjected to decidualization for the indicated time-points. Total 
RNA was then extracted and subjected to RT-qPCR analysis. PRL, IGFBP1 and HSD11B1 transcript levels were normalised against the levels 
of L19 and expressed in arbitrary units (A.U.). The induction of decidual marker genes was comparable between the two groups at each time-
point (P > 0.05). Note the logarithmic Y-axis. NP/Low CFU denotes cultures from the non-pregnant group with MSC deficiency. 
96 
4.2.4 Aberrant EnSCs secretome is associated with 
subsequent failed implantation 
While the expression of many decidual genes, including PRL, IGFB1 and HSD11B1, 
increases exponentially as the differentiation process unfolds, a host of cytokines and 
immunomodulators are secreted in a biphasic manner, characterized by a rapid rise 
in response to a deciduogenic signal and followed by a gradual decline (Salker et al., 
2012b). We used a multiplex suspension bead immunoassay to measure the 
secretion of 45 cytokines and immunomodulators in undifferentiated and decidualizing 
cultures. Out of the 23 factors detectable in a majority of samples, 19 were 
differentially secreted upon decidualization of cultures for either 2 or 8 days in the 
pregnant group. The bifurcation in the dendrogram following hierarchical clustering of 
regulated cytokines demonstrate that the decidual secretome profile is more divergent 
on day 2 of differentiation when compared to day 8 or day 0 (Figure 4.3). In the 
pregnant group, differentially secreted factors between undifferentiated cells (day 0) 
and cells decidualized for 8 days (day 8) included IL-13, CXCL1, IL-6 and IL-8. 
The secretome profiles of EnSC cultures from the non-pregnant group were 
qualitatively different and disordered, illustrated by the lack of bifurcation in the 
dendrogram (Figure 4.4). Hierarchical clustering of regulated cytokines showed a 
disordered pattern with both undifferentiated (day 0) and day 8 secretome profiles 
aligning with day 2 samples. When compared to cultures from the pregnant group, six 
factors (LIF, IL-6, VEGF-A, VEGF-D, BDNF, and CXCL12) were no longer 
differentially secreted in cultures associated with ART failure. 
Next, we used partial least squares regression (PLSR) analysis to evaluate the 
temporal multivariate differences in the secretome profiles associated with successful 
or failed implantation. As shown in Figure 4.5, the secretome profiles were less 
divergent in cultures from the pregnant compared to the non-pregnant group, at least 
in undifferentiated cells and cells decidualized for 8 days. The PLSR model indicated 
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that the inherent secretome differences associated with ART failure were most 
pronounced in undifferentiated EnSCs. Decidual transformation of the cultures led to 
a partial convergence in secretome profiles between both clinical groups. Notably, the 
three most divergent cultures on both day 0 and day 8 in the failed implantation group 
corresponded to the cultures with the lowest CFU-F activities (Figure 4.1).  
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Figure 4.3. Divergent EnSC secretome prior to successful implantation 
Differentially secreted factors upon decidualization were hierarchical clustered using a Euclidean distance for the pregnant group. The bifurcation 
in the dendrogram above the heat map in the pregnant group indicates that the secretory response in decidualizing EnSCs is most distinct after 
2 days of differentiation.  
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Figure 4.4. Divergent EnSC secretome prior to failed implantation. 
The same analysis was performed on decidualizing cultures from the non-pregnant group. By contrast, the temporal secretome changes in cultures 
associated with implantation failure (non-pregnant) were both qualitatively different and disordered. The colour keys are depicted on the right of 
the heat maps.
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Figure 4.5. Two-dimensional Partial Least Squares (PLS) loading plots of undifferentiated and decidualized secretomes in primary EnSC 
cultures from pregnant and non-pregnant patients. 
PLS regression analysis was used to evaluate the temporal multivariate differences in cytokine and immune-modulatory secretome profile as a 
result of implantation. The analysis showed that the secretome profiles are less divergent in implantation-positive cultures, at least in 
undifferentiated cells and cells decidualized for 8 days. Furthermore, the differences in secretomes were most pronounced in undifferentiated 
cells. Decidualization leads to convergence of secretomes, although not in MSC-deficient cultures (blue triangles). The X-axis represents Principle 
Component 1 and Y-axis Principle Component 2. NP/Low CFU refers to cultures from the non-pregnant group with MSC deficiency. 
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Regression coefficient values were used to identify factors that are most 
closely associated with successful implantation. CCL3, also known as 
macrophage inflammatory protein 1α (MIP1α), exhibited the highest regression 
coefficient value in undifferentiated cultures, indicating a positive association 
with implantation (Supplementary Figure 1). Congruent with the PLSR plots 
(Figure 4.5), the strength of this association diminished upon decidual 
transformation of EnSCs ( 
 
 
 
 
 
 
Supplementary Figure 2). A combination of weakly associated factors was 
required to generate an association with implantation and secreted factors in 
decidualizing cells ( 
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Supplementary Figure 2). For example, a mixture of a positive factor (IL-6) and 
several negative factors (CCL11, CCL5, IL-18, EGF and VEGF-D), all with regression 
coefficient less than a magnitude of 0.2, is associated with a successful implantation 
in cultures decidualized for 8 days.  
4.2.5 Impact of the EnSC secretome on human blastocyst 
development 
To understand the impact on embryo development due to temporal changes of 
decidualizing EnSC secretome, vitrified day 5 human blastocysts were warmed and 
scored on morphology (Table 4.2). Late day 5 embryos were subjected to assisted 
hatching and then cultured for 24 hours in 40 µl microdroplets of culture supernatant 
of undifferentiated EnSCs and cells first decidualized for either 2 or 8 days. Separate 
pools of culture supernatants were established from the pregnant and non-pregnant 
groups. The morphology of the embryos was rescored following 24 hours of 
incubation, and the development of the embryos was evaluated, and growth rates (0, 
1 or 2) determined. Increasing growth rates correspond to better development (Table 
4.2). Analysis of the embryo growth rates demonstrated that the secretome of 
undifferentiated EnSCs compromised blastocyst development, exemplified by a 
growth score of 0 in 13 out of 23 (57%) embryos. By contrast, only 3 out of 34 (9%) 
embryos had a growth score of 0 when cultured in the supernatant of decidualizing 
EnSCs (Chi-square test: P < 0.005; Figure 4.6 A). There was no statistical difference 
in the growth rates of human blastocysts cultured in the secretome of EnSC 
decidualized for either 2 or 8 days.  Also, no significant differences were found in the 
growth rates between embryos cultured in medium conditioned by EnSC cultures from 
pregnant versus non-pregnant patients, whether decidualized or not (data not shown).  
Finally, the embryonic response to secreted decidual factors was examined more 
closely by comparing the cytokine content of human blastocysts cultured in the 
supernatant of EnSCs decidualized for either 2 or 8 days. Multiplex suspension bead 
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immunoassay allowed quantification of 20 analytes in microdroplets of 18 embryos 
cultured in medium conditioned by early decidualizing cells (day 2) and 19 embryos 
cultured in the supernatant of late decidualizing cells (day 8). Following hierarchical 
clustering, the dendrogram showed that the cytokine/chemokine profiles of embryos 
cultured in the supernatant of EnSCs decidualized for 2 days were unrelated to either 
growth rate or clinical group, suggesting an embryo-specific response (Figure 4.6B). 
By contrast, the secretome profiles of embryos cultured in day 8 supernatant 
clustered, except one sample, with the clinical groups, indicating the lack of a 
significant embryonic secretory response (Figure 4.6 C).  
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Figure 4.6. The impact of EnSC secretome on human blastocysts. 
A, growth rates (scored 0, 1, and 2) of human blastocysts cultured in conditioned medium from undifferentiated (n = 24) and decidualizing EnSCs 
(day 2 and day 8) (n = 33). *** indicates P < 0.005. B, Hierarchical clustering using a Euclidean distance of 20 cytokines and chemokines measured 
in microdroplets of human blastocysts cultured in the conditioned medium of EnSC decidualized for 2 days. P: pregnant, NP: non-pregnant, GR: 
growth rate. C, Hierarchical clustering using a Euclidean distance of 20 cytokines measured in microdroplets of human blastocysts cultured in the 
conditioned medium of EnSC decidualized for 8 days. 
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4.3 Discussion 
In this study, we examined if EnSCs contribute to failed implantation. Study subjects 
were recruited solely because of the need for ART, irrespective of the cause of 
infertility or previous treatment cycles. There are various factors that affect egg and 
embryo quality during an IVF treatment that determines the outcome of the treatment. 
This might be (i) age and ovarian reserve, (ii) protocol for controlled ovarian 
stimulation (COH), (iii) sperm quality and (iv) embryo selection. However, the embryo 
transfer procedure is considered as the rate limiting step in the success of ART.  
We reasoned that deficiency of endometrial MSCs could lead to aberrant EnSC 
function and implantation failure (Lucas, 2016; Barragan, 2016). Although overall 
CFU-F activity at passage 1 was comparable between the pregnant and non-pregnant 
group, three cultures associated with failed implantation were deficient in clonogenic 
MSCs. The secretome of these cultures was markedly divergent from other cultures. 
This observation supports our hypothesis that the abundance of endometrial stem cell 
populations is an important determinant of reproductive outcome, although further 
studies are needed. Overall, the induction of ‘classical’ decidual marker genes was 
not informative in terms of predicting reproductive success or failure, which was 
disappointing as the same markers have been widely used to determine the impact 
of reproductive disorders on the differentiation potential of EnSCs (Klemmt, 2006; 
Piltonen, 2015; Salker, 2010). However, the level of induction was highly variable 
between cultures, which probably reflects the clinical heterogeneity of the study 
population.  
For implantation to take place, differentiating EnSCs must transit through distinct 
functional phenotypes in response to elevated circulating progesterone levels and 
rising cellular cAMP levels (Gellersen and Brosens, 2014a, Jones et al., 2006b). This 
transitional pathway is characterised first by an acute auto-inflammatory phase, which 
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is followed by a profound anti-inflammatory response. The initial auto-inflammatory 
response associated with the decidual transformation of EnSCs renders the 
endometrium receptive to embryo implantation (Salker et al., 2012b), whereas 
acquisition of a mature secretory phenotype enables the endometrium to respond to 
individual embryos in a manner that either supports further development or facilitates 
early rejection (Brosens, 2014). Secretome analysis demonstrated that EnSCs from 
the pregnant group closely phenocopied this transitional pathway in culture, 
exemplified by the marked and distinct secretory response on day 2 of decidualization. 
By contrast, this transitional pathway was clearly disordered in cultures from the failed 
implantation group. In addition, these cultures no longer exhibited temporal changes 
in the secretion of the main factors involved in inflammation (IL-6), angiogenesis and 
lymphangiogenesis (VEGF-A, VEGF-D), endometrial receptivity and embryo 
development (LIF, BDNF) (Cha, 2012; Kawamura, 2009; Kim, 2014; Krussel, 2003; 
Stewart, 1992). 
Notably, the difference in secretome between the two groups of cultures was most 
pronounced in undifferentiated cells. CCL3, a potent inflammatory chemokine 
involved in innate immunity as well as wound repair (Chen et al., 2013, DiPietro et al., 
1998a), was most strongly associated with successful pregnancy, which emphasises 
further the importance of transient endometrial inflammation for implantation. Upon 
decidual transformation, the secretory profiles in both the pregnant and non-pregnant 
group tended to converge, albeit with some notable exceptions. This is a potentially 
important observation for some reasons. First, it suggests that endometrial defects 
associated with reproductive failure could be more prominent in the proliferative 
phase of the cycle. Second, the convergence in secretomes, if recapitulated in vivo, 
suggests that delaying transfer by a few days could potentially be beneficial for 
women at risk of implantation failure. Finally, previous studies reported that the 
107 
 
 
 
decidual response in cultured EnSCs from recurrent miscarriage patients becomes 
increasingly divergent as the differentiation process unfolds (Salker, 2010; Salker, 
2011; Salker, 2012), which indicates that different pathways are involved in failed 
implantation and early pregnancy loss. 
From the analysis of secretome, we showed that CCL3 in the undifferentiated culture 
secretome has a positive association with implantation. In response to bacterial 
infections in the liver, CCL3 expression increases resulting in recruitment of NK cells 
(Dalod et al., 2002). CCL3 is involved in the recruitment of macrophages to the site of 
injury, thus improving the angiogenic and collagen production activity, helping in 
wound repair (DiPietro et al., 1998b). CCL3 was undetectable in endometrial stromal 
cells, following hormone withdrawal following 12 days of decidualization (Evans and 
Salamonsen, 2012).  
IL-6, as found in the secretome of 8-day decidualized stromal cells, shows a positive 
correlation with successful implantation. IL-6 is a proinflammatory cytokine and acts 
on target cells via activation of the JAK-STAT pathway and is involved in stimulation 
and invasion of trophoblast (Jovanović and Vićovac, 2009, Suman and Gupta, 2014). 
IL-6 level increases during decidualization and implantation (Godbole and Modi, 
2010) and knockout of IL-6  results in endometrial defects and reduced implantation  
sites (Robertson et al., 2000). It is thought that  IL-6 is critical for implantation due to 
its role in recruitment of immune cells, which is required for trophoblast invasion. 
Additionally, induced pluripotent cellular reprogramming is associated with an 
increase in IL-6 expression. SASP associated  IL-6   is reported to be critical for 
inducing pluripotency in the surrounding cells (Chiche et al., 2016).  
My work shows a positive correlation of CCL3 and IL-6 with successful implantation. 
CCL3 might be involved in transient endometrial inflammation during decidualization 
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thus recruiting immune cells. Likewise, IL-6 induced reprogramming might be vital for 
the preparing the endometrial environment for implantation of a healthy embryo. 
Further investigations need to be carried out to affirm this association.  
A delicate balance between endometrial receptiveness and selectiveness are 
required for the successful reproductive outcome.  High receptivity with low selectivity 
is thought to lead to ‘super fertility’ resulting in recurrent pregnancy loss. Likewise, 
high selectivity with low receptivity may result in recurrent implantation failure. (Lucas 
et al., 2016a, Macklon and Brosens, 2014b) 
Aberrant decidual responses in purified primary EnSCs culture have been linked to a 
variety of reproductive disorders, including endometriosis (Aghajanova, 2010; 
Klemmt, 2006; Velarde, 2009), polycystic ovarian syndrome (Piltonen, 2015), and 
recurrent miscarriage (Salker, 2010; Salker, 2011; Salker, 2012). These pioneering 
studies demonstrated that the responsiveness of EnSCs to steroid signals and other 
cues is not predetermined, but occurs in a disease-specific manner. 
The events that cause implantation failure is unclear. Based on mouse studies, it is 
widely assumed that unsuccessful implantation reflects the failure of the embryo to 
breach the luminal epithelium, either because of intrinsic defects in the conceptus or 
due to a lack of expression of receptivity genes in surface epithelium. Consequently, 
embryos are thought to remain free-floating in the uterine lumen until they degenerate 
and die. In humans, this paradigm has been challenged for a number of reasons 
(Lucas et al., 2013), foremost because human embryos are intrinsically invasive and 
cannot enter diapause (dormancy) like their murine counterparts. Arguably, the 
heightened invasiveness may relate to the fact that most human pre-implantation 
embryos are chromosomally mosaic (Lucas et al., 2016a). Based on genome-wide 
screening of individual blastomeres, in excess of 70% of high-quality cleavage-stage 
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IVF embryos reportedly harbor cells with complex large-scale structural chromosomal 
imbalances, some caused by meiotic aneuploidies but most by mitotic non-disjunction 
(Fragouli et al., 2013, Mertzanidou et al., 2013, Vanneste et al., 2009). The incidence 
of aneuploidy in human embryos is estimated to be an order of magnitude higher than 
in other mammalian species (Fragouli et al., 2013). Differentiated stromal cells are 
involved in biosensoring of the implanting embryo (Mansouri-Attia et al., 2009). 
Hence, the luminal epithelium in the human endometrium may not be as important a 
barrier as in mice. If so, the stromal microenvironment before the window of 
implantation may be directly embryotoxic, irrespective of the developmental potential 
of the conceptus.  
In this chapter, we found that disordered temporal changes in the secretome of 
decidualizing cultures are associated with subsequent implantation failure. It is 
evident that a community of resident cells, ranging from immature progenitor cells to 
mature and senescent cells, makes up the stromal compartment of the endometrium. 
It is conceivable that the constituents of this community fluctuate from cycle to cycle 
with transient imbalances contributing to sporadic IVF failure. The effect caused by 
damaged or deficient progenitor populations is likely to be more severe and could 
account for recurrent implantation failure. 
Analysis of human blastocysts shows that the stromal microenvironment is a major 
determinant of embryo survival.  Our findings demonstrate that the secretome 
changes associated with undifferentiated EnSCs transitioning to fully decidualized 
cells induce a graded embryo response, ranging from embryonic growth arrest to a 
transient embryo-specific secretory response and finally quiescence. Although the 
EnSC secretome was divergent between the pregnant and non-pregnant groups, no 
discernible difference in embryo response was observed. This may reflect that EnSC 
conditioned medium was pooled for the embryo experiments, that only a limited 
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number of blastocysts were available for these experiments, or that the duration of 
incubation was too short. Another potential pitfall is that these experiments were 
performed ‘out-of-phase’ as there is no evidence that day six human embryos are 
already embedded in the decidualizing stroma. However, there is histological 
evidence of a Carnegie stage 5a human embryo (post-fertilization age of 7 to 8 days) 
surrounded by EnSCs. Thus, while our embryo experiments may indeed be ‘out-of-
phase’, it is probably only by 1 or perhaps two days. 
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Supplementary Figure 1. Regression coefficient analysis of non-decidualizing 
cultures of pregnant group (day 0) 
 
 
 
 
 
 
 
 
Supplementary Figure 2. Regression coefficient analysis of decidualizing 
cultures of pregnant group (day 2 or day 8) 
Analysis demonstrated that the strength of the association of CCL3 and 
successful implantation diminishes upon differentiation of EnSCs. In 
decidualizing cells, a positive factor (IL-6) and several negative factors (CCL11, 
CCL5, IL-18, EGF and VEGF-D), all with a regression coefficient of < 0.2, were 
associated with successful implantation. 
112 
 
 
 
Table 4.2. Morphology scores and growth rates of human embryos cultured in 
EnSC conditioned medium 
EnSC Pregnant Morphology  
score post  
warming 
Growth rate  
after 24h of  
culture 
Undifferentiated Yes BL2 0 
Undifferentiated Yes BL3BA 0 
Undifferentiated Yes BL3CB 0 
Undifferentiated Yes BL3CA 1 
Undifferentiated Yes BL2 1 
Undifferentiated Yes BL4AA 2 
Undifferentiated Yes BL3BA 2 
Undifferentiated Yes BL3BB 0 
Undifferentiated Yes BL3BC 0 
Undifferentiated Yes BL4CB 0 
Undifferentiated Yes Collaps 0 
Undifferentiated No BL3BA 1 
Undifferentiated No BL2 0 
Undifferentiated No BL3AB 2 
Undifferentiated No BL8 2 
Undifferentiated No BL3BB 0 
Undifferentiated No BL2 0 
Undifferentiated No BL4BA 1 
Undifferentiated No BL3BB 1 
Undifferentiated No BL3BB 0 
Undifferentiated No BL2 0 
Undifferentiated No BL4CB 0 
Undifferentiated No BL3CB 1 
Decidualized 
(D2) 
Yes BL3BB 2 
Decidualized 
(D2) 
Yes BL4CB 1 
Decidualized 
(D2) 
Yes BL3CB 2 
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Decidualized 
(D2) 
Yes BL4BB 2 
Decidualized 
(D2) 
Yes BL3CB 2 
Decidualized 
(D2) 
Yes BLBCB 2 
Decidualized 
(D2) 
No BL4CB 1 
Decidualized 
(D2) 
No BL4BB 1 
Decidualized 
(D2) 
No BL3AA 1 
Decidualized 
(D2) 
No BL3BB 1 
Decidualized 
(D2) 
No BL4BB 2 
Decidualized 
(D2) 
No BL3BC 0 
Decidualized 
(D2) 
No BL2 2 
Decidualized 
(D2) 
No BL3AA 2 
Decidualized 
(D2) 
No BL3AA 2 
Decidualized 
(D2) 
No BL3BB 1 
Decidualized 
(D8) 
Yes BL3BA 2 
Decidualized 
(D8) 
Yes BL3CB 2 
Decidualized 
(D8) 
Yes BL3BB 1 
Decidualized 
(D8) 
Yes BL3BA 1 
Decidualized 
(D8) 
Yes BL3CC 2 
Decidualized 
(D8) 
Yes BL8 1 
Decidualized 
(D8) 
Yes BL2 1 
Decidualized 
(D8) 
No BL3BB 0 
Decidualized 
(D8) 
No BL3BA 2 
Decidualized 
(D8) 
No BL3AA 2 
Decidualized 
(D8) 
No BL3CB 2 
Decidualized 
(D8) 
No BL3CC 1 
Decidualized 
(D8) 
No BL3BB 2 
Decidualized 
(D8) 
No BL3BB 2 
Decidualized 
(D8) 
No BL4BB 2 
Decidualized 
(D8) 
No BL3AC 0 
Decidualized 
(D8) 
No BL4BB 2 
Decidualized 
(D8) 
No BL4CB 2 
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Embryos were scored on morphology post warming using the Gardner and Schoolcraft 
criteria. After culture for 24h in EnSC supernatant, embryos were morphologically 
evaluated and scored with growth rates 0, 1 or 2 to indicate development based on 
expansion and morphology scores of ICM and TE: 0: embryo was degraded or did not 
develop further; 1: embryo moderately expanded or significantly expanded further 
accompanied with a “C”-score for the TE and/or ICM; 2: embryos significantly 
expanded with ≥ “B”-score for the TE and/or ICM 
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Chapter 5  
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5 In-depth characterization of eMSCs / ePCs cells. 
5.1 Introduction 
The endometrium is an excellent model of controlled tissue regeneration and 
remodelling. Its regeneration is unparalleled as the endometrium increases to a 
thickness of up to 6-8 mm in a week’s time following menstruation. This vast 
regenerative potential of the endometrium is presumed to be attributed to the 
presence of epithelial and mesenchymal stem/progenitor cells, which has been 
reported in recent years  (Gargett et al., 2007, Gargett et al., 2016, Meng et al., 
2007a).  
Following each menses, the endometrium undergoes physiological angiogenesis to 
facilitate regeneration and implantation (Gargett, 2007 239; Barragan, 2016 49). 
Perturbations in cyclical remodelling or effective communication between the 
endometrium and embryo may result in pregnancy complications including infertility 
and implantation failure (Evans et al., 2016, Brosens et al., 2014b). 
The dynamic endometrium is comprised of two major zones: functionalis, a transient 
layer with glands extending from surface epithelium along with supportive stroma and 
basalis. Basalis layer consists of a basal layer of glands, stroma, vasculature and 
lymphoid aggregates. Functionalis layer is shed during menstruation and 
regeneration starts from basalis layer (Padykula et al., 1984, Padykula, 1989, Jabbour 
et al., 2006). Specific or combination of markers has been reported for perivascular 
cells capable of regeneration localised around blood vessels in functionalis layer and 
as well as in a basal layer of the endometrium (Gargett et al., 2016). Sushi domain 
containing-2 (SUSD2) antigen, was used to isolate perivascular cells using magnetic 
activated cell sorting (MACS) method with a W5C5 antibody, specific to the antigen 
(Masuda et al., 2012b). Endometrial stem cells (eMSCs) can be purified on the basis 
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of their coexpression of two perivascular cell surface markers- CD140β and CD146. 
This method requires using fluorescence-activated cell sorting (FACS) or two 
sequential magnetic sorting (Schwab and Gargett, 2007). Sequential magnetic bead 
selections may also affect the cell viability during cell sorting. The single marker 
SUSD2 magnetic cell purification  is less damaging and resulting in high yield of cells 
in comparison to FACS isolation (Schwab and Gargett, 2007, Masuda et al., 2012a).  
Since there are several terminologies for  cellular subpopulation within endometrium, 
to uncomplicate, we have come up with new nomenclature based on niche and their 
potency, listed in Table 5.1. 
The unique property of human endometrium is its sequential regulation of 
proliferation, decidualization and shedding of the functionalis layer through every 
menstrual cycle (Gellersen and Brosens, 2014a).Progesterone induced 
decidualization commences from the endometrial stromal cells surrounding the spiral 
arteries. Endometrial stem/progenitor cells (SUSD2+/ePCs, CD146+/PDGFR-β+) are 
reported to be localised around the spiral arteries throughout the endometrium. A 
recent study reported that menstrual phase has cells of higher self-renewal capability 
and more stem/progenitor population could be isolated from the basal layer of the 
endometrium (Shan et al., 2016). These perivascular cells, when decidualized in vitro, 
produced higher levels of cytokines and chemokines that are responsible for inducing 
decidualization and may play a role in homing of trophoblast cells to the spiral arteries 
(Murakami et al., 2014, Evans et al., 2016).   
ePCs account for 7.0 ± 0.5% of the total endometrial stromal cell population and it is 
enriched with clonal cells compared to EnSCs (Masuda et al., 2012b, Murakami et al., 
2013a). Clonogenicity is the ability of the single cell to multiply and produce progeny 
of its own when seeded at low cellular density. Colony forming unit-fibroblast (CFU-
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F) assay is a primary assay to identify the presence of stem cells within any tissue 
(Teixeira et al., 2008). Human endometrium has clonogenic epithelial (0.15%) and 
stromal (1.3%) population (Chan et al., 2004).  For the culture of the clonogenic 
population in vitro, there is a vital need for growth factors, epidermal growth factor in 
the case of epithelial cells and basic fibroblast growth factor (bFGF) in the case of 
clonogenic endometrial stromal cells (Schwab et al., 2005).  
ePCs cells exhibit differentiation potential and have the ability to form adipocytes, 
chondrocytes, osteoblasts (Masuda et al., 2012b) and smooth muscle cells (Su et al., 
2014). Cultured EnSCs can differentiate into a single lineage, and the potential is 
lesser extent compared to eMSCs (Gargett et al., 2016). Studies show that cultured 
EnSCs differentiated into chondrocytes (Wolff et al., 2007), pancreatic β like cells 
(Santamaria et al., 2011), neurogenic (Wolff et al., 2011), megakaryocytes (Wang et 
al., 2012b) and oligodendrocyte precursors (Ebrahimi-Barough et al., 2013). 
Characterization of ePCs and EnSCs cells revealed that over 12 days of in vitro 
culture EnSCs became positive for the SUSD2 epitope. The SUSD2 expression is 
contact dependent and is under the control of Notch signalling pathway (Murakami et 
al., 2014). Gene profiling of cultured ePCs cells shows that these cells have a 
perivascular, pericytic gene signature suggestive of a role in angiogenesis during 
regeneration following in the case of placentation and in the absence of implanting 
embryo, menstruation (Evans et al., 2016). 
Pluripotent stem cells that are committed to their lineage are capable of forming 
organoids, which is defined as a collection of the self-organizing structure. (Lancaster 
and Knoblich, 2014b). There is a major leap in the field of organoid formation from 
pluripotent stem cells, (Eiraku and Sasai, 2012, Eiraku et al., 2011, Eiraku et al., 2008, 
Nakano et al., 2012, Sato et al., 2009, Suga et al., 2011). There have been several 
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attempts to establish endometrial epithelial organoid cultures (Blauer, 2012, Rinehart 
Jr et al., 1988).  Studies have shown that a 3D layered structure could be created 
using epithelial and stromal cells, as a model for the attachment of trophoblast cells 
in vitro (Wang et al., 2012a). Endometrial stromal cell and embryo co-culture systems 
have demonstrated that active embryo selection by decidualized stromal cells is 
critical for reproductive success (Brosens et al., 2014b). Understanding embryo 
implantation may help to enhance the success of ART  (Koot et al., 2012).    
In this chapter, I demonstrate that freshly isolated ePCs and EnSCs cells are 
divergent not only in their gene expression profile but also functionally. I have 
characterised mesenchymal stem cells (eMSCs), a subpopulation of ePCs and transit 
amplifying cells (eTAs) a subpopulation of EnSCs, based on their gene expression 
pattern, clonal ability under varying oxygen concentration, and their angiogenic 
potential. I have observed a unique potential for eMSCs to organise themselves into 
a macroscopic 3D structure when seeded on Matrigel in the presence of angiogenic 
media, termed ‘Endometrial Regenerative Bodies (ERBs) Further analysis on the 
ability of ERBs to differentiate, re-epithelialize was carried out. 
  
120 
 
 
 
Table 5.1. Nomenclature for cell types within the endometrium. 
Cell Type Marker New terminology 
Stemness 
Clonal SUSD2+ 
Marker 
undefined 
Endometrial 
mesenchymal stem 
cells ((eMSCs) 
 
 
 
 
Perivascular 
cells 
SUSD2+ 
Endometrial 
pericytes ((ePCs) 
Clonal SUSD2- 
Marker 
undefined 
Endometrial transit 
amplifying cells 
((eTAs) 
Endometrial 
stromal cells 
SUSD2- 
Endometrial stromal 
cells ((EnSCs)) 
 
  
121 
 
 
 
5.2 Results 
5.2.1 Gene signatures of ePCs and EnSCs 
To characterise the constituent perivascular and non-perivascular cell populations of 
the endometrial stromal compartment, single-cell suspensions were prepared from 
three mid-luteal biopsies and separated into ePCs and EnSCs cell fractions by 
magnetic-activated cell sorting (MACS). RNA sequencing profiled the transcriptomes 
of these samples. Per sample, on average, 22 million single-end reads were 
sequenced. Z-scores of the transcripts-per-million (tpms) values for the differentially 
expressed genes were calculated and a heat map of this association is depicted in 
Figure 5.1A. Based on tpms, out of 23,712 expressed genes, within ePCs, 13 genes 
were upregulated (Figure 5.1 A), and 232 genes were downregulated. List of 
downregulated genes with P < 0.05 are listed in Appendix 2. With further stringent 
analysis, it was found that 27 genes were upregulated exclusively in EnSCs (Appendix 
3).  
Of these 13 genes, SUSD2 was the highest differentially expressed gene between 
the two groups.  (Figure 5.1 B). Gene Ontology (GO) annotation of this gene list 
showed that these genes were involved in various biological processes including cell 
adhesion (P = 0.03), cell contraction, metabolic processes and response to stimuli.  
qRT-PCR on six samples from the same populations used in the RNA-Seq validated 
differential gene expression between the two groups. (Figure 5.2). To test whether 
freshly MACS isolated ePCs retain any in vivo phenotypic markers, I examined the 
endometrial tissue distribution of 13 differentially expressed genes using The Human 
Protein Atlas (http://www.proteinatlas.org/). I successfully annotated 12 out of 13 
genes and identified seven genes- ANGPT2, CCDC102B, DCLK1, EPHA3, 
GUCY1A2, OLFML2A, POSTN that share the same restricted tissue distribution as 
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SUSD2, characterised by prominent immunostaining surrounding the endometrial 
arterioles (Figure 5.3) (Table 5.2).  
Data mining of Gene Expression Omnibus (GEO) database showed the changes in 
the expression levels of five of the perivascular niche genes- CNTN1, DCLK1, 
GUCY1A2, OLFML2A, PDE1A over the course of a menstrual cycle ( 
 
Figure 5.4).  These genes were expressed higher in proliferative phase and reduced 
towards the late secretory phase. This shows that these perivascular niche cells 
involvement in the proliferation of the endometrium following menstruation. 
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Figure 5.1. Gene signature in ePCs. 
A. Clustered heat map of top-ranked differentially expressed transcripts in three 
paired freshly isolated ePCs and EnSCs. B. Pairwise analysis of RNA-sequencing 
data showing fold enrichment in ePCs cells of novel endometrial perivascular 
markers. Data represent mean ± SEM. 
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Figure 5.2. Validation of RNA sequencing using RT-qPCR. 
mRNA transcript expression of 13 differentially expressed genes in freshly isolated 
ePCs and EnSCs in six paired biological replicates. mRNA was harvested after 
separation of cells from fresh biopsies and transcript expression analysed by qRT-
PCR. *** indicates P < 0.001. ** indicates P < 0.01. * indicates P < 0.05. Data 
represent mean ± SEM. 
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Figure 5.3. Tissue distribution of perivascular genes enriched in freshly MACS 
isolated ePCs. 
The micrographs were obtained from The Human Protein Atlas 
(http://www.proteinatlas.org/). 
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Table 5.2. Histologic expression of perivascular niche genes. 
Gene 
Name 
Stroma 
Staining 
Glandular 
Staining 
Perivascular 
Staining 
ANGPT2 Low Not detected Low 
CCDC102B Low Medium Low 
CNTN1 Not detected Low Not detected 
DCLK1 Not detected Low Low 
EDIL3 Low Medium Not detected 
EPHA3 Not detected Low Low 
F2RL3 Not listed Not listed Not listed 
GUCY1A2 Medium Medium Medium 
OLFML2A Not detected Low Low 
PDE1A Medium Medium Not detected 
POSTN Not detected Low Low 
SELE Not detected Not detected Not detected 
SUSD2 Low Medium Medium 
 
Tissue distribution of perivascular niche genes based on the micrographs obtained 
from The Human Protein Atlas (http://www.proteinatlas.org/). 
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Figure 5.4. Expression of perivascular niche genes through the menstrual cycle 
GEO profile microarray of genes expressed by ePCs during the proliferative, early 
secretory, mid-secretory and late secretory phases of the menstrual cycle in 28 
subjects using Affymetrix Human Genome U133 Array. *P < 0.05; ** P < 0.01; ***P < 
0.001. Data are presented as means ± S.E.M 
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5.2.2 Functional characterization of ePCs and EnSCs  
Stem cell niche cells maintain the homoeostasis of the tissue by continuous and rapid 
replacement of differentiated cells. This renewal process occurs by rapid proliferation 
and subsequent migration (Leedham et al., 2005). Since ePCs and EnSCs are 
localised around blood vessels, I wanted to further assess their niche properties by 
characterising their proliferation, migration and contractile ability. 
Real-time monitoring of proliferation was carried out using xCELLigence. 
Freshly isolated ePCs and EnSCs cells from three mid-luteal biopsies were 
cultured in the xCELLigence proliferation assay plate and proliferation 
monitored over three days. Proliferative capacity did not vary between ePCs 
and EnSCs during the first 20 hours of monitoring. However, ePCs cells showed 
a massive increase in proliferation following this time point. ( 
 
 
 
 
 
 
Figure 5.5 A). The proliferation of ePCs increased (5-30 fold) over time and reached 
maximum towards 72 hours whereas EnSCs was slow and maintained a steady level.  
Real-time migration was monitored in freshly isolated ePCs and EnSCs 
populations using the xCELLigence system. Cells were seeded onto a double 
chambered migration assay plate, with basic fibroblast growth factor (bFGF) 
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used as a chemoattractant. Analogous to the results obtained from the 
proliferation assay, the rate of migration was no different between ePCs and 
EnSCs cells up to 15 hours, after which the rate of migration was higher in ePCs 
cells ( 
 
 
 
 
 
 
Figure 5.5 B). After 32 hours, the migration tails off as the cells have migrated covered 
the surface of the bottom chamber of the migration assay plate. 
The contraction ability of ePCs and EnSCs cells was measured using depth 
sensing indentation device in collaboration with School of Engineering, the 
University of Warwick, following the previously described protocol (Jin et al., 
2016). Cells were mixed with collagen and were allowed to polymerise in 35mm 
dishes. Following stimulation, the contraction force was measured using the 
device. The contraction force is significantly higher in ePCs cells (P < 0.05) ( 
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Figure 5.5 C).  
Taken together, these observations show that proliferation, migration, and contraction 
are enhanced in ePCs population in the endometrial stroma, showing their 
perivascular niche origin. 
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Figure 5.5. Functional characterization of ePCs and EnSCs cells. 
A. Real-time monitoring of proliferation of ePCs or EnSCs cells over 60 hours using xCELLigence RTCA system (n=3). B. Real-time monitoring 
of migration of ePCs or EnSCs cells over 50 hours using xCELLigence RTCA system (n=3). C. Measurement of contractility force between ePCs 
and EnSCs cells using depth sensing indentation device. All experiments were carried out in three paired biological replicates (n=3).       * indicates 
P < 0.05. Data represent mean ± SEM. 
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5.2.3 Oxygen consumption of ePCs and EnSCs cells 
Mitochondrial respiration was measured using Seahorse XF Extracellular Flux 
Analyzer by injecting mito-stress agents such as Oligomycin, Carbonyl cyanide-4 
(trifluoromethoxy) phenylhydrazone (FCCP) and Rotenone. Oligomycin inhibits ATP 
synthase (complex V) and the decrease in oxygen consumption rate (OCR) following 
injection of oligomycin correlates to the mitochondrial respiration associated with 
cellular ATP production. FCCP is an uncoupling agent that collapses the proton 
gradient and disrupts the mitochondrial membrane potential. As a result, electron flow 
through the electron transport chain (ETC) is uninhibited, and oxygen is maximally 
consumed by complex IV. The FCCP-stimulated OCR can then be used to calculate 
spare respiratory capacity, defined as the difference between maximal respiration and 
basal respiration. Spare respiratory capacity is a measure of the ability of the cell to 
respond to increased energy demand. The third injection is rotenone, a complex I 
inhibitor. Rotenone shuts down mitochondrial respiration and enables the calculation 
of nonmitochondrial respiration driven by processes outside the mitochondria (Tan et 
al., 2015).  
There was no significant difference in the basal respiration before injection of 
Oligomycin. Following the injection of Oligomycin, there was no significant difference 
in the adenosine triphosphate (ATP) turn over. However, after FCCP injection, the 
oxygen consumption reached the maximal respiration (Figure 5.6 A), and there was 
a clear difference between OCR of ePCs and EnSCs cells (P = 0.02) (Figure 5.6 B). 
When rotenone was injected, mitochondrial respiration of both cell fraction was shut 
down, and there was no difference in non-mitochondrial respiration. Overall there was 
a significant difference in the oxygen consumption rate between ePCs and EnSCs 
cells as measured by Seahorse XF Bioanalyzer.  
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This suggests that ePCs cells are less metabolically active. Furthermore, the 
extracellular acidification rate (ECAR) was measured high in ePCs cells compared to 
EnSCs cells. These results indicate oxygen consumption is lower in ePCs cells, 
indicative of that these are perivascular cells or stem cell niche cells. 
5.2.4 Colony forming unit- fibroblast (CFU-F) activity under 
hyperoxia and physoxia 
Since oxygen consumption was lower in ePCs cells, I wanted to analyse whether 
oxygen concentration has an impact on the stem cell population. To evaluate this, 
CFU-F were carried out under a normal laboratory oxygen concentration-hyperoxia 
(21% O2) and a low oxygen concentration-physoxia: a near physiological oxygen 
concentration (3% O2) (Figure 5.7 A). We have chosen 3% oxygen concentration as 
mesenchymal stem cell niche’s oxygen concentration was reported to be 2-8% 
(Kofoed et al., 1985, Harrison et al., 2002). At 21% O2, eMSCs formed small sized 
colonies, whereas no or very few colonies formed in eTAs. At 3% O2, the number of 
colonies formed by TAs was significantly higher (Figure 5.7 B) whereas eMSCs 
formed larger colonies with a greater surface area than at 21% O2 (Figure 5.7 C). 
Overall, the low oxygen concentration has a positive impact on the size and number 
of the colonies derived from both ePCs and EnSCs. Oxygen concentration similar to 
niche condition favours the growth of colonies.  
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Figure 5.6. The metabolic profile of ePCs and EnSCs. 
The difference in metabolism was measured by oxygen consumption rate (OCR) and extra cellular acidification rate (ECAR) using Seahorse XF 
Analyzer in three paired ePCs and EnSCs. Mito stress compounds were injected sequentially and oxygen consumption rate was measured (n=6). 
Data represent mean ± SEM.
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Figure 5.7. Cloning efficiency under 21% O2 (hyperoxia) and 3% O2 (physoxia). 
A. Representative images of clones obtained after subjecting ePCs/EnSCs to colony forming unit assays (CFU-F) under 21% oxygen and 3% 
oxygen. B. Colonies with > 50 cells were counted, and cloning efficiency (CE) calculated for three paired ePCs/EnSCs replicates. C. Area of 
colonies was measured using Adobe Photoshop (n=3). * indicates P < 0.05. Data represent mean ± SEM. 
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5.2.5 O2 dependent regulation of PV gene signature in eMSCs 
and eTAs under 21% O2 and 3% O2 
Next, I wanted to study the expression of perivascular specific gene expression in 
endometrial eMSCs and eTAs. For this, CFU-F was carried out on MACS separated 
eMSCs and eTAs with cells at a clonal density of 50 cells/cm2. eMSCs and eTAs were 
cultured under 21% O2 and 3% O2 for 15 days, RNA was harvested and cDNA was 
synthesised. RT-qPCR was carried out for reference gene L19 and 13 genes which 
were highly expressed in RNA-seq of ePCs cell fraction.  
Under hyperoxia, two of the 13 genes, POSTN and CCDC102B were expressed 
significantly higher in eMSCs compared to eTAs. In comparison, CNTN1 was 
enriched in eTAs (Figure 5.8 A).  
Under physoxia, five out of thirteen genes were enriched in eMSCs: POSTN, 
GUCY1A2, ANGPT2, EPHA3, and F2RL3. CNTN1 expression which was higher in 
eTAs was reversed under physoxia condition (Figure 5.8 B).  
When gene expression was compared between eMSCs under hyperoxia and 
physoxia, five genes were upregulated: POSTN, GUCY1A2, PDE1A, ANGPT2 and 
EPHA3. CCDC102B was enhanced in the eMSCs fraction ( Figure 5.9 A). Similarly, 
when comparing TAs, under physoxia, OLFML2A was enriched, and CNTN1 was 
increased under hyperoxia (Figure 5.9 B). Considering all the data together, under 
hyperoxia, eMSCs and eTAs were almost similar as only two genes were differentially 
expressed. Under physoxia, the difference between eMSCs and eTAs widens as five 
of the perivascular niche genes are induced in eMSCs. Even within eMSCs cultured 
in hyperoxia and physoxia, physoxia increase the expression of perivascular niche 
genes. This might be due to perivascular niche has a low oxygen concentration, and 
MSCs reside in a low oxygen niche to maintain their naïve state. 
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Figure 5.8. Oxygen-dependent gene expression in eMSCs and eTAs under 
21%O2 or 3% O2. 
Magnetically isolated ePCs and EnSCs cells were subjected to colony forming unit 
assays under 21% oxygen and 3% oxygen. At the end of 15 days, RNA was harvested 
from eMSCs, and eTAs cells and mRNA transcript expression of 13 differentially 
expressed genes were analysed in six paired biological replicates, in triplicate, using 
RT-qPCR. A. Differential gene expression between eMSCs and eTAs cells cultured 
under 21% oxygen (n=6). B. Differential gene expression between eMSCs and eTAs 
cells cultured under 3% oxygen (n=6). ** indicates P < 0.01. * indicates P < 0.05. Data 
represent mean ± SEM.
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Figure 5.9. Oxygen-dependent gene expression in eMSCs or eTAs under 
varying oxygen conditions. 
Magnetically isolated ePCs and EnSCs cells were subjected to colony forming unit 
assays under 21% oxygen and 3% oxygen. At the end of 15 days, RNA was harvested 
from eMSCs, and eTAs cells and mRNA transcript expression of 13 differentially 
expressed genes were analysed in six paired biological replicates, in triplicate, using 
RT-qPCR. A. Differential gene expression between eMSCs cells cultured under 21% 
and 3% oxygen (n=6). B. Differential gene expression between eTAs cells cultured 
under 21% and 3% oxygen (n=6). *** indicates P < 0.001. ** indicates P < 0.01. * 
indicates P < 0.05. Data represent mean ± SEM. 
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5.2.6 Angiogenic potential of eMSCs 
To check the differentiation potential of eMSCs and eTAs, I investigated the ability of 
these cell types to form tubules when seeded on Matrigel in the presence of 
angiogenic media. CFU-F from three mid-luteal biopsies separated into ePCs, and 
EnSCs cell fractions were cultured for 15 days, cells were trypsinized, and 50,000 
cells were seeded on Matrigel in a 96-well plate.  Following overnight incubation, wells 
were examined for the presence of tubules and imaged using a phase contrast 
microscope. Images were analysed using ImageJ for the area covered by either tubes 
or cells. eMSCs formed tubules which covered significantly larger areas on the 
Matrigel compared to eTAs. No tubes were formed by eTAs (Figure 5.10).  
5.2.7 Formation of ERBs 
While analysing the angiogenic potential of eMSCs and eTAs, I fortuitously found the 
formation of tissue structures in most of the wells with eMSCs and several from eTAs. 
The most common structure is shown in Figure 5.11 A, was a three-lobed triangular 
structure. Because these structures showed rapid generation overnight, we coined 
the term ‘endometrial regenerative bodies’ or ERBs. These structures formed when 
cultured on Matrigel and in the presence of the angiogenic media. These structures 
were probed for endothelial marker von Willebrand Factor (vWF), which came out 
negative (result not shown). The ERB were fixed, processed and sectioned at 5 µm 
thickness and stained with hematoxylin and eosin (H & E). H & E staining of the 
structure revealed that the section resembled the stained biopsy section of the 
endometrium (Figure 5.11 B). 
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Figure 5.10. Angiogenic assay of eMSCs and eTAs cells. 
After CFU-F, eMSCs and eTAs cells were trypsinized, and 5x104 cells were seeded 
on Matrigel with angiogenic media and cultured overnight for angiogenic assay. A. 
Representative wells of the angiogenic assay from eMSCs and eTAs cells. Imaged 
using phase contrast microscope (magnification: ×4). B. The area covered either by 
tubes or cells were measured in percentage using Adobe Photoshop. The assay was 
carried out in 3 biological replicates in triplicates. ** indicates P < 0.01. Data represent 
mean ± SEM.  
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Figure 5.11. Gross morphology of Endometrial Regenerative Bodies (ERBs). 
Most of the eMSCs and few of eTAs cells formed structures termed ERBs. A. 
Morphology of ERBs formed from either eMSCs or eTAs cells with three-lobed 
triangular structures, considered as optimal ERBs. Imaged using phase contrast 
microscope (magnification: ×4). B. Sagittal section of ERB stained with Hematoxylin 
and eosin (H&E) (magnification: ×4). 
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5.2.8 Time-lapse imaging  
While characterising the ERBs, the striking observation was their rapid formation 
overnight. To delineate the formation of ERB, time-lapse imaging was carried out 
every 5 minutes for 48 hours with 5% CO2 and 37 o C.  The images over 48 hours  
suggested that the stages of ERB formation can be separated into 3 major steps: (i) 
during 0-9 hours, there was an initial rapid contraction of cell layer; (ii) through 12-21 
hours, further compaction in the peripheral edges; (iii) 22-48 hours, circular structure 
became more organized into the final triangular three-lobed structure (Figure 5.12). 
5.2.9 ERB formation from live and formalin fixed  
For further characterization, I wanted to confirm that the formation of ERBs was not 
due to the contraction of Matrigel. To evaluate this, three biological replicates of 
eMSCs were harvested from CFU-F plates and counted.  Cells were either fixed with 
formalin or left untreated. The untreated and formalin fixed eMSCs were subjected to 
ERB formation assay on Matrigel in the presence of angiogenic media. 100% of 
untreated cells formed structures whereas there was no ERB formation in the formalin 
fixed eMSCs. In formalin-fixed cells, there was no clumping or cell aggregation either. 
This shows that the ERB formation is due to the movement of cells of the surface of 
Matrigel rather than the shrinkage of Matrigel (Figure 5.13). 
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Figure 5.12. Time-lapse imaging of ERB formation. 
ERB formation was recorded for 48 hours using time-lapse imaging microscope to 
show a representative change through time. Differential interference contrast (DIC) 
microscopy images were taken every 5 minutes. Representative images obtained at 
3-hour intervals are shown.  
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Figure 5.13. ERB formation from live and formalin fixed eMSCs cells. 
eMSCs cells were trypsinized, counted, and a portion was fixed in 100 μl formalin for 10 min and the other portion of cells without any treatment, 
which served as a positive control. These cells were seeded on Matrigel in the presence of angiogenic media. A. representative images of 
structures formed from live eMSCs cells and no structure in the fixed eMSCs population. N=3 in triplicates. B. Percentage of ERB formation was 
calculated from the number of structures formed.
A B 
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5.2.10 Analysis of ERB formation from endometrial 
stromal cell subpopulation 
During initial formation of ERBs, there were few structures formed by eTAs. I wanted 
to analyse the potential of other cell populations within the endometrium to form ERBs 
when seeded on Matrigel in the presence of angiogenic media. For this experiment, 
the cell types used were: eMSCs, eTAs, ePCs, EnSCs and unselected endometrial 
stromal cells (uESCs). Different cell types were seeded, checked for the formation of 
ERBs the following day and imaged using a phase contrast microscope. 
Comparatively, eMSCs formed more ERBs (67%), followed by eTAs (15%), whereas 
there were no structures formed by neither ePCs and EnSCs cells nor endometrial 
stromal cells (Figure 5.14). Overall ERB formation potential is highest in eMSCs, 
lesser in eTAs and absent in the other cell types.  
5.2.11 Effect of oxygen concentration on ERB formation 
Since the concentration of oxygen had an impact on size and number of colonies 
formed both in eMSCs and eTAs, I assessed whether it had any impact on ERB 
formation or size. For this experiment, CFU-F was carried out in physoxia and 
hyperoxia. Following 15 days of culture, eMSCs were harvested and seeded for ERB 
formation assay, and the physoxia treated eMSCs were moved to hyperoxia for ERB 
formation assay and vice versa (Figure 5.15 A). The following day, the ERBs were 
imaged using phase contrast microscope and area measured. eMSCs that were 
cultured and ERB assay in hyperoxia had a significantly larger area compared to 
those cultured entirely in physoxia (Figure 5.15 B). The activation of eMSCs is vital 
under hyperoxia which is crucial for the formation of ERBs whereas under physoxia 
these cells are in a naïve state.  
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Figure 5.14. ERB formation within an endometrial stromal subpopulation. 
To identify which population of cells are capable of forming ERBs, different population were analysed- (i) paired eMSCs and eTAs cells (n=9) (ii) 
magnetically selected ePCs and biopsies (n=6) (iii) unselected population (n=6). A. Representative images of ERBs formed from (i) eMSCs, and 
eTAs population and cells without any structures from (ii) magnetically selected ePCs and EnSCs cells and (iii) unselected population. B. 
Percentage of organoids formed was calculated based on the number of structures formed. ** indicates P < 0.01. Data represent mean ± SEM. 
A B 
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Figure 5.15. Effect of oxygen on ERB structure. 
To analyse the effect of oxygen of ERB structure, eMSCs and ERB were cultured in varying oxygen concentrations- (i) P > P; (ii) H > P; (iii) P > H 
and (iv) H > H. A. Schematic diagram of the experimental plan. B. Representative images of structures formed under varying oxygen 
concentrations. n=3 in triplicates. B. area of structures formed was measured using ImageJ. * indicates P < 0.05. Data represent mean ± SEM. 
Data represent mean ± SEM. P denotes Physoxia; H denotes Hyperoxia 
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5.2.12 Re-epithelialization of ERB 
As the morphology of ERB was similar to endometrial stromal tissue, I evaluated 
whether these structures could support endometrial epithelial cells (EECs). For this 
assay, ERBs were formed using eMSCs as described previously in Matrigel and 104 
human endometrial epithelial cells were seeded. This ERB and epithelial cell 
coculture were incubated at 37oC with 5% CO2 overnight. The following day, ERBs 
with cocultured epithelial cells were fixed and stained using Vimentin, a marker for 
stromal cells and Cytokeratin 18, a marker for epithelial cells. Visualisation using a 
spinning disc microscope showed a single layer of epithelial cells formed on the ERB 
tissue structure (Figure 5.16). Therefore, I could demonstrate that ERB structure can 
be made more complex with the addition of other cell types relevant to the human 
endometrium.  
5.2.13 Effect of agitation on cocultured ERBs 
Lancaster and Knoblich (2014) showed that brain organoids were short lived due to a 
shortage of gas supply to the centre of the organoid and can be maintained in vitro 
for a longer period using agitation. Similarly, I hypothesised that agitation could 
enhance the lifespan of ERB. For this experiment, ERBs were formed as described 
earlier with and without coculture of EECS, overnight. The following day, ERBs were 
removed carefully from Matrigel into a new 96-well plate, which contained specialised 
organoid media. These ERBs and cocultured ERBs were imaged using a phase 
contrast microscope and placed on a plate shaker which was agitated at 250 rpm for 
over two days, along with controls without any agitation.  After two days, agitated 
ERBs and cocultured ERBs along with controls were imaged. Static and agitated 
ERBs maintained the structure irrespective of the agitation. This showed that ERBs 
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could be removed from Matrigel and maintained in liquid media, without disruption of 
the structure.  
ERBs cocultured with EEC, both under static and agitated conditions, formed a 
smooth surface around the edges, whereas it was not observed in those without 
EECs. (Figure 5.17). 
5.2.14 Morphology of decidualized ERB 
For determining whether the ERBs function similar to in vivo, ERBs were differentiated 
using cAMP and MPA for eight days and controls were maintained without any 
treatment. Following differentiation, the morphology and gene expression were 
analysed. After six days of decidualization, ERBs were fixed and sectioned. 
Undecidualized stromal cells have a fibroblast-like appearance with elongated and 
indented nuclei, whereas decidualized cells have rounded nuclei, which is similar to 
in vivo H&E stained sections (Figure 5.18). 
For gene expression, ERBs were untreated or decidualized for 8 days. These ERBs 
were harvested for RNA, cDNA was synthesised and analysed for putative decidual 
markers; PRL and IGFBP1 in 3 different paired ERBs. 
PRL and IGFBP1 mRNA level expression were more than 100-fold induction in 
response to cAMP and progesterone treatment, compared to the control (Figure 5.19 
A, B).  
Since PR regulates decidual markers, I analysed the mRNA expression PR and ER 
in response to decidualization for over eight days. The expression of ER reduced 
whereas the expression of PR increased, in response to decidualization (Figure 5.19). 
Taking together, the morphology change and gene expression in response to cAMP 
and MPA, ERBs respond in the similar way to stromal cells respond to decidual cues. 
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Figure 5.16. Immunohistochemistry of ERBs co-cultured with endometrial 
epithelial cells (EECs). 
ERBs were formed from eMSCs cells (1×105) overnight, and primary EECs (1×104) 
were co-cultured for 24 hours. Co-cultured ERBs were fixed, sectioned and stained 
for Vimentin (red-eMSCs) and Cytokeratin 18 (green-EECs). These sections were 
imaged using spinning disc microscope. A. A spinning disc stitched image at 
magnification: ×10. B. A spinning disk image at 40x. 
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Figure 5.17. Effect of agitation on ERBs co-cultured with EECs. 
ERBs made of eMSCs, and ERBs co-cultured with EECs were cultured at the 
standard static condition and imaged using phase contrast microscope at 
magnification: ×4 (D0). One of the ERB co-cultured with EECs was agitated at 250 
rpm for 48 hours and re-imaged at magnification: ×4 (D2). 
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Figure 5.18. Hematoxylin & Eosin staining sections of untreated and 
decidualized ERBs. 
ERBs were treated with 2% DCC or 2% DCC in the presence of cAMP + MPA for six 
days. The staining shows that undecidualized cells (D0) have a fibroblast-like 
appearance with elongated and indented nuclei, whereas the D6 cells have rounded 
nuclei, which is similar to in vivo H&E stained decidualized sections.  
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Figure 5.19. Induction of decidual markers and changes in nuclear receptors. 
A. Classical decidual markers PRL and IGFBP1 were induced upon decidualization 
for eight days. The induction is shown as fold change. Three biological replicates in 
triplicate. B. Nuclear receptor ESR1 responsible for oestrogen binding went down 
whereas progesterone binding PGR increased with decidualization treatment. 
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5.3 Discussion 
5.3.1 Regeneration potential of the human endometrium 
Human endometrium undergoes dynamic changes through the reproductive life of a 
woman to meet the demand of embryo implantation and highly invasive placenta 
(Evans et al., 2016). The endometrium undergoes around 400 menstrual cycles with 
a high level of cellular turnover and in turn the massive level of tissue regeneration. It 
undergoes controlled tissue remodelling and grows from 0.5-1mm into massive 7 mm 
thick tissue following menstrual shedding (McLENNAN and RYDELL, 1965). Behind 
this regeneration, there is a rapid angiogenesis that occurs under strict regulation. 
During embryogenesis, the endometrium is formed by the fusion of the mucosal lining 
of paramesonephric tubes, is composed of two major zones: functionalis and basalis. 
The basalis layer has glands, stroma, supporting vasculature and lymphoid 
aggregates. Stem/progenitor cells are located in the basal layer and progenitor cells 
multiply rapidly into transient amplifying cells eventually moving into the functional 
layer participating in the active regeneration and remodelling of the endometrium 
(Okulicz et al., 1997). 
5.3.2 ePCs gene expression 
ePCs have been identified to be pericytic. ePCs are localised to basalis layer and 
around the vessels in the functionalis layer. Transcriptomic analysis of cultured ePCs 
cells confirmed that they have a perivascular phenotype. The notable perivascular 
markers that are enriched in culture are NOTCH3, MCAM (CD146), AOC3, ELN, and 
MYH11. Pericytic or MSC related genes that were enriched in cultured ePCs cells are 
NT5E (CD73), ENG (CD105), ITGA5 (CD49e), ALCAM (CD166), CD44 (CD44), 
ITGB1 (CD29), THY1 (CD90) and PDGFRB (CD140b). Meanwhile, secretome 
analysis of decidualized ePCs and EnSCs cells show that they elicit a divergent 
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decidual response, a proinflammatory response by ePCs and an anti-inflammatory 
response by EnSCs cells (Murakami et al., 2014).  
In this chapter, the transcriptomic characterization was carried out for magnetically 
sorted fresh ePCs and EnSCs cells. Within the EnSCs population, the expressed 
gene signature is widely related to an immune cell population. This is because the 
depletion of immune cells was not carried out before the RNA sequencing. Though 
there was a strong immune signature within EnSCs population, there was a tight gene 
signature that is differentially expressed only in ePCs population. The genes that were 
differentially expressed in ePCs population are ANGPT2, CCDC102B, CNTN1, 
DCLK1, EDIL3, EPHA3, F2RL3, GUCY1A2, OLFML2A, PDE1A, POSTN, SELE, and 
SUSD2. 
ANGPT2 and MMPs secreted by uNK cells are vital in spiral artery remodelling during 
pregnancy (Robson et al., 2012). Following menstruation, in the presence of VEGF, 
ANGPT2 secreted by perivascular cells might be involved in the blood vessel 
regeneration. ANGPT2 is competitive and mostly antagonistic to ANGPT1; it 
destabilises blood vessel walls and vessel regression in the absence of VEGF 
(Maisonpierre et al., 1997). In the presence of VEGF, it promotes vessel sprouting 
and endothelial cell migration (Lobov et al., 2002, Pourjafar et al., 2016). ANGPT2 is 
expressed by endothelial cells in some physiological conditions such as wound 
healing. It is upregulated under physoxia by growth factors including VEGF and bFGF 
(Mandriota and Pepper, 1998, Okada et al., 2015).  
Glycosylphosphatidylinositol (Zhang et al.) anchored neuronal membrane protein, 
CNTN1 is an adhesion molecule (Mikami et al., 2009) and a key ligand and activator 
of NOTCH1 (Schweitzer et al., 2007). Studies show that it plays a major role in 
adhesion, migration, and invasion in thyroid cancer and upon knockdown inhibits 
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cyclinD1 (Shi et al., 2015). CNTN1 might be playing a similar role in endometrial cells 
regulating cellular physiological processes. 
DCLK1 has been previously reported to be involved in neuroblast proliferation, 
migration and differentiation (Shu et al., 2006).  DCLK1 has a domain that can bind 
tubulin and enhance microtubule polymerization. DCLK1 plays a role in stem cell fate 
decision in a 3D environment based on the onset of stress due to stiffening of the 
polyisocyanopeptide-based hydrogels (Das et al., 2016).As ePCs are located around 
blood vessels DCLK1 could contribute to proliferation, migration during the vessel 
remodelling following embryo implantation. 
EDIL3, a glycoprotein, secreted by endothelial cells and is regulated by physoxia or 
vascular injury. During angiogenesis, it has been implicated in vascular remodelling 
(Choi et al., 2008). It promotes endothelial cell adhesion and migration (Penta et al., 
1999).Following menstruation EDIL3 might be secreted by endothelial cells.   
EPHA3, an ephrin family protein member, has a major function in tumour progression 
and expressed in the vascular rich regenerating human endometrium.  This is gene 
is controlled by HIF1A and is involved in cell contraction and migration (To et al., 
2014).  
F2RL3 or PAR4, a member of protease-activated receptor (PAR) family, when 
activated follows G-protein signalling (Gq) and cause a calcium mobilisation. F2RL3 
promotes the activity of some calcium-regulated kinases and phosphatases that 
control PAR4 induced cellular responses such as platelet activation and vascular 
remodelling. PAR4-G12/13 interaction causes Rho activation that controls cytoskeletal 
responses in vascular smooth muscle cells and endothelial cells (French and 
Hamilton, 2016).  
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Guanylate Cyclase 1, catalyses the conversion of guanosine triphosphate (GTP) to 
3',5'-cyclic GMP and pyrophosphate. The protein encoded by this gene GUCY1A2 is 
an alpha subunit of this complex, and it interacts with a beta subunit to form the 
guanylate cyclase enzyme and activated by nitric oxide (RefSeq, 2012).  
OLFML2A is a regulator that mediates smooth muscle differentiation process through 
growth factor, TGF-β. Smooth muscle differentiation is a significant process in 
vasculogenesis and angiogenesis (Shi et al., 2014). 
PDE1A regulates vascular smooth muscle growth by maintaining the homoeostasis 
of cyclic nucleotides via hydrolysis of cAMP or cGMP. This has a major function in the 
transformation of vascular smooth muscle cells from contractile to synthetic 
morphology, following biological/mechanical injury or in vitro culture. This conversion 
gives the vascular smooth muscle cells the capacity to migrate, proliferate and to 
produce extracellular matrix proteins (Nagel et al., 2006). 
Periostin, a matricellular protein that is activated by tissue damage and repair. POSTN 
activates PI3K/Akt pathway that regulates several functions such as cell survival, 
proliferation, migration and wound healing (Eun et al., 2010).  
Cell adhesion molecules such as endothelial selectins (SELE) are expressed at the 
vascular stem cell niche, to which stem/progenitor cells adhere. SELE is usually 
expressed by endothelial cells at the site of inflammation, providing a way for 
inflammatory cells to adhere and migrate towards the site of inflammation or injury. 
SELE is crucial in stem cell niche, and it promotes stem cell proliferation (Winkler et 
al., 2012). 
Data mining for the perivascular niches GEO database showed that five out of thirteen 
genes were expressed at a higher level during proliferative phase compared to other 
phases. A recent study characterised endometrial stem and progenitor population in 
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during three phases of the menstrual cycle and different layers of the endometrium. 
This study warrants that the self-renewal capability of stem cells is high during 
menstrual phase followed by proliferative phase (Shan et al., 2016). In this study, the 
higher expression of few of the genes of perivascular niche during proliferative phase 
(GEO profile) shows that the activation of a niche for regeneration of the functionalis 
layer following menstruation.  
A similar study by Spitzer et al. (2012) compared transcriptomics of various cell 
populations within the human endometrium. In their comparison of eMSCs (MCAM 
(CD146+/PDGFRβ+) with endometrial stromal fibroblast populations (MCAM (CD146 
−/PDGFRβ+), there were 762 significantly differentially expressed genes: 378 up-
regulated and 384 down-regulated. Out of 378 upregulated genes, some genes were 
comparable to the list of genes enriched in the perivascular population. The genes 
are PDE1A, ANGPT2, GUCY1A2, DCLK1, CCDC102B, EPHA3 and OLFML2B, a 
member of Olfactomedin family. 
Another study by Barragan et al. (2016) compared FACS isolated eMSCs and 
endometrial stromal fibroblasts (Gomaa et al.). In this population, when compared to 
MACS isolated ePCs and EnSCs cell population, the genes that were upregulated in 
FACS isolated eMSCs were: ANGPT2, CCDC102B, DCLK1, PDE1A, GUCY1A2, 
OLFML2A, and SUSD2.  CNTN1, EDIL3, and POSTN were among the genes that 
were downregulated. This shows that these genes that are upregulated in ePCs cells 
have a robust gene expression irrespective of the marker or method of isolation.  
5.3.3 ePCs functional characterization 
As most of the differentially expressed genes within ePCs population play a role in 
proliferation, migration, contraction and are induced by physoxia, experiments were 
set out to analyse whether there are any differences in the functional characteristics 
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of ePCs and EnSCs cells. From the experimental results, it is clear that there is a 
divergence between perivascular ePCs and non-perivascular EnSCs populations, not 
only at gene level but also in functional level.  
In the case of ePCs, there is more proliferation and migration compared to EnSCs 
cells. This might be because stem cells can proliferate in response to injury or wound 
healing (Caplon, 2005). ePCs cells have more clonogenic potential compared to 
EnSCs cells, which shows that eMSCs are enriched within the ePCs population 
(Murakami et al., 2013a). Previous studies show that eMSCs have migratory 
properties and migrate in a controlled manner towards chemotactic signals such as 
bFGF, IL-6, SDF-β and VEGF (Schmidt et al., 2006). Use of bFGF as a 
chemoattractant demonstrated the enhanced migration of ePCs cells in comparison 
to EnSCs cells.  
5.3.4 ePCs oxygen consumption 
Oxygen consumption of ePCs cells was lower when were compared to EnSCs cells. 
Energy metabolism studies analysed eMSCs on their metabolic profile and found that 
during proliferation and differentiation, they consume glucose mainly and produce 
lactic acid (Wang et al., 2005, Grayson et al., 2006, Mischen et al., 2008, Follmar et 
al., 2006). Under standard laboratory oxygen conditions, eMSCs consume glucose 
and produce lactic acid, which is termed as ‘Warburg effect.' When cultured under 
hypoxic condition, the rate of glycolysis increases, which is termed as ‘Pasteur effect’ 
(Krebs, 1971).  
Mesenchymal stem cells stay in a hypoxic niche, where the oxygen concentration 
ranges from 2-9%.  Levels of oxygen determine the stem cell fate regarding 
differentiation and proliferation, regulated through HIF1-α. Some studies show that 
MSCs maintained in hypoxic conditions rather than laboratory oxygen concentrations 
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improve growth kinetics, gene stability and expression of chemokine receptors 
(Haque et al., 2013). Since the CFU-F is a method for quantification of stem cells, we 
used this method to study the effect of oxygen concentration on eMSCs and eTAs. 
The results reveal that physoxia has a significant increase in colony size and 
efficiency irrespective of cell types.  
5.3.5 Effect of low oxygen concentration on eMSCs and eTAs 
I wanted to analyse the perivascular gene expression pattern in eMSCs and eTAs 
under varying oxygen concentrations and also to check whether the near in vivo 
conditions had any effect on gene expression pattern.  I have demonstrated that 
physoxia maintained the perivascular niche gene expression in a more robust way in 
eMSCs, compared to eMSCs maintained in normal laboratory oxygen condition. This 
result supports the fact that the low oxygen concentration or physiological oxygen 
concentration can improve the genetic stability of cells in culture (Haque et al., 2013). 
5.3.6 Angiogenic potential of eMSCs 
 We have demonstrated the angiogenic potential of eMSCs by using Matrigel tube 
formation assay. For this assay, normal DMEM media was substituted with Medium 
200, an angiogenic culture medium. The results showed that eMSCs can form tubes 
on the surface of Matrigel whereas there was no tube formation in eTAs. This 
demonstrates that eMSCs could reorganise on Matrigel and differentiate into an 
angiogenic lineage. Tube formation is possible as stromal cells and endothelial cells 
have a mesenchymal origin. Previously, endometrial stromal cells were shown to form 
tube-like sprouting on a 3D fibrin matrix (Lebovic et al., 2000). 
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5.3.7 Plasticity in forming ERBs 
Following angiogenic assay using eMSCs and eTAs on Matrigel with angiogenic 
induction media, we observed macroscopic tissue structures (ERBs) that were rapidly 
formed following 16-18 hours of incubation. Human endometrium displays rapid 
degeneration and regeneration with tightly regulated tissue remodelling that results in 
a healed, scar-free tissue and fully regenerated functionalis layer in 2 weeks, 
(Cousins, 2014), with significant angiogenesis that occurs in a routine, physiological 
basis (Girling and Rogers, 2005). A number of attempts have been made in the past 
to create epithelial organoid culture including, intestinal epithelial organoids (Gjorevski 
et al., 2016), airway organoids (Tan et al., 2017) , salivary gland spheroids (Shin et 
al., 2016) and several  attempts in the case of endometrial epithelial organoids (Bläuer 
et al., 2005, Bläuer et al., 2008, Gargett et al., 2009). The ERBs on Matrigel formed 
structures that are mostly three-lobed triangular structures, which were similar to 
structures that were formed by fibroblasts on Matrigel under the influence of TGF-β1 
in relevance to wound healing (Fan et al., 2015). 
We identified that frequency of ERB formation is higher in eMSCs and to an extent in 
eTAs. The formation of ERBs from eTAs partly might be attributed to the low volume 
of W5C5+ antibody utilised during magnetic isolation. Also, it should be considered 
that eMSCs are lineage precursors of eTAs as reported in a recent study (Barragan 
et al., 2016)Compared to other cell populations including unsorted stromal 
populations or MACS sorted ePCs and EnSCs cells, the ERB formation is more 
specific to the eMSCs population.  
The shape of ERBs varied from three-lobed triangular structures to two-lobed 
structures and malformed structures. Similar variations in the organoid structures 
were reported previously in the case of cerebral organoids, where they have devised 
a classification system naming them suitable and sub-optimal organoids (Lancaster 
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and Knoblich, 2014a). Similar terminologies could be utilised to discriminate types of 
ERBs based on their structure.  
5.3.8 ERB characterization 
Time lapse imaging of ERBs overnight gave an insight into their formation, in which 
the cells initially form a sheet-like structure and followed by inward contraction of cells 
towards the centre. After a few hours, there was a proliferation of cells at the edges 
of the structure which then fold up around the edges, slowly transforming the circular 
structure into a three-lobed triangular structure. During the first hour of ERB formation, 
it can be observed that there is a movement of Matrigel, due to polymerization. We 
confirmed that this contraction does not result in ERB formation by seeding formalin 
fixed eMSCs and observed a lack of structure formation or movement of the cells.  
5.3.9 Effect of oxygen concentration on ERB formation 
Physoxia had a significant effect on size and area of clonogenic population of eMSCs 
and eTAs, in our experiments. Additionally, it can be concluded that eMSCs cultured 
for ERBs in normal laboratory oxygen conditions formed larger triangular three-lobed 
structures, whereas, the ERBs cultured in physoxia condition were malformed or 
smaller.  
Organoids are self-organized structures derived from stem or progenitor cells that 
differentiate into complex tissue structures containing multiple cell types (Lancaster, 
2014). We increased the cellular complexity of the ERB by culturing it with endometrial 
epithelial cells, to form an epithelialized structure. Epithelialized ERBs may be able to 
recapitulate human endometrium which could be used as a novel in vitro implantation 
model. Immunostaining following ERB re-epithelization showed that epithelial cells 
could line a layer of transformed eMSCs. It is important to achieve glandular formation 
within the ERB structure, which calls for a more complex culture method, to 
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authenticate ERB as an appropriate in vitro implantation model.  Time lapse imaging 
of fluorescent tagged eMSCs and endometrial epithelial cells might shed light on 
spatial orientation and cell sorting within the organoid structure.   
5.3.10 Effect of agitation 
Lancaster and Knoblich (2014a) showed that agitation improved the nutrient and gas 
exchange to the inner core of cerebral organoid. We found that with agitation, the 
structures can be maintained for a shorter period, but this preliminary data is 
inconclusive, as longer time exposure of agitation is required to examine whether it 
has any specific impact on either structure or longevity of the ERB.  
5.3.11 Reepithelization of ERBs 
I aimed to increase the cellular complexity of the ERB, by the addition of human 
endometrial epithelial cells (HEECs) to re-epithelialize the tissue. This was done to 
develop the ERB into an organoid that is capable of recapitulating the human 
endometrium-like structure for the development of a novel implantation model. 
Immuno-staining of co-cultured ERBs shows a layer of epithelial cells lining a mass 
of eMSCs. This is promising for further expanding the cellular complexity of ERBs.   
5.3.12 Functional differentiation of ERBs 
 Finally, I investigated whether the ERBs were capable of recapitulating endometrial 
biological functionality. I decided to decidualise the ERBs as it is indispensable 
implantation. 
The results indicated that ERBs respond to hormonal actions of MPA and cAMP. The 
morphological transformation was like that of previously reported (Gellersen, B., et 
al., 2003). Further, the RT-qPCR confirmed the characteristic changes in gene 
expression for decidualized cells with the induced expression of decidual markers 
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PRL and IGFBP1. Similarly, PR and ER expression represent changes as expected 
during decidualization reactions.  
Following menstruation, eMSCs play a major role in repair and reconstitution of the 
functional layer of the endometrium along with the rapid angiogenesis. Relative 
deficiency in eMSCs population results in perturbed proliferation followed by aberrant 
decidual response leading to implantation related issues. A recent study from our 
group compared eMSCs and eTAs population within the control (N = 28) and recurrent 
miscarriage group (N = 31) and demonstrated that there is about 41% reduction in 
eMSCs in recurrent miscarriage group (Lucas et al., 2015). This shows that deficiency 
of eMSCs might lead to recurrent pregnancy loss.  
In this chapter, I have decided to focus on ePCs, a specific population from which 
eMSCs could be isolated. I have shown perivascular ePCs cells have a unique gene 
signature, and as a result, differ functionally from non-perivascular EnSCs cells. The 
ePCs population is rich in clonogenic cells, or eMSCs have higher propensity to 
prosper under lower oxygen concentrations and have higher angiogenic potential. 
The structures that were identified during an angiogenic assay, ERBs, is first 
endometrial stromal cell structure to be reported. eMSCs have more potential of 
forming ERBs and better tissue organisation when cultured under normal oxygen 
concentration. These structures can be made more complex by coculturing with 
epithelial cells and can be decidualized. Further, complex structural modifications of 
ERBs along with frequent nutrient and hormonal perfusion will facilitate to achieve a 
tailor-made, patient specific novel in vitro embryo implantation model that could be 
used to understand implantation related issues which will eventually aid in developing 
treatments. Three decades ago, the concept of endometrial stem/progenitor cells was 
proposed as a reason for the immense regenerative potential (Prianishnikov, 1978). 
Stem cell self-renewal and differentiation are associated with cell cycle advancement 
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that enables tissue homoeostasis (Pauklin and Vallier, 2014).  Our recent study shows 
that human endometrial stromal cells have a distinct subpopulation of cells ranging 
from eMSCs, eTAs, ePCs, EnSCs, pre-senescent cells and senescent cells 
(unpublished data). The quality of eMSCs defines the nature of the estrogen-mediated 
proliferation, subcellular population and decidualization, leading to the success of 
pregnancy.  
Stem cell properties are defined by the tissue-specific microenvironment (Fuchs et 
al., 2004, Scadden, 2014). The perivascular niche of human endometrium around the 
spiral arterioles consists of quiescent and active eMSCs, transient amplifying cells, 
and adjacent non-stem cells.  
In this study, I demonstrate that there is a difference between ePCs and EnSCs at the 
transcriptomic level, in vitro. The genes that were differentially expressed in ePCs 
population are ANGPT2, CCDC102B, CNTN1, DCLK1, EDIL3, EPHA3, F2RL3, 
GUCY1A2, OLFML2A, PDE1A, POSTN, SELE and SUSD2. These genes are 
involved in various functions such as cell adhesion, cell contraction, metabolic 
processes and response to stimuli.  
I have shown that the contractile capacity of perivascular cells is increased compared 
to that of non-perivascular cells. Contractile properties of these cells provide stability 
and functionality to blood vessels as well as regenerative capacity. (Wanjare et al., 
2013).  
My data also shows that oxygen consumption of ePCs was lower than EnSCs. This 
result is counterintuitive considering ePCs perivascular localisation. In the case of 
HSCs, a revised physoxia niche model of stem cells have been proposed, which 
suggests that the bone marrow cavity exhibits a higher oxygen concentration in 
arteriole-rich endosteal zones. However, the oxygen concentration is low in 
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perisinusoidal and periarteriolar regions,  where the stem cells are proposed to reside 
(Nombela-Arrieta and Silberstein, 2014).  
These results show that perivascular cells are adapted to their niche properties with 
enhanced contractile, adhesive and migratory properties and low oxygen 
consumption to maintain cell number and stemness.  
Next, I characterised eMSCs, a subpopulation of ePCs with colony generating ability. 
The experimental results show that eMSCs and eTAs are enriched when cultured 
under physoxia conditions. Further, eMSCs could express more perivascular niche 
genes when cultured under physoxia. Thus, I report that physoxia condition is more 
supportive of eMSCs mimicking in vivo conditions.  
eMSCs also formed 3D structures that resemble the uterine mucosa when cultured in 
Matrigel. These novel organoids, termed endometrial regenerative bodies (ERBs), 
epithelialize when co-cultured with endometrial epithelial cells and decidualize in 
response to differentiation cues. 
Previous studies have attempted to achieve an in vitro embryo implantation model 
with various coculture methods with simplistic monolayer culture, or with cell inserts 
using immortalised/transfected cells to study implantation of trophoblast cells or 
hatched embryo (Holmberg et al., 2012) (Singh et al., 2010, Zhang et al., 2012) 
(Teklenburg and Macklon, 2009) (Bentin-Ley et al., 1994, Bentin-Ley et al., 1999, 
Bentin-Ley et al., 2000, Lopata et al., 2002) In this study, we are in the early stages 
of the development of a novel, rapidly generated in vitro implantation model.   
Hyperoxia supports the formation of ERBs as this likely recapitulates physiological 
conditions. These ERBs are capable of re-epithelization which means it does not 
require any inserts or coculturing. These structures are capable of decidualizing and 
express decidualization markers that are needed for embryo implantation.  
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ERBs could be a unique new resource to study an array of endometrial disorders 
tailor-made for patients. The results presented in my work show that ERBs could be 
manipulated to recapitulate near in vivo structure. The ultimate aim of the future work 
to develop this model to define mechanisms involved in embryo implantation failure.  
My results show that ERBs express steroid hormone receptors (ESR1 and PGR). This 
raises the possibility of sequential treatment with oestradiol and progesterone leading 
to cyclic gene expression changes. Therefore, this model could be developed to 
investigate cell senescence and uterine natural killer cell infiltration further.  
As this is a model for implantation, once the model is optimised with regard to cellular 
complexity and biological functionality, embryo implantation experiments can begin.  
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Chapter 6  
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6 General discussion 
The human endometrium is considered a dynamic tissue which undergoes complex 
tissue remodelling and regeneration at least 400 times during a women’s reproductive 
life. The endometrium consists of glandular and luminal epithelium within a cellular 
vascular stroma. The stromal cell population has previously been considered to be a 
homogeneous fibroblast cell population. However, in this thesis, I provide evidence 
that it is a combination of stem-, progenitor-, transit amplifying-, pre-senescent-  and 
senescent-cells. (Unpublished work). The balance of these cell types is key in 
maintaining tissue homoeostasis. The ability of the endometrium to continuously 
complete cycles of shedding, regeneration and differentiation is attributable to 
endometrial stem cells which have unique high regeneration potential (Gargett et al., 
2012a), compared to other adult stem cells (Somasundaram, 2016).  Stem cells act 
to replenish tissue in the event of injury or insult. Cyclical menstruation is a 
physiological injury-like event, which is thought to provide a signal activating the stem 
cell niche, thereby recruiting stem cells for regeneration. The stem cell niche in the 
endometrium is localised perivascularly around the spiral arteries. This localisation 
ensures the provision of factors that are necessary for maintaining the number, as 
well as the quiescent nature of the stem cells (Murakami et al., 2014). 
Decidual transformation of the endometrium starts around the spiral arteries. 
Perivascular cells and non-perivascular cells mount a diverse decidual response in 
the endometrial stroma. It is thought that decidualised perivascular cells secrete 
factors establishing a chemokine gradient, attracting trophoblasts for invasion 
(Murakami et al., 2014).   
Decidual transformation of human endometrium equips the endometrium for the 
detection and selection of high-quality embryos and to discard poor quality embryos 
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(Gellersen and Brosens, 2014a). Fetal loss prevents maternal investment in poor 
quality embryos even before placental perfusion (Bielanska et al., 2002). 
Decidualization reprograms the endometrial stromal compartment at transcriptomic, 
proteomic and epigenetic levels. This reprogramming of the endometrium enables it 
to regulate trophoblast invasion, resist inflammatory and oxidative stress and allow 
embryo implantation (Gellersen et al., 2007).  
This thesis has investigated the (i) robustness of clonal eMSCs /TA cell isolation from 
mid-luteal biopsies, (ii)  assessment of the impact of tissue injury (i.e. biopsy) on 
endometrial clonal cell populations in different patient groups, (iii) validation of the link 
between aberrant decidualization and reproductive failure, (iv) In-depth 
characterization of eMSCs / ePCs cells.   
In summary, I provide data showing that: 
(i) Quantification of clonal (eMSCs/TA) cells in mid-luteal biopsies obtained 
in consecutive cycles revealed increased levels in the 2nd biopsy obtained 
from miscarriage, but not infertile patients. 
(ii) In-depth characterization of primary stromal cell cultures before IVF 
treatment showed that disordered temporal changes in the secretome of 
decidualizing cultures are associated with subsequent implantation failure. 
(iii) Characterization of perivascular eMSCs, which drive endometrial 
regeneration, highlighted the unique properties of these cells in terms of 
gene expression, metabolism, and clonogenic and angiogenic potential. 
(iv) eMSCs also formed 3D structures that resemble the uterine mucosa when 
cultured in Matrigel. These novel organoids termed endometrial 
regenerative bodies (ERBs), epithelialize when co-cultured and 
decidualize in response to differentiation cues. 
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6.1 Future directions 
One of the most striking findings of my thesis is the significant increase in endometrial 
clonal cell population following luteal phase biopsy in a subset of women with a history 
of miscarriage. This supports recent findings that endometrial stem cell deficiency and 
heightened cellular senescence are associated with recurrent pregnancy loss (Lucas 
et al., 2015).  Furthermore, a randomised controlled pilot study is now underway at 
University Hospitals Coventry and Warwickshire. In this study, 100 miscarriage 
patients without a history of conception delay are randomised to either mid-luteal 
endometrial biopsy or mock biopsy. The primary study outcome is miscarriage rate of 
pregnancies conceived within three cycles. It is anticipated that the study will be 
completed in late 2017.  
Decidualizing endometrial stromal cells (EnSCs) surround the implanting embryo, but 
their role in implantation failure is poorly understood. Our results show that the 
temporal changes in the secretome of decidualizing EnSCs underpin the transition of 
a hostile to a supportive endometrial microenvironment. In addition to that, the 
perturbation in this transitional decidualization pathway precedes implantation failure. 
Thus, the endometrial defects associated with implantation failure are present before 
ART; it has potential clinical ramifications. It raises the prospect that screening could 
minimise the risk of subsequent treatment failure. 
Amongst the highly enriched perivascular genes, a potential marker could be 
identified for eMSCs. Furthermore, ERBs could represent a unique new resource to 
study an array of endometrial disorders in a patient-specific manner. It could be 
developed into a model to define mechanisms involved in embryo implantation failure 
and to uncover molecular mechanisms that predict and prevent persistent 
reproductive failure. However, multiple further characterizations are required before 
this becomes a potential therapeutic option.   
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Although my work has begun to answer some important questions, it has also raised 
many new questions. If the trauma influences the clonal population, what effect does 
it have on other populations with the endometrium? As an expansion of the clonal 
population following trauma was not observed in infertile patients, does implantation 
failure reflect an imbalance in the various cellular ratios? As I have shown that the 
secretome is a temporal signature of implantation, it would be interesting to determine 
the transcriptomic map of the patient groups from this study, which could potentially 
lead to the expression of an aberrant secretome. Finally, further work with ERB 
formation could potentially reveal differences in patient groups which in turn may 
depend on the quality of the stem cells and niche within these patients.   
In summary, the evidence presented in this thesis demonstrated that dyshomeostasis 
between stromal subpopulations, which may be caused by eMSCs deficiency or 
dysfunction, precedes reproductive failure. 
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Appendix 1. List of primers 
 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
SELE ACC AGC CCA GGT TGA ATG GGT TGG ACA AGG CTG TGC 
POSTN CAC CAA GGT CAC CAAATT CAT TTC CTC ACG GGT GTG TCT C 
ANGPT2 TGC AAA TGT TCA CAA ATG CTA 
A 
AAG TTG GAA GGA CCA CAT GC 
DCLK1 CTC AGG CAA GTC GCC AAG AAG AGA GGG GGC GGT ACA 
F2RL3 GCT GCT GCA TTAC TCG GAC ACG TAG GCA CCA TAG AGG 
TTG 
EPHA3 CTGGATTCAAAAACAATTCAAGG TCCACACCACTGATCTCTTCC 
PDE1A GCATACAGGGACAACAAACAAC TCTCAAGGACAGAGCGATCAT 
GUCY1A2 GAGGACTGCTTCGAGATTGTATC TGGTTCTAATCACAAACGGGGTA 
OLFML2A CACGCCTACGTCCACAAGG TCATAGTGCCTCAACTGCTCA 
CCDC102B TCATGGGCTACAATCTCATGCT CGCAGGCGAAGTTCTTCAC 
CNTN1 TGTTGAGGCTTCCGACAAAGG AATGAGTGGGATGAATTTGCTGA 
EDIL3 AGCATACCGAGGGGATACATT CAAGGCTCAACTTCGCATTCA 
L19 GCGGAAGGGTACAGCCAAT GCAGCCGGCGCAAA 
SUSD2 CTGGATGGACCTGAAAGGAA AGCATGATGGAGACCCTGTC 
PRL AAG CTG TAG AGA TTG AGG 
AGC AAA C 
TCA GGA TGA ACC TGG CTG 
ACT A 
IGFBP1 CGA AGG CTC TCC ATG TCA 
CCA 
GT CTC CTG CCT TGG CTA AAC 
ESR1 CCCACTCAACAGCGTGTCTC CGTCGATTATCTGAATTTGGCCT 
PGR ACCCGCCCTATCTCAACTACC AGGACACCATAATGACAGCCT 
11HSDB1 AGC AAG TTT GCT TTG GAT GG AGA GCT CCC CCT TTG ATG AT 
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Appendix 2. Downregulated genes in ePCs (P < 0.05) 
 
 
Gene 
symbol 
 
Fold change 
(log 2) 
P-value 
WDFY4 
 
4.09 0.0001 
SERPINB2 
 
5.99 0.0005 
GBP5 
 
2.55 0.0005 
CD3D 
 
4.76 0.0006 
CYTIP 
 
5.59 0.0006 
CD84 
 
4.44 0.0012 
SCML4 
 
6.85 0.0013 
CD96 
 
5.42 0.0013 
IL1B 
 
4.97 0.0014 
ITGB7 
 
2.62 0.0022 
LCK 
 
3.71 0.0025 
CXCL9 
 
2.16 0.0029 
HMHA1 
 
3.08 0.0029 
CTLA4 
 
4.19 0.0030 
MSR1 
 
5.47 0.0032 
ICOS 
 
6.37 0.0033 
EMB 
 
4.80 0.0038 
ZNF831 
 
5.10 0.0041 
EREG 
 
3.81 0.0041 
PLEK 
 
4.78 0.0050 
CCL4 
 
5.56 0.0053 
IKZF3 
 
3.18 0.0056 
PIK3R5 
 
6.20 0.0057 
TLR2 
 
2.08 0.0058 
LAT2 
 
3.61 0.0058 
ITK 
 
7.88 0.0061 
CD52 
 
3.88 0.0061 
PTPRC 
 
6.24 0.0061 
IFI30 
 
2.80 0.0062 
VAV3 
 
2.26 0.0063 
CST7 
 
3.98 0.0063 
CD53 
 
2.54 0.0064 
FGD3 
 
4.41 0.0067 
OLR1 
 
5.24 0.0068 
C20orf26 
 
3.08 0.0071 
SELL 
 
4.58 0.0073 
ARRB2 
 
2.56 0.0073 
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SLFN12L 
 
3.78 0.0074 
KLRC2 
 
7.44 0.0075 
ITGAM 
 
3.97 0.0076 
CLEC7A 
 
6.58 0.0077 
CCR5 
 
4.25 0.0078 
NFAM1 
 
5.29 0.0079 
LCP1 
 
2.47 0.0081 
TARP 
 
6.32 0.0082 
CD300E 
 
4.93 0.0084 
P2RY10 
 
5.73 0.0086 
CYFIP2 
 
2.84 0.0087 
KIF21B 
 
2.77 0.0087 
DOCK2 
 
7.18 0.0088 
LAIR1 
 
2.90 0.0090 
SLA2 
 
2.65 0.0090 
BIN2 
 
4.75 0.0094 
CCL3 
 
5.81 0.0094 
CTSS 
 
2.06 0.0095 
IL2RG 
 
5.92 0.0097 
MS4A7 
 
6.10 0.0101 
FASLG 
 
5.26 0.0102 
HLA-DQA1 
 
4.92 0.0103 
LY86 
 
4.35 0.0103 
GATA3 
 
4.39 0.0104 
CXCR4 
 
2.36 0.0105 
FMNL1 
 
2.47 0.0109 
HCAR3 
 
4.52 0.0113 
MYO1G 
 
5.57 0.0113 
FOLR2 
 
7.51 0.0115 
CD3E 
 
7.38 0.0115 
MAP4K1 
 
3.69 0.0118 
HLA-DRA 
 
2.84 0.0119 
CCR1 
 
4.44 0.0120 
FCGR2A 
 
5.95 0.0123 
PIK3CG 
 
2.57 0.0128 
THEMIS 
 
4.40 0.0132 
GPR174 
 
5.95 0.0132 
CD8A 
 
4.77 0.0132 
C1orf162 
 
2.64 0.0135 
GPR183 
 
4.45 0.0136 
EOMES 
 
7.74 0.0141 
GPRIN3 
 
1.92 0.0141 
177 
 
 
 
CD300A 
 
3.09 0.0144 
PIK3AP1 
 
5.29 0.0147 
CD163 
 
8.33 0.0148 
SLA 
 
5.01 0.0148 
DOCK8 
 
2.97 0.0156 
SP140 
 
3.89 0.0156 
ITGAL 
 
5.65 0.0157 
HAVCR2 
 
5.14 0.0157 
HCLS1 
 
2.67 0.0157 
RASSF5 
 
3.54 0.0158 
IGJ 
 
5.79 0.0162 
KLRD1 
 
4.23 0.0164 
SELPLG 
 
3.45 0.0174 
AOAH 
 
3.80 0.0176 
CD244 
 
4.42 0.0177 
LAPTM5 
 
3.85 0.0178 
CD209 
 
4.43 0.0179 
PYHIN1 
 
5.37 0.0179 
NCKAP1L 
 
6.74 0.0183 
SAMSN1 
 
5.59 0.0186 
THEMIS2 
 
2.82 0.0187 
IL21R 
 
4.95 0.0191 
GPR65 
 
5.58 0.0191 
MS4A4A 
 
6.10 0.0192 
PRKCB 
 
5.65 0.0193 
SCN9A 
 
3.95 0.0200 
PTK2B 
 
2.24 0.0200 
CRTAM 
 
5.14 0.0200 
SLAMF7 
 
4.95 0.0202 
SH2D1B 
 
3.12 0.0202 
NCF4 
 
4.94 0.0204 
LCP2 
 
1.66 0.0215 
ARHGAP15 
 
3.45 0.0219 
DTHD1 
 
3.07 0.0225 
PARVG 
 
3.97 0.0225 
MPEG1 
 
4.03 0.0228 
GNG2 
 
2.54 0.0229 
HCAR2 
 
3.56 0.0231 
TAGAP 
 
4.35 0.0232 
ALOX5AP 
 
4.74 0.0232 
CD200R1 
 
5.68 0.0235 
PTGER4 
 
3.49 0.0237 
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TNFSF8 
 
3.10 0.0241 
CD2 
 
5.78 0.0243 
WAS 
 
3.88 0.0243 
SCN3A 
 
3.41 0.0245 
VSIG4 
 
5.94 0.0245 
CD86 
 
6.96 0.0247 
IFNG 
 
5.41 0.0247 
IRF8 
 
1.79 0.0247 
IL10RA 
 
4.87 0.0250 
CLEC5A 
 
3.57 0.0252 
IL18RAP 
 
5.32 0.0253 
SLFN13 
 
2.29 0.0254 
PLCG2 
 
1.87 0.0259 
MYB 
 
2.74 0.0261 
IKZF1 
 
5.41 0.0267 
CD1E 
 
5.46 0.0269 
TYROBP 
 
6.62 0.0271 
GFI1 
 
3.51 0.0274 
KLRC3 
 
4.65 0.0274 
KLRB1 
 
4.99 0.0275 
BCL2A1 
 
2.11 0.0281 
SRGAP3 
 
2.15 0.0284 
PLCB2 
 
3.91 0.0287 
CD14 
 
3.87 0.0288 
CARD11 
 
4.43 0.0290 
CD69 
 
3.28 0.0291 
MS4A1 
 
5.84 0.0293 
CYBB 
 
5.99 0.0302 
AIF1 
 
5.20 0.0303 
NCAM1 
 
3.02 0.0304 
PTPN6 
 
2.21 0.0306 
ATP8B4 
 
2.84 0.0307 
CAPG 
 
2.71 0.0309 
MS4A6A 
 
7.07 0.0313 
GZMK 
 
5.48 0.0322 
RUNX3 
 
6.04 0.0324 
ARHGAP9 
 
3.97 0.0325 
RGS1 
 
6.37 0.0326 
HCK 
 
4.26 0.0335 
KLHL6 
 
3.12 0.0343 
B3GNT7 
 
2.66 0.0343 
PTPN22 
 
4.29 0.0351 
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NKG7 
 
6.09 0.0360 
MYBL1 
 
2.76 0.0362 
GZMB 
 
7.65 0.0363 
FCGR3A 
 
5.66 0.0365 
RAC2 
 
6.18 0.0366 
APOBR 
 
4.73 0.0367 
WDR65 
 
4.35 0.0374 
TESPA1 
 
5.88 0.0376 
 
MRC1 
 
4.01 0.0380 
CLEC12A 
 
5.13 0.0389 
STAT4 
 
3.46 0.0392 
CXCR3 
 
4.92 0.0398 
SORL1 
 
1.81 0.0400 
C3AR1 
 
3.76 0.0402 
XCL1 
 
7.59 0.0408 
BCL11B 
 
5.68 0.0410 
CDHR1 
 
2.84 0.0412 
CYTH4 
 
4.93 0.0415 
HPGDS 
 
5.24 0.0433 
LY9 
 
4.40 0.0434 
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Appendix 3. Upregulated genes in EnSCs (P < 0.05) 
 
Gene symbol                                                    P-value 
RHOH 
 
0.029682 
APOBEC3H 
 
0.034655 
MATK 
 
0.0297 
LST1 
 
0.022994 
SEMA3D 
 
0.003382 
GZMH 
 
0.033204 
SIGLEC10 
 
0.025167 
CD48 
 
0.01013 
SIRPG 
 
0.013398 
KLRC4 
 
0.017714 
CD6 
 
0.023111 
SH2D1A 
 
0.043566 
CD300LB 
 
0.041055 
MS4A2 
 
0.04327 
VAV1 
 
0.001838 
TBX21 
 
0.001865 
ZNF683 
 
0.028305 
LILRB4 
 
0.014437 
ADAMDEC1 
 
0.042495 
CD3G 
 
0.038125 
SLAMF1 
 
0.009059 
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